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The endolysosomal system is a multifunctional system and is involved in catabolism,
antigen presentation and regulation of hormones. The descriptions of, and functions
assigned to organelles within the system are often applied using different criteria. Further,
the properties of the hydrolases within the system, and the organelles that house them are
usually studied in isolation from one another. Considering that the endolysosomal system
may be extremely dynamic, an understanding of the system as an integrated whole is a
necessary first step. Thus, a review of the endolysosomal system was undertaken. It was
determined that the enzymes within the endolysosomal system are probably subject to .
'organelle-dependent' regulation, i.e. the organelles create the appropriate luminal conditions
for these enzymes to work. It is also likely that the effectors of these luminal conditions
are regulated in a manner that is related to GTPase networks that control much of the cell's
functions. The organisation of the endolysosomal system may be hierarchical, with
proteases being downstream effectors of a system that is regulated at the whole body level.
The main endoprotease class within the endolysosomal system are cysteine proteases. A
literature review suggested that these enzymes may not be redox regulated within the
endolysosomal system. However, the lysosomal endoprotease cathepsin B has been
implicated in many pathologies where it is operating in pH and redox conditions different
from the endolysosomal system. To study this, cathepsin B was isolated from bovine
livers using a novel procedure that exploits the ability of tertiary butanol to temporarily
inhibit protease interactions in tissue homogenates. This would prevent artefactual, as well
as protease-inhibitor interactions. This novel procedure resulted in increased yields of
cathepsin B. Cathepsin D, an aspartic protease, was isolated using established methods.
In order to test the hypothesis that cathepsin B may be redox regulated in vivo, cathepsin B
activity and stability were measured in cysteine and/or cystine-containing redox buffers.
Cathepsin B activity in cysteine-containing buffers was similar at pH 6.0 and pH 7.0, over
all thiol concentrations tested. In contrast, the stability of the enzyme was greater at pH
6.0 than at pH 7.0. This suggests that the enzyme's operational pH in vivo may be < pH
7.0. The activity of the enzyme was depressed in glutathione-containing buffers. When
assessed in cysteine:cystine redox buffers (pH 6.0 - 7.0) cathepsin B was active over a
broad redox potential range, suggesting that cathepsin B activity may not be redox regulated.
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The present study of the endolysosomal system was motivated by a number of questions
which had arisen in the course of previous studies in this laboratory, especially concerning
the possible involvement of endolysosomal proteases in invasive cancer. In this, the
enzymes are secreted from the endolysosomal system and operate extracellularly, under
conditions which may be very different in terms of pH, ionic strength and redox potential.
How are the enzymes secreted and could they function under extracellular conditions?
Moreover, immunolabelling studies in this laboratory had shown that ras transformation of
the MCF-lOA immortal-but-not-tumourigenic human breast cancer cell line, into the
tumourigenic MCF-10AneoT cell line, caused a marked change in the distribution of
'lysosomes' in the cell. How was this to be interpreted? Finally, looking ahead, many
studies on the possible therapy of protease-based diseases have aimed at the rational design
of specific inhibitors, targeting the protease active site, and which would thus largely be
competitive inhibitors. Is this a valid approach and could it be applied to endolysosomal
proteases involved in cancer and other diseases?
Early on, a schism in the literature was recognised, between groups who could broadly be
called "biochemists", whose work is based largely on organelle fractionation, and "cell-
biologists", whose work is largely based on microscopy, histochemistry and
immunocytochemistry. The extent of this schism is illustrated by the fact that the two
groups attached completely different meanings to the term 'lysosome', for example.
Clearly some reconciliation between the two bodies of literature was needed. Moreover,
there appeared to be a complete void in the literature concerning the effect of redox
potential on endolysosomal proteases. This was surprising as cysteine proteases
predominate in the endolysosomal system and these enzymes are readily inactivated by
oxidation during isolation. Moreover, there exists a cysteine transporter which pumps
cysteine, an effective reducing agent, into the 'lysosome': what could its purpose be?
It thus came to be realised that a necessary preface to any experimental work aimed at
addressing the questions outlined above, would be a comprehensive review of the
endolysosomal system and its proteases, with a view to establishing what is known about
the system and how endolysosomal proteases operate, both inside and outside of the
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system, and how proteolysis in the system may be regulated. In the event, this review
proved to be a larger task than anticipated. The literature is vast and each paper had to be
carefully interpreted, for example in terms of, "what does this author actually mean when
they use the term 'lysosome'?", and many papers, in effect, needed translating from the
language of biochemistry to that of cell biology and vice versa. Much information also
needed interpretation and integration along the lines of, "how would this enzyme operate in
the conditions created by this organelle system?". In this task the author was perhaps
uniquely placed as this laboratory has solid foundations, and international collaborations, in
protein biochemistry, enzymology and cell biology, including all levels of microscopy and
immunocytochemistry. A holistic consideration of the properties of the enzyme's,
established in vitro, with their operation in the context of the endolysosomal system is th':!s
a feature of the studies reported here.
In the end, the review of the endolysosomal system became as much a work in itself as a
preface to laboratory work. For this reason, it was published as an independent study and,
in the structure of this thesis, it has been given a chapter of its own (Chapter 2). Chapter 3
comprises an omnibus, "Materials and Methods" chapter. The review reported In
Chapter 2 confirmed the void in information pertaining to the effect of redox potential on
endolysosomal proteases and the experimental work reported in this thesis (Chapter 5) is
largely aimed at filling this gap. Before the enzymes could be studied, however, they had to
be isolated and the methods used, including some novel approaches developed in the course
of this study, are reported in Chapter 4. In Chapter 6, a look forward is taken to consider
the possibilities for controlling inappropriate proteolytic activity, in pathologies such as
invasive cancer, either by the use of rationally designed protease inhibitors or by alternative
strategies suggested by the insights provided by this study. Chapter 7 partly comprises a
discussion in which the findings on the effects of redox potential are interpreted in the
context of the endolysosomal system, reviewed earlier. Also reported in Chapter 7 is a
holistic, retrospective, consideration of endolysosomal proteolysis, leading on to the
development of a model describing the operation of endolysosomal proteolysis in the
context of the whole body system.
3
CHAPTER 2
A REVIEW OF ENDOLYSOSOMAL PROTEOLYSIS AND ITS
REGULATION
2.1 Introduction
The principal protein-degrading systems within the cell are the endolysosomal,
proteosome-ubiquitin and calpain systems. In contrast to the ubiquitin and calpain
proteolytic systems, the endolysosomal system carries out non-specific, bulk proteolysis.
The endolysosomal membrane creates a sealed, limited environment that allows for
optimum functioning of its hydrolases, and yet prevents inappropriate autodegradatiori.
The membrane also houses transporters that remove amino acids generated by proteolysis
to the cytoplasm.
Apart from degradation per se, the endolysosomal system is also involved in related
functions such as regulation of signal transduction, antigen presentation, and storage. These
functions are split among the various organelles making up the system, which may be
thought of as distinct, but connected environments. At the most basic level the operation of
the endolysosomal system of all cells types consists of enzymes that are responsible for
degrading substrate that enters the endolysosomal system. The substrate, in turn, must be
channelled to the enzymes. Both the enzyme and substrate are maintained in (separate)
sealed compartments prior to proteolysis. These sealed environments must be capable of
meeting, with creation of an environment that allows for optimal degradation of the
substrate. As shown in Fig. 2.1, there exists the possibility of regulation at five points: i) at
the point of acquisition of substrate by the endolysosomal system, ii) at the meeting of
enzyme (E) and substrate (S) by fusion of their respective compartments, iii) at the
establishment of conditions supporting proteolysis (or not) within the (fused) organelle
and, possibly (iv) at the point of egress of product from the system. Point (v) represents
the possibility of an enzyme being retained in a lysosome for a greater or lesser period
(perhaps in an inactive form, but in any event separate from substrate). In terms of flux
through the system, regulation at (i) and (ii) could be called 'upstream regulation' while
regulation at (iii), (iv) and (v) could be termed 'downstream regulation'.
4
p
Figure 2.1. A schematic representation of the endolysosomal system,
showing possible points at which regulation may be effected. The different
colours indicate that the compartments shown may have different intra-
luminal conditions, especially pH. (i)-(v) are possible points of regulation
of the system.
Regulation of substrate acquisition into the endolysosomal system, and of organelle
fusion/budding events (steps i and ii, Fig. 2.1) is effected by several signalling networks
(reviewed by Guallier et al., 1999; Matozaki et al., 2000; Qualmann et al., 2000; Sechi and
Wehlan., 2000; Clague and Urbe, 2001; Di Fiore and De Camilli, 2001; May and Machesky,
2001; Stenmark and Olkkonen, 2001; Miaczynska and Zerial, 2002). The signalling
networks may include small G-proteins and their signalling cascades, the actin network,
and/or phosphatidylinositol 3-phosphate and associated kinases (Guallier et al., 1999;
Matozaki et al., 2000; Qualmann et al., 2000; Sechi et al., 2000; Clague and Urbe, 2001; Di
Fiore and De Camilli, 2001; May and Machesky, 2001; Stenmark et al., 2001; Miaczynska
and Zerial, 2002). These signalling networks interact with the endolysosomal system
through interface molecules that are part of both endocytosis and the signalling networks
(Matozaki et al., 2000; Clague and Urbe, 2001; Di Fiore and De Camilli, 2001). This review
will focus largely on possible regulatory mechanisms operating at points (iii) and (v), i.e. on
factors which may affect the activity of the enzymes per se. Observations by Kominami et
al. (1983) of the large accumulation of hepatic autophagic vacuoles containing undigested
material, after treatment of rats with leupeptin in vivo, suggests that there may be no
feedback regulation of the endolysosomal proteolysis system (e.g. from step (iv) to steps
(i), (ii) or (iii), Fig. 2.1).
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2.2 Organisation of the endolysosomal pathway
The basic organisation of the endolysosomal pathway in a mammalian epithelial cell is
depicted in Fig. 2.2, though details may vary with cell type. Currently, there are two
models to explain how the organelles within the endolysosomal pathway are related to each
other (Murphy, 1991; Griffiths, 1996). While the two theories differ on the temporal
organisation of the pathway, the spatial and functional aspects are very similar.
The 'maturation model' suggests that each organelle along the endocytic pathway 1S a
transient, but distinct, compartment that matures into the next organelle along the pathway.
In this model, the early endosome is envisioned as being formed de novo by the fusion of
uncoated primary endosomes derived from the plasma membrane. This transient
compartment then matures into a transient late endosome, which in turn matures into a
lysosome, the terminal organelle (Murphy, 1991). Each maturation stage has its own
unique set of biochemical markers associated with it. These markers and membrane
components are recycled by carrier vesicles during maturation (Murphy, 1991). In a related
model, proposed by Thilo et at. (1995), maturation occurs from the primary endosome until
a pre-lysosomal compartment is formed. This compartment then communicates with the
lysosome through vesicular traffic.
In the 'pre-existing compartment model', the early and late endosomes'are considered to be
stable, specialised compartments linked by vesicular traffic (Griffiths, 1996). The early and
late endosomes are regarded as 'compartments', which are stable and do not undergo
maturation, but are capable of homotypic fusion. 'Vesicles', unlike compartments, were
considered incapable of homotypic fusion. Compartments are considered to be more


















Figure 2.2. Schematic representation of the endolysosomal system. The
major organelIes of the endosomal system, the early endosome, late
endosome and lysosome are shown. Solid arrows between these organelles
may represent vesicular traffic, maturation, or direct fusion. Additional
components of the endolysosomal system, i.e. phagosomes and autophagic
vesicles, are not shown in this simplified diagram..
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The first organelle along the endolysosomal pathway, the early endosome (Fig. 2.2), is a
major sorting station. Based on the recycling behaviour of ligand-receptor complexes, the
early endosome population may be subdivided into at least two sub-populations, the
sorting and recycling endosomes (Ghosh et aI., 1994). The luminal pH within the sorting
endosome is between pH 6.3-6.5, and is generated by an H+-ATPase and regulated
electrogenically by a Na+, K+-ATPase (Fuchs et aI., 1989; Cain et aI., 1989). At this
slightly acidic pH, ligands like low density lipoprotein (LDL) and <xrmacroglobulin (<X2M ),
dissociate from their cognate receptors. The receptors are recycled to the plasma
membrane, whilst their ligands, LDL and <X2M, are trafficked to the late endosome (reviewed
by Mellman, 1992). Some receptors, like the transferrin (Tfn) receptor can be recycled to
the plasma membrane directly from the sorting endosome (fast cycle), or directed to the
recycling endosome and then to the plasma membrane (slow cycle) (Sakai et al., 1998). The
recycling endosome may also play a role in directing receptors to the leading edge of
migrating cells (Sakai et aI., 1998).
The next stage on the endolysosomal pathway is the endosome carrier vesicle (BCY) or
multivesicular body (MVB) (Fig. 2.2). ECVs appear to be large (004-0.7 ~m), usually
spherical vesicles, often with a membrane enriched luminal content (reviewed by Griffiths,
1996; Gruenberg et aI., 1989; Aniento et aI., 1993) and are responsible for transferring
material from early to late endosomes (Griffiths, 1996). Formation of ECVs is dependent
on the acidification of their luminal interior and can be blocked by the vacuolar ATPase (V-
ATPase) inhibitor, bafilomycin Al (Clague et aI., 1994). Indeed, the luminal pH of the ECV
drops from that of the early endosome to pH 5.0-5.5 (Killisch et al., 1992). Endocytosed
material may not always be transferred to late endosomes via the Eey. In the mouse
macrophage cell line 1774, early and late endosomes are capable of fusing directly with each
other (Jahraus et al., 1998). This suggests that certain cell types may have specialised
endocytic fusion machinery depending on their function.
Distal to the endosome carrier vesicle is the late endosome (sometimes called the pre-
lysosomal compartment) followed by the lysosome. A modern definition of a lysosome is
that it is, "the terminal organelle on the endocytic pathway and is devoid of recycling
receptors" (Griffiths, 1996). Complicating the field of endolysosomal proteolysis is the
fact that not all authors make a distinction between the late endosome and the lysosome. In
the original papers of de Duve et al. (see de Duve, 1983), 'lysosomes' were defined on the
8
basis of two criteria; the existence of a limiting membrane and the presence within the
organelle of acid hydrolases. Thus to many authors, lysosomes are any organe1les
containing acid hydrolases, i.e. 'lysosomal' enzymes!. However, from a modem
perspective, this definition encompasses early and late endosomes, lysosomes, phagosomes
and autophagosomes. Recently it has been found that not all 'lysosomal' enzymes have an
acidic pH optimum (Butor et ai., 1995; Dehrmann et ai., 1996), and that not all late
endosomes/lysosomes are acidic (Butor et al., 1995).
Both late endosomes and lysosomes contain 'lysosomal' hydrolases and lysosome
associated membrane proteins (LAMPs) (Griffiths, 1996) and both are enriched in
Iysobisphosphatidic acid (Clague, 1998). Lysobisphosphatidic acid is a phospholipid
found in high concentrations on the internal membranes of late endosomes where it may
play an important role in the degradation of glycolipids, and transport of membrane
proteins and lipids (Gruenberg, 2001). Under certain conditions the two organe1les may
also have similar distributions in density gradients. However, there are differences, e.g.
mannose 6-phosphate receptors (MPRs), and the regulatory (RH) domain of the cAMP-
dependent protein kinase, are found on late endosomes but not lysosomes (Griffiths, 1996)
but, to date, no specific marker has been described for lysosomes. Their ultrastructural
morphologies are also different. Late endosomes have a complex morphology (Griffiths,
1996) organised by microtubules (Meresse et aI., 1995). In sections, they often have a
multivesicular appearance, with intraluminal membrane whorls (see e.g. Tjelle et aI., 1996;
Bright et aI., 1997). By contrast, lysosomes appear as roughly spherical, electron dense
organe1les with a simpler organisation (Griffiths, 1996; Bright et aI., 1997). Based on their
relatively simple ultrastructure, and their markers, lysosomes may be closer to 'vesicles'
than to 'compartments' (Griffiths, 1996). A significant difference between lysosomes and
other 'vesicles', though, is their capacity to undergo homotypic fusion (Ward et aI., 1997).
1 In referring to 'lysosomal' hydrolases here, the term 'lysosomal' is put in quotation marks
because some of these enzymes are, in fact, not limited to lysosomes but are found
throughout the endolysosomal system.
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Late endosomes and lysosomes are apparently in dynamic equilibrium. Fluid phase
markers, like BSA-gold, are distributed between the late endosome and lysosome after
extended chase periods (Griffiths, 1996). Their concentrations of LAMPs are
approximately equal, suggesting that their membranes are also in equilibrium. The
mechanisms involved in establishing equilibrium may include vesicular transport (Berg et a!.,
1995), "kiss and run" events (Storrie and Desjardins, 1996) or direct fusion (reviewed by
Luzio et aI., 2000) and may vary with cell type. Despite their close association, late
endosomes and lysosomes have distinct functional differences. Although containing only
20% of the total hydrolase pool, late endosomes are the main site for proteolysis (Tjelle et
aI., 1996; Bright et al., 1997). By contrast, lysosomes contain the bulk of the 'lysosomal'
hydrolase pool but only ca. 20% of total proteolysis takes place in lysosomes. .It has
consequently been suggested that lysosomes may act as storage organelles for these
hydrolases (Griffiths, 1996; Tjelle et a!., 1996).
Fusion of late endosomes and lysosomes produces a hybrid organelle with properties of
both (Luzio, 2000). Bafilomycin Al did not decrease late endosome-lysosome fusion
suggesting that acidification was not a requirement for hybrid formation (Mullock et aI.,
1998). However, lysosome recondensation from the hybrid organelle was dependent on a
functional V-ATPase (Pryor et al., 2000). A further requirement for hybrid organelle
formation was the presence of intra-organellar calcium and calmodulin. Intra-organellar
calcium is also required for fusion and recondensation of lysosomes to and from the hybrid
organelle (pryor et a!., 2000).
Although the lysosome is the terminal organelle of the endolysosomal system, lysosomes
should not be viewed as dead-end organelles as 'secretory lysosomes' may be a feature of
many normal cells (Andrews, 2000). An increase in intracellular Ca2+ levels typically
results in secretion of about 5-15% (rising to 60% in hematopoietic cells) of the total
content of lysosomes. A rise in Ca2+ levels causes lysosomal membranes to fuse with the
cell membrane resulting in exocytosis of the lysosomal contents (Andrews, 2000). The
process is thought to be regulated by synaptotagmin VII (Martinez, et al., 2000) and may
constitute a mechanism for the repair of damaged plasma membrane (Reddy et al., 2001).
Mechanisms for the secretion of 'lysosomal' proteases are clearly of interest in the context
of cancer, where these enzymes have been purported to play an extracellular role. Many
cells of hematopoietic origin are capable of exocytosing multivesicular bodies (late
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endosomes/lysosomes) containing internal vesicles called exosomes. These exosomes may
be involved in multiple functions including T-lymphocyte stimulation (reviewed by Denzer
et al., 2000).
2.3 Rab proteins direct membrane fusion event within the cell.
Membrane fusion events between the various organelles within the endolysosomal system
are highly regulated within a cell. As described in Fig 2.1 (step (ii)) the dynamics of these
fusion events may contribute to the regulation of proteolysis within the cell. The details of
these regulatory events have been reviewed extensively elsewhere (Ferro-Novick and Jahn,
1994; Schimmoller et al., 1998; Valentijn and Jamieson, 1998; Gerst, ~999; Gonzalez and
Scheller, 1999; Rodman and Wandinger-Ness, 2000).
In order for two membranes to fuse, at least two criteria have to be met. Firstly, the
membrane fusion event must be specific. This ensures that movement along the
endolysosomal pathway is vectorial. Secondly, the electrostatic force generated by two
membranes in close proximity to each other must be overcome. The specificity of
membrane fusion events is largely directed and regulated by Rab proteins (Schimmoller et
al., 1998; Rodman and Wandinger-Ness, 2000). Rab proteins belong to the Ras superfamily
of small GTPases. They are highly conserved and are ubiquitously distributed throughout
eukaryotic cells. Approximately 40 Rab isoforms have been described and these confer
specificity to the distinct intracellular transport routes within the cell (Valentijn and
Jamieson, 1998; Rodman and Wandinger-Ness, 2000).
Unique structural elements on individual Rab proteins allow them to recognise and be
localised to their target membranes. Most Rabs are geranylgeranylated, enabling membrane
association. However, Rab proteins will only associate with their target membranes in the
GTP-bound conformations. GTP hydrolysis leads to inactivation of the Rab protein and
subsequent loss of membrane association (Schimmoller et al., 1998). This Rab GTP/GDP
cycle is affected and regulated by several proteins such as GDP dissociation inhibitor
(GDI), GTPase activating protein (GAP), mammalian suppresser of sec4 (Mss4) and GDI
displacement factor (GDF) (Valentijn and Jamieson, 1998). These proteins are in turn
regulated by signalling networks (Matozaki et al., 2000). Thus, the fusion between
substrate- and protease- containing organelIes may be integrated with signalling networks.
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These, networks, as will be described later, may also influence the luminal endolysosomal
environment.
Rabs may play a role in the regulation of membrane budding and cargo selection into the
vesicles. Rab effectors may connect a vesicle to the cytoskeleton, and thus play a role in
vesicle movement. Rabs and their effectors have also been shown to interact directly with
the actin network and may affect motor protein activity of vesicles on microtubules.
Further, Rab effector proteins could act as molecular tethers, regulating vesicle docking with
a target membrane (reviewed by Rodman and Wandinger-Ness, 2000). Recent evidence,
however, suggests that Rab proteins may exert their action on the acceptor membrane (i.e.
the membrane receiving the vesicle) rather than on the donor/vesicle membrane for COP-II
vesicles involved in ER to Golgi transport (Cao and Barlow, 2000). Whether this IS a
general feature of membrane docking-fusion reactions remains to be determined.
Rab proteins may also activate the SNARE (soluble N-ethymaleimide sensitive factor
receptor) fusion machinery. Thus, Rab proteins are central regulators in membrane fusion
events within the cell. The SNARE fusion machinery is the mimimal requirement for fusion
between two membranes (Weber et al., 1998). There are two distinct groups of SNARE
proteins, v-SNARES and t-SNARES, based on their membrane association. SNARE
complexes are formed by the interaction of vesicle- or v-SNARES, with a cognate target- or
t-SNARE on the target membrane. In order to prevent inappropriate fusion reactions, the
SNARE proteins are probably protected by other factors such as Sec 1p (Schimm6ller
et al., 1998). Deprotection of the SNARE proteins is undertaken by Rabs or Rab effectors.
The cytosolic v- and t- SNARE domains are believed to associate with each other in a coiled
coil structure or a closely related helical bundle structure. This association is energetically
favoured and may provide some of the energy that helps drive fusion between the two
membranes (Gerst, 1999). Dissociation of the SNARE complex is undertaken by NSF and
ATP (Gerst, 1999).
Finally, Rab proteins also undergo an apparently futile cycle of GTP hydrolysis that is not
associated with vectorial membrane fusion. This allows Rabs to act as timers for membrane
fusion events, affecting the kinetics of these events, as well as the size and shape of
organelles (Rybin et al., 1996). This is an important property of these molecules, as it
suggests a mechanism by which proteolysis could be regulated within the endolysosomal
system. Rab proteins, which are localised to specific membranes, and intrinsically have the
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ability to regulate rates of membrane fusion, may thus regulate the fusion events between
substrate- and protease- containing organelles (step (ii), Fig. 2.1). Rab proteins, and their
appropriate effectors, together with the appropriate signalling networks may play a integral
role in regulating and co-ordinating proteolysis within the endolysosomal system.
2.4 Delivery of substrates into the endolysosomal system
Substrates destined for degradation can enter the endolysosomal proteolytic environment
by three broad mechanisms: endocytosis, autophagy, and phagocytosis. These processes
all result in environments which support proteolysis by a common set of lysosomal
hydrolases. These environments are reviewed below with the aim of finding common
luminal features that may provide insight into the regulation of endolysosomal proteolysis.
2.4.1 Endocytosis
Endocytosis can be divided into three distinct mechanisms: receptor mediated endocytosis,
constitutive endocytosis and caveoli formation. Ligand-receptor complexes entering the
endolysosomal system can be sorted into one of three pathways, i) the entire ligand-
receptor complex may be recycled back to the plasma membrane, ii) the ligand-receptor
complex may dissociate, with the receptor being recycled and the ligand directed further
along the pathway; or iii) the entire ligand-receptor complex may be targeted to the later
stages of the pathway (see Wamock, 1999 and references therein). This sorting process
thus occurs within the early or late endosomes.
In contrast to receptor mediated endocytosis, substrates entering the pathway by fluid
phase endocytosis are constitutively directed to further stages along the endolysosomal
pathway. Pulse-chasing fluid phase markers, such as horseradish peroxidase and BSA-gold,
into a cell first labels early endosomes (5 min), and with longer chase times (> 30 min) the
later endosome populations become labelled (see for example Aniento et aI., 1993;
Rabinowitz et aI., 1992).
2.4.2 Autophagy.
There are three distinct autophagic mechanisms: macroautophagy, microautophagy, and
import of cytosolic polypeptides into the endolysosomal system. Autophagy is
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responsible for the destruction of most endogenous proteins, the removal of obsolete and/or
damaged organelles, cellular remodelling during differentiation, metamorphosis and ageing
(Seglen and Bohley, 1992; Blommaart et aI., 1997). In vitro it may be activated by serum
withdrawal or when amino acids are limiting. The regulation of autophagy has been
reviewed by Blommaart et al. (1997).
Macroautophagy occurs when entire regions of the cytoplasm are sequestered by a
membrane and degraded. This process occurs in at least three distinct stages that are
characterised by morphological and biochemical changes to the sequestered cytosol. These
stages from sequestration to degradation occur rapidly, with a half-life of approximately
9 min (Pfeifer et aI., 1978). The first stage is referred to as sequestration, and is
characterised by the formation de novo of an organelle referred to as a nascent autophagic
vesicle (AVi) or the phagophore. A consistent terminology to describe the various stages of
autophagy has not yet emerged, and the terminology of Dunn (1990a,b) will be used here.
The signals responsible for the sequestration step are not known but may involve G-
proteins (Ogier-Denis et aI., 1995; 1996; Petiot et aI., 1999), or perhaps protein conjugation
(see Mizushima et al., 1998 and Kirisako et aI., 1999 and references therein).
The source of the sequestering membrane is a matter of dispute but it may originate from
the rough endoplasmic reticulum (Dunn, 1990a) or the post-Golgi region (Yamamoto et aI.,
1990a,b). AVis have a distinctive structure with membrane structures and entire organelles
engulfed by the forming AVi (see for example Fig. 1 in Lawrence and Brown, 1992). The
AVi does not have lysosomal hydrolases or LAMPs associated with it (Dunn, 1990b;
Tooze et aI., 1990; Rabouille et a!., 1993). It is therefore presumed that the AVi is not
involved in proteolytic degradation of the engulfed cytoplasm.
The AVi apparently undergoes biochemical and morphological changes (maturation),
acquiring lysosomal membrane proteins (like LAMPs) and hydrolases that subsequently
allow it to degrade the sequestered substrate (Dunn, 1990b; Tooze et aI., 1990; Rabouille et
a!., 1993). The AVi also develops an acidic luminal interior (Dunn, 1990b; Stmmhaug and
Seglen, 1993) and becomes capable of proteolysis. The fully matured vesicle is called an
AVd (Dunn, 1990a,b). In contrast to the AVi, the AVd usually has a single membrane, the
other membrane structures presumably having been degraded or recycled.
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The mechanism of AVd formation from the AVi has not been resolved. The AVi may fuse
directly with lysosomes, rapidly converting it to an AVd (Lawrence and Brown, 1992).
Alternatively, Tooze et al. (1990) showed that the endocytic and autophagic pathways
converge after the AVi and early endosome stages, respectively, resulting in formation of
amphisomes. In either case, the AVd acquires its lysosomal hydrolases from the
endolysosomal system.
2.4.3 Phagocytosis
Although a number of cell types are capable of phagocytosis, the most important
professional phagocytes are neutrophils and mononuclear phagocytes (van Oss, 198~).
This discussion will be limited to macrophages. Macrophages have a complement of
cysteine-endoproteases similar to that of most epithelial cells. Presumably the components
necessary for a fully functional proteolytic system are the same, or very similar, in both cell
types. A notable exception is that macrophages contain the powerful cysteine
endoprotease, cathepsin S (Kirschke et al., 1998).
Phagocytosed particles are usually in the size range of 0.3-0.5~ or larger. Their adhesion
to the macrophage surface may depend on a number of forces: van der Waals-,
hydrophobic-, electrostatic- or receptor-mediated interactions (van Oss, 1986). The
adhesion of a particle to the membrane surface triggers a cascade of signalling events
(reviewed by Kwiatkowska and Sobota, 1999) leading to the formation of a phagosome.
Initially, the phagosome lumen resembles the extracellular environment but the phagosome
soon undergoes a series of biochemical changes (maturation), accompanied by changes to the
lumen environment. This process is Rab-dependent and involves fusion of the developing
phagosome with endocytic organelles (Mayorga et aI., 1991; Pitt et aI., 1992; Desjardins
et aI., 1994; Iahraus etal., 1998). The changes to the phagosome include: V-ATPase-
dependent acidification, and acquisition of Rabs, LAMPs and lysosomal hydrolases
(Mellman et aI., 1986; Claus et aI., 1998). Some phagocytosed pathogens escape
destruction by disturbing the maturation process. For example phagosomes which ingest
Mycobacterium avium cells fail to acidify (Sturgill-Kozycki et aI., 1994) and those ingesting
Mycobacterium bovis cells fail to incorporate Rab 7 (Via et al., 1997) and consequently do
not participate in late endocytic fusion events (Via et aI., 1997; Jahraus et aI., 1998). Thus,
the pathogen escapes destruction by the hydrolases found in late endosomes/lysosomes.
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The above discussions on endocytosis, autophagy, and phagocytosis are not intended to be
exhaustive, but merely to describe how substrate enters the endolysosomal system, and
what the requirements are for generating a proteolytic environment. The luminal
requirements are summarised in Table 2.1, and are discussed in greater detail below.
Table 2.1 Common luminal features of proteolytic organelles of the endolysosomal system.
OrganelIe Hydrolase LAMP MPR V- Luminal Cysteine References
ATPase Ca2+ transporter
early + + + + ? Claus et of. (1998);
endosome Griffiths (1996); MelIman
cathepsin et of. (1986)
H
late + + + + + ? Griffiths (1996); Hasilik
endosome (1992); Mellman et al.
(1986); Pryor et al.
(2000)
lysosome + + + + + Griffiths (1996), Hasilik
(1992); Mellman et al.
(1986); Pryor et of.
(2000)
hybrid + + + ? + ? Bright et al. (1997);
organelle Luzio et of. (2000); Pryor
et al. (2000)
autophagic + + + + ? DUIlI1, (1990b); Lawrence
vacuole and Brown, (1992);
(AVd) Rabouille et al. (1993);
Tooze et al. (1990)
phagosome + + + ? ? Claus et al., (1998);
Griffiths (1996); Jahraus
et al. (1998); Mellman et
al. (1986); Dunn, 1990b;
Tooze et of. (1990);
Rabouille et of. (1993)
2.5 Common features of endolysosomal lumen proteolytic environments.
2.5.1 The enzymes
Most of the soluble endolysosomal hydrolases are synthesised as preproenzymes (Hasilik,
1992). The signal peptide is cleaved co-translationally and the hydrolases fold into their
precursor form within the ER lumen. These precursors undergo Asn-linked glycosylation
and carbohydrate processing, which continues in the Golgi. Within the Golgi, two
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enzymes, N-acetylglucosaminylphosphotransferase and a-N-acetyl-glucosaminidase, add a
mannose-6-phosphate label (Kornfeld, 1986; Hasilik, 1992). The labelled precursors thus
become ligands for the membrane bound MPRs which direct them to the endolysosomal
system (reviewed by Komfeld, 1986 and Hasilik, 1992). Glycosylation may also serve to
protect the hydrolases themselves from destruction within the endolysosomal system
(Bohley and Seglen, 1992).
There are over 50 'lysosomal' hydrolases, and some of these enzymes show no sequence
homology to each other. Their recognition by the phosphotransferase therefore involves
common tertiary structural features (Tikkanen et aI., 1997; Cuozzo et al., 1998; Lukong
et aI., 1999). There are two MPRs; the 275 kDa cation-independent MPR (ci-MPR) and
the 46 kDa cation-dependent MPR (cd-MPR) (Komfeld, 1986). These receptors have
different affinities for the soluble precursors depending on their carbohydrate structure
(Ludwig et al., 1995). Together, these two receptors are able to efficiently sort the diverse
array of soluble precursors for targeting to the endolysosomal system. Evidence also exists
for MPR-independent targeting mechanisms (Hasilik, 1992). Within the endolysosomal
system, proteolytic removal of a pro-piece serves to generate the mature, active enzyme.
The endolysosomal protease pool may be divided into endo- and exopeptidase pools The
endoprotease pool (Table 2.2) is made up mainly of cysteine and aspartic proteases, whilst
the exopeptidase pool is made up of cysteine and serine proteases. Serine proteases, which
are the most numerous and diverse hydrolase class in nature, are notably absent from the
endoproteolytic pool. The serine protease, cathepsin G, is found exclusively in
hematopoietic cells, and is not a true endolysosomal enzyme (Table 2.2).
It is presumed that the rate-limiting steps in substrate hydrolysis are effected by
endoproteases. Thus, the present discussion will focus on these enzymes, most of which
belong to the Cl family of cysteine proteases (Table 2.2). The C1 family ,all show a
common fold with the archetypal protease of this family, papain. These enzymes are bi-
lobular with left (L) and right (R) domains. These domains are highly conserved and all
members show common secondary structure elements in their respective domains. Indeed,
differences between these proteases are usually due to deletions or insertions in the loop
regions between the conserved structural elements that make up the papain fold (Kirschke
et aI., 1998).
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Table 2.2 Endoproteases found within the endolysosomal system.
Name Catalytic group M r (kDa) Operating pH pI Distribution
Cathepsin B Cys 27 5-6.5 5.4 ubiquitous
Cathepsin D Asp 42 2.8-5.0 5.5-6.5 ubiquitous
Cathepsin E Asp 100 2.5 4.1-4.4 ?
Cathepsin G Ser 30 7.5 10 PMNLs
Cathepsin H Cys 28 5.0-6.5 7.1 ubiquitous·
Cathepsin L Cys 29 4.5-6.0 5.8-6.1 ubiquitous
Cathepsin N Cys 34 3.5 6.2 ubiquitous
Catl1epsin S Cys 24 5.0-7.5 6.3-6.9 ?
Cathepsin T Cys 34 6.9 ? ?
Cathepsin K Cys 27-29 6.0-6.5 ? osteoclasts
Legumain Cys 31 4-6 ? ubiquitous
The active site is in a deep cleft between the Land R domains. The active site cysteine,
Cys 25 (papain numbering), and histidine, His 159 (papain numbering), form a thiolate-
imidazolium ion-pair that is responsible for catalysis. Other highly conserved residues are
an asparagine (Asn 175), which is believed to orientate the imidazolium ring, and glutamine
(Gin 19) which is part of the oxyanion hole. Substrate binds into the active site in an
extended conformation and the carbonyl carbon of the scissile bond undergoes nucleophilic
attack from the active site thiol. This results in the release of the amine product. The
resultant acyl-enzyme reacts with water to release the carboxyl product (deacylation),
resulting in the regeneration of the free enzyme. A detailed description of the catalytic
mechanism is provided by Storer and Menard (1994).
Why has this family of proteases been selected in preference to other proteases types?
Perhaps uniquely, these enzymes have the following features that make them well-suited to
the endolysosomal system:
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• The nascent enzymes must be capable of being recognised by the phosphotransferase
system within the ER. This recognises structural features, and not a linear sequence
(Tikkanen et aI., 1997; Cuozzo et a/., 1998; Lukong et aI., 1999). This may thus place
limits on the hydrolases that could be accommodated within the system. Gene
duplication would have been a proficient mechanism for ensuring that variants of these
unique enzymes would be present within the endolysosomal system.
• The lysosomal cysteine proteases are required to cleave a wide variety of substrates.
Thus the active sites of these enzymes may not be optimised for a specific substrate.
However, the catalytic mechanism of this class of cysteine peptidases is very efficient
when compared to the catalytic mechanism employed by serine proteases, for example




The luminal conditions of pH and redox potential within the late endolysosomal system
are designed to denature substrates, allowing for increased hydrolytic efficiency. These
conditions may be in a constant state of flux, allowing many different hydrolase classes
to operate within the system. The cysteine proteases must be stable to these
denaturing conditions, and in addition, must be capable of operating over a broad pH
range. The enzymes themselves also have to be fairly resistant to proteolysis. The ion
pair of the papain superfamily appears to be active over a wide pH range (Storer and
Menard, 1994), a requirement that cannot be met by any of the other proteolytic
classes. This would allow these enzymes to operate in the dynamic endolysosomal
proteolytic environment (Butor et aI., 1995). However, in contrast to the other
members of the papain superfamily the lysosomal enzymes tend to be unstable at
neutral to alkaline pH values (Kirschke et al., 1998). This may protect the cell against
these enzymes. The enzymes themselves appear to be stable to the denaturing
conditions within the endolysosomal system, and have half-lives that run from days to
weeks (Bohley and Seglen, 1992).
Some of the cysteine proteases are restricted to specific organelles. For example,
cathepsin H appears to be restricted to the early endosome in 1774 macrophages (Claus
et aI., 1998). This suggests that this enzyme must have features that restrict it to a
specific organelle, at least in this cell type.
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• Finally, endolysosomal proteinases may be capable ofregulation without the need for
inhibitors. There is no evidence of intra-endolysosomal inhibitors, and yet proteolysis
may be shut-down in (storage) lysosomes. This suggests that these enzymes have
properties that allow them to be regulated within the endolysosomal system.
Thus, quite apart from being efficient hydrolases, these enzymes appear to fulfil a number
of requirements that allow them to operate within the endolysosomal environment. Of
these additional requirements, the ability to be regulated, without the need for intra-
endolysosomal inhibitors, may be amongst the most significant.
Cathepsin D is an aspartic endoprotease found within the endolysosomal system. Unlike
its cysteine protease counterparts, this enzyme is capable of operating at very acidic pHs.
Thus cathepsin D could effect proteolysis at pHs where the cysteine proteases may be
inactivated by oxidation or protonation of the active site thiol.
The enzyme cathepsin B, whch was the focus of this investigation, will be discussed in
greater detail in Chapter 4.
2.5.2 LAMPs
LAMPs are the major protein constituents of late endolysosomal membranes, which is
consistent with a putative role in protecting these membranes from hydrolysis and thus
preventing leakage of the hydrolases into the cytoplasm. The phagosome, the AVd, the late
endosome and the lysosome are all enriched in LAMP proteins. LAMPs are ubiquitously
distributed throughout mammalian cells, and make up as much as 50% of the total protein
found on 'lysosomal' membranes. LAMP-1 and LAMP-2 are evolutionarily related: both
are type I membrane proteins, with a short cytoplasmic tail, a transmembrane region and a
large luminal domain. The short (10-11 residue) cytoplasmic tail contains targeting
information directing the LAMPs to the late endosome/lysosome (reviewed in Peters and
von Figura, 1994). Proteolytic processing of this tail probably ensures that the protein is
retained by these organelles (Guamier et aI., 1993). Although LAMPs and MPRs are
directed to the same organelles, they use different targeting machinery (Karlsson and
Carlsson, 1998).
The large luminal domain of the LAMPs has a high carbohydrate content with 16-20 N-
linked-glycosylation sites as well as O-linked-glycosylation sites. The luminal domain of
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these proteins also has a Pro-rich hinge region and 4 contiguous disulfide bridges (peters and
von Figura, 1994). The high sialic acid content of their carbohydrate moieties contributes to
their low pI, which may be of functional significance. LAMPs may participate in
aggregation of the soluble lysosomal contents (Jadot et aI., 1997). This could be due to the
low pI of the LAMPs, allowing these proteins to behave as cation-exchangers. This
putative regulatory mechanism will be discussed in greater detail below. When expressed on
the cell surface, LAMPs may also play a role in cell adhesion processes (Silverstein and
Febbraio, 1992).
LAMP-1 (Andrej ewski et al., 1999) and LAMP-2 (Tanaka et aI., 2000) deficient mice have
recently been generated. The LAMP-1 deficient mice were viable and fertile, and had
lysosomes that had similar properties to control lysosomes. The loss of LAMP-1
appeared to be compensated by increased expression of LAMP-2 (Andrejewski et aI.,
1999). LAMP-2 mutants, on the otherhand, showed increased mortality when compared to
control mice, and showed an extensive accumulation of AVis. This data suggests that
LAMP-2 is necessary for maturation of the AVi to the AVd (Tanaka et aI., 2000). The
LAMP~l and LAMP-2 double mutation is lethal (Andrejewski et al., 1999).
2.5.3 The cysteine transporter
The primary function of endolysosomal proteolysis is to degrade macromolecules for
recycling into anabolic reactions. Egress of the products of proteolysis from this sealed
environment is largely undertaken by transporters, which have been described for
carbohydrate monomers, nucleosides, amino acids and ions (reviewed by Pisoni and
Thoene, 1991). Two of the transporters that could be involved in regulating the redox
potential of the endolysosomal environment are the cystine and cysteine-specific
transporters and the possible role of these in supporting lysosomal proteolysis will be the
focus of this discussion.
Disulfide bridges are important in the structural stability of proteins and reduction of these
in the endolysosomal environment may increase the rate of proteolysis. Cysteine is
believed to be the physiological reducing agent involved (Pisoni and Thoene, 1991).
However, reduction of disulfide bridges by cysteine results in the generation of cystine
(Lloyd, 1992), which is poorly soluble and crystallises unless removed from the
endolysosome. This occurs in the disease, cystinosis, due to a defect in the cystine
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transporter (Pisoni and Thoene, 1991). The properties of the cystine transporter have been
evaluated in vitro using counter-transport and trans-stimulation studies, although such
studies are complicated by the heterogeneity of 'lysosomal' preparations.
In contrast to other 'lysosomal' transporters, the cysteine-transporter effects a net influx of
cysteine into 'lysosomes'. When human fibroblasts were incubated with [35S]cystine, at
least 50-60% of the total radioactivity taken up by the cells was found associated with
'lysosomes' in the form of cysteine (Pisoni et a!., 1990). This uptake occurred rapidly (2-5
min) and the transporter was found to be highly specific. Transport into the 'lysosome'
was stimulated when the pH outside was greater than the luminal pH (Pisoni and Velilla,
1995). Cystei ne-transport activity has also been described in lysosomal fractions from
macrophage and B-celllymphoma cell lines (Gainey et a!., 1996). In the B-cell lymphoma
cell line, cysteine transport activity was also detected in antigen processing compartments
(Gainey et a!., 1996), suggesting that reduction may be a feature of antigen processing.
The 'lysosomal' cysteine transporter, like most endolysosomal transporters, has not been
isolated and therefore its intracellular location has not been directly established. However,
there is evidence that disulfide reduction occurs in the late endosome compartments rather
than in early endosomes (Feener et al., 1990; Collins et al., 1991), suggesting that the
cysteine transporter may not be present in early endosomes.
The presence of the cysteine transporter can be interpreted as evidence of reducing
conditions within the endolysosomal environment. Indeed, the proteolytic environment
may be reducing, but the situation is not as simple as often presented. That reduction does
occur is evident from studies on toxins like diphtheria toxin, which requires reducing
conditions to be active (Collier and Kandel, 1971; Moskaug et a!., 1987). Further, reduction
appears to be an essential component of antigen processing (see for example Collins et a!.,
1991; Merkel et a!., 1995), e.g. presentation of the insulin A chain requires that the cysteine
residues are in the thiolate form (Hampl et al., 1992). Further, Gainey et a!. (1996)
demonstrated that antigen-presentation of antigens with disulfide bonds, occurs in
compartments capable of cysteine-transport. The effect may also be a general one, that
reducing conditions enhance substrate proteolysis, which is not limited to antigen
proceSSIng.
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Reducing conditions may affect both proteases and their substrates. It is often assumed
that a reducing environment is necessary for the activity of the lysosomal cysteine
proteases. However, although isolated cysteine proteases do require reducing agents in
order to be active, there is no evidence that these enzymes are oxidised in vivo (Wilcox and
Mason, 1992; Krepela et aI., 1997; 1999). Oxidation may be an isolation artifact. In the
reduced, activated, form the isolated enzymes are more stable to neutral pH conditions
(Dehrmann et aI., 1996). As will be described below, the late endolysosomal environment
may not always be acidic and may cycle up to neutral or even alkaline conditions. A
reducing environment may serve to stabilise these proteases during the purported pH
changes.
Reducing conditions would also affect the substrate proteins. It was found that substrates
with disulfide links are cleaved with greater efficiency by lysosomal proteases in the
presence of a reducing agent (Kooistra et aI., 1982; Mego, 1984). Reducing agents are
believed to work synergistically with the proteases by reducing the disulfide links, relaxing
the substrate structure and exposing more sites for proteolysis. Thus, a reducing
endolysosomal environment does seem to confer several advantages for proteolysis.
However, Lloyd (1992) has pointed out that the stoichiometry of the reduction reaction
itself does not necessitate the continuous influx of cysteine and has suggested that the
cysteine transporter may simply serve an anaplerotic function, replenishing cysteine lost to
auto-oxidation. It must also be questioned how endolysosomal proteins containing essential
disulfide bridges (e.g. cathepsins and LAMPS) are protected against reduction.
A further question is the effect of (low) pH on the reduction potential within the
endolysosomal system. Feener et al. (1990) constructed a probe ([125I]tyn_SS_PDL),
consisting ofe25I]iodotyramine linked to poly-D-lysine by a 3-(propionyldithio)propionic
acid spacer, that was acid stable and resistant to proteolysis but sensitive to reduction.
These authors found that this probe was only inefficiently reduced within the
endolysosomal system and suggested that the Golgi/trans-Golgi may be the main site of
reduction. In experiments in vitro, the probe was inefficiently reduced by cysteine (5 mM)
at low pH (Feener et aI., 1990). A basis for this result can be found by considering the
effect of pH on reduction potential. At fixed cysteine/cystine concentrations, redox
potential is inversely proportional to pH so the reduction potential will be more oxidising at
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lower pH. Low pH conditions within the endolysosomal system may thus generate a
relatively oxidising environment.
How may this evidence for and against a reducing endolysosomal proteolytic environment
be reconciled? The extremely rapid sequestration of cysteine by 'lysosomes' (pisoni et al.,
1990), we believe, is inconsistent with a purely anaplerotic function for the cysteine
transporter as suggested by Lloyd (1992). Moreover, the experiments describing the
synergistic effects of cysteine on proteolysis were all undertaken at acidic pH (Kooistra
et aI., 1982; Mego, 1984), suggesting that reduction is not precluded by low pH. To keep
the reduction potential more or less constant, however, at low pH a higher concentration of
cysteine and/or a lower concentration of cystine is required. Perhaps the function of the
cysteine and cystine transporters is thus to maintain the redox potential within limits by
ensuring an influx of the thiol and efflux of the disulfide.
The cytosolic redox buffer is glutathione and cytosolic GSHlGSSG ratios range from 30: 1 to
100: 1, which corresponds to a redox potential of ca. -221 to -236 mV (Hwang et aI., 1992).
Protein disulfide bridges are largely formed in the ER secretory pathway by the enzymes
Erolp (in yeast) and enzymes of the protein disulfide isomerase (PDI) family (Frand et aI.,
2000). The redox buffer in the ER/Golgi secretory pathway is also glutathione but here it is
more oxidising than the cytosol, with a GSHlGSSG ratio of 1: 1 to 5: 1 and a redox potential
of ca. -160 to -170 mV (Hwang et aI., 1992). This is in agreement with the optimum
GSHlGSSG ratio for the in vitro activity of PDI. However, in vivo, Pdi 1P (the yeast
analogue of PDI) occurs largely in the disulfide form and Frand et al. (2000) have argued
that this balance point is due to efficient oxidation by Erol p and relatively inefficient
reduction by GSH. In the disulfide form, PDI-type enzymes can act as oxidases,
transferring disulfides directly to oxidisable proteins.
An essentially opposite situation may obtain in the endolysosomal system where efficient
hydrolysis requires the reduction of protein disulfide bridges. Here the reducing agent is
thought to be cysteine but the cysteine/cystine concentration is unknown. Nevertheless,
modelling of the Nernst equation (Appendix 1) reveals that to achieve a redox potential of
-160 to -170 mV (i.e. the same as in the ER) at pH 5.0 with a cysteine/cystine redox buffer
(at 1 mM total half-cystine), a cysteine/cystine ratio of ca. 180:1 to 200:1 is required and to
achieve -221 to -236 mV (i.e. the same as in the cytosol) requires ratios of 500: 1 to 600: 1.
Thus, the dependence of redox potential on pH, could provide a reason for the existence of
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the cysteine transporter. A lysosomal reductase, gamma-interferon-inducible lysosomal
thiol reductase (GILT) has been described (Arunachalam et al., 2000), which is optimally
active at acidic pH, is activated by cysteine (and not by glutathione) and is capable. of
reducing protein disulfides. Although details are unknown, it is possible that reduction of
protein disulfides may follow a scheme such as shown in Fig. 2.3.
Cysteine
transporter ...





0 transporter- Cystine Reduced GILT Oxidised protein.....
Membrane Endolysosomal lumer
Figure 2.3. A hypothetical scheme for reduction of substrate proteins III
the endolysosomal system.
The proposed interposition of GILT between cysteine and oxidised proteins is analogous to
the interposition of PDI between oxidants and protein substrates in the ER and could play a
similar role in introducing greater efficiency and specificity into the reduction reactions. For
example, the fact that the e25I]tyn-SS-PDL probe of Feener et a!. (1990) was not reduced
may be because GILT could not recognise this substrate. Similarly, lysosomal proteases
with disulfide links may have structural features that exclude them as substrates for GILT.
Hydrogen peroxide is produced by normal cellular metabolism, and redox recycling drugs
(Ollinger and Brunk, 1995). A consequence of having cysteine sequestered in lysosomes is
that it may combine, at low pH, with intra-lysosomal iron and hydrogen peroxide, to
produce hydroxyl radicals by Fenton reactions (Zdolsek et al., 1993; Brunk et al., 1995; and
Gamer et aI., 1997). Hydroxyl radicals are highly destructive reactive oxygen species and
damage lipids, DNA and proteins (Allen, 1991). These reactions could contribute to
lysosomal leakage, which could effect processes like apoptosis. The lysosomal membrane
is highly enriched with the anti-oxidant a-tocopherol, to a significantly higher degree than
even mitochondria (Rupar et a!., 1992). This may decrease leakage from the lysosome by
inhibiting oxidant damage of the membrane.
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2.5.4 Acidification
An acidic luminal environment is important for the following functions:
• Receptor-mediated endocytosis and recycling. Receptors, like the mannose-6-
phosphate receptor, require acidic conditions in order to discharge their ligands and
recycle.
• Movement/maturation of organelles. ECV formation requires a functional V-ATPase
(Clague et al., 1994) suggesting a link between the movement of substrate along the
endolysosomal pathway and acidification.
• Activity of membrane transporters. 'Lysosomal' membrane transporters, like the
cystine transporter (Gahl and Tietze, 1985), have acidic pH optima that effectively
ensures that amino acid transport is from the lysosome to the cytoplasm (Pisoni and
Thoene, 1991).
• Activation of lysosomal hydrolases and proteolysis. Many of the lysosomal
hydrolases are proteolytically processed to their mature forms under acidic conditions
(Hasilik, 1992), some by auto-processing. Further, many of these hydrolases have
acidic pH optima and are therefore maximally active under acidic conditions. An acidic
environment may also contribute to denaturation of substrate proteins, increasing the
rates of proteolysis.
An acidic luminal environment is established by the vacuolar-H+ATPase (V-ATPase) and a
redox chain (Gille and Nohl, 2000), both of which pump protons into the lumen. The V-
ATPase is made up of two multi-subunit sectors: VG, an integral membrane sector and Vb
which is essentially a cytoplasmic sector. The Vo sector is made up of at least nine
subunits (lOO, 38,19, 176-kDa), and is responsible for proton translocation. The VI sector
is also made up of at least nine subunits (733, 583, 40, 34, 33-kDa) and is responsible for the
ATPase activity. The ATP binding regions are found on the 73 kDa A-subunits which
show a high degree of cooperativity in ATP catalysis (reviewed by Futai et al., 1998). Also
found within the A-subunit is a conserved region known as the P-Ioop. The P-Ioop has a
cysteine residue (Cys 254) which is capable of undergoing thiolldisulfide exchange with
Cys 532, allowing for redox regulation of the V-ATPase (Feng and Forgac, 1994). Disulfide
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bond formation is believed to induce a conformational change, depressing ATPase activity
and inhibiting proton translocation (Feng and Forgac, 1994). This mechanism provides a
further link, though of a different type, between redox potential and pH.
Although the V-ATPase is responsible for translocating protons into the endolysosomal
lumen environment, regulation of the pH of this environment also depends on other factors.
Continuous influx of protons into an organelle would result in the generation of a net
positive membrane potential which would inhibit further proton translocation. It is
believed that inwardly-directed chloride ion channels, and perhaps cation-channels also,
may help regulate the pH of an organelle (reviewed by Futai et aI., 1998). The pH of
'lysosomes', two days after isolation, and in the absence of Mg ATP, remains relatively
constant. This suggests that 'lysosomal' pH is maintained by a Donnan-type equilibrium
(Moriyama et aI., 1992). As described above, the early endosome pH is regulated by a
Na+/H+-exchanger that helps to create an internal positive membrane potential, inhibiting
further proton uptake (Fuchs et aI., 1989; Cain et al., 1989). The number of V-ATPase
molecules found on an organelle may also influence the pH of that organelle.
Given the importance of an acidic environment to the proper functioning of the
endolysosomal system, are alllysosomes acidic? Some of the cysteine endoproteases found
within the endolysosomal system are capable of working over a broad pH range. In fact, in
vitro, cathepsin B has a neutral pH optimum against synthetic substrates (Willenbrock and
Brocklehurst, 1985a; Khouri et aI., 1991; Hasnain et aI., 1992; Moin et aI., 1992; Dehrmann
et aI., 1996). Cathepsin S is also capable of operating at neutral pH (Kirschke et aI., 1998).
Butor et al. (1995) confirmed the late endolysosomalllysosomallocation of two enzymes,
sialic acid-specific 9-0-acetyl-esterase and glycosyl-N-asparaginase, both of which have
neutral to alkaline pH optima and further demonstrated that not alllysosomes were acidic.
They suggested that the 'lysosomal' pH may cycle between acidic and neutral pHs. At
that time, however, it was not known that most proteolysis takes place in late endosomes
and not lysosomes (Tjelle et aI., 1996; Bright et aI., 1997), though it remains to be
demonstrated that this is also true for the hydrolysis of the glyco moieties of glycoproteins.
The concept oflysosomes as storage organe1les was also not fully developed. Nevertheless,
it may be assumed that, taken as a whole, the pH of the luminal environment of the
endolysosomal pathway may be highly dynamic, allowing for the optimal activity of the
different hydrolases found within the system. In the endolysosomal system, a pH cycle
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similar to that suggested by Butor et al. (1995) may exist as a consequence of a late
endosome/lysosome traffic cycle.
2.5.5 Luminal calcium
The role of cytoplasmic calcium in lysosomal homotypic fusion (Bakker et aI., 1997),
lysosome-plasma membrane fusion (Andrews, 2000), and phagosome-lysosome fusion
(Jaconi et aI., 1990; Malik et al., 2001) has been well documented. However, the role of
luminal calcium in regulating proteolysis within these organelles has not been as extensively
studied. To the author's knowledge the role of intra-organellar calcium in regulating
phagosome function is unknown. Autophagy, however, appears to depend on
intracellularly sequestered calcium (Gordon et aI., 1993) though the identity of the
organelle(s) involved is not known. 'Lysosomes' have been shown to be an intracellular
pool for calcium (Hailer et aI., 1996), and the existence of a lysosomal calcium transporter
has been demonstrated (Lemons and Thoene, 1991). As discussed above, hybrid organelle
formation is dependent on calcium release from the lumen oflate endosomes and lysosomes
to facilitate membrane fusion (pryor et aI., 2000). Luminal calcium may also play a role in
lysosome reformation from the hybrid organelle (pryer et al., 2000). The effect that luminal
calcium plays on lysosomal proteases has not, to the author's knowledge, been reported.
2.6 Regulation of endolysosomal proteolysis
2.6.1 Are endolysosomal proteases regulated by intra-luminal redox conditions?
A conceivable control mechanism for endolysosomal cysteine proteinases is via regulation
of the redox conditions in the intra-luminal environment as discussed above. Both
cathepsins Band L are stable in the range pH 4.5 to pH 6.5 and, in Vitro, require a reducing
environment for activity (Kirschke et aI., 1998), which is thought to be required to maintain
the active site cysteine in a thiol form. However, there is no evidence that these enzymes
are oxidised in vivo. Labelling of cathepsin B in isolated mouse liver lysosomes with the
inhibitor Z_[125I]_Tyr-Ala-CHNa did not increase with the addition of DTT or cysteine
(Wilcox and Mason, 1992). These two reducing agents also did not enhance the activity of
cathepsin B in extracts from lung carcinomas and lungs (Krepela et aI., 1997; 1999). This
suggests that redox regulation of the active site thiol may not occur in the endolysosomal
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proteolytic environment. Further, it also suggests that these enzymes may not necessarily
be oxidised upon their secretion into the extracellular environment.
Whilst the active site thiols of these enzymes may not be oxidised, it is possible that their
ionisation state may be altered. At very low pH, the activity of the cathepsins is
depressed. This may be related to a pH-dependent change in the ionisation state from a
thiolate (RS-) to a thiol (RSH) form. However, at low pH cathepsin D would be active
(Table 2.2).
A report by Krepela et al. (1999) suggested that cathepsin B may be inhibited by low
concentrations of the thiol (RSH) form of cysteine, which acts as a competitive inhibitor.
The inhibitory effect of the thiol form of cysteine could be reversed by increasing
concentrations of the thiolate (RS-) form, and was less prevalent at higher pH. These
authors suggested that cysteine may bind into the SI' subsite of the enzyme, inhibiting its
function. This subsite varies between the different cathepsins (Kirschke et aI., 1998) and
this may not be a general regulatory mechanism for all the enzymes. However, since
cathepsin B is the most prevalent endoprotease, regulating its function may significantly
affect proteolysis within the endolysosomal system.
A study of the effects of changes in redox potential on the activity of (100% active)
cathepsin B, showed that redox potential per se had very little effect on the activity
(Chapter 5) It is concluded that although the endolysosomal lumen may be reducing,
changes in cysteine/cystine-induced redox potentials are probably not involved in regulating
endolysosomal proteases. Moreover, an expectation of any regulatory mechanism is that it
should include all hydrolases within the system and other endolysosomal hydrolases, e.g.
Cf.. -glucosidase, have no cysteine residues which could be affected by redox changes.
Unfortunately, the cysteine transporter has not been isolated and its intracellular location,
e.g. lysosomes vs late endosomes, and whether it is present in autophagic vacuoles, has not
be determined. Thus, at this stage, it is not possible to unequivocally state that reducing
conditions are, or are not, a necessary attribute of a proteolytic compartment.
2.6.2 Regulation by pH.
Regulation by pH changes, in contrast to redox changes, could simultaneously influence
many enzyme classes. Factors that could regulate the luminal pH include: the redox state of
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the cysteine on the P-Ioop of the V-ATPase, the presence of cr transporters on the
organelle, a Donnan-type equilibrium, the number of V-ATPases found on that organelle
(reviewed by Futai et a!., 1998), and possibly also a membrane redox chain (Gille and Nohl,
2000). What is notclear is how these factors work together to establish the lumen pH. As
described above the lumen pH may be dynamic. Within the early endosome, pH appears to
be regulated by G-proteins (reviewed by Wamock, 1999), which respond to transporter
entry into the early endosome. Also, Na+/K+ exchangers help modulate this environment.
The (relatively high) pH within this environment allows cathepsin H to function optimally.
Acidification could also contribute to the storage of endolysosomal enzymes by
complexation. Kostoulas et al. (1997) found that elastase and other enzymes within the
azurophil granules of human neutrophils bound to sulfonated glycosaminoglycans by
electrostatic interactions at low pH. It was proposed that this may be a storage mechanism
for these enzymes. Pryor et a!. (2000) suggested that lysosome condensation may be
similar to secretory granule formation. A feature of secretory granules is that they contain
condensed cores of aggregated proteins, a morphology similar to that of lysosomes
(Griffiths, 1996). Using bovine pituitary gland cells, it was demonstrated that the granule
content proteins and the luminal domains of granule membrane proteins could aggregate at
low pH « pH 5.5). A similar result was obtained for bovine adrenal glands, although
aggregation depended on the presence of Ca2+. Proteins destined for constitutive secretion
did not aggregate with the granule content and luminal membrane proteins, and this
property may serve as a segregation mechanism for those proteins to be stored and those
that are constitutively secreted (Colomer et aI., 1996).
The aggregation of lysosomal enzymes at pH 4.8 in Chinese hamster ovary (CHO) cells has
been described (Buckmaster et al., 1988). This aggregation was disrupted by NaCI,
suggesting an electrostatic mechanism. Horseradish peroxidase (HRP) that had beeri chased
into the CHO cells failed to aggregate with the lysosomal enzymes, suggesting that
aggregation was specific. Jadot et at. (1997) showed aggregation of rat liver lysosomal
enzymes at low pH. This aggregation occurred between pH 4.5-5.0, and was mediated by
the integral membrane protein LAMP-2. Under these low pH conditions, lysosomal
enzymes bind by electrostatic interactions to the LAMP-2 proteins, immobilising them in a
matrix. This process was specific for the eleven lysosomal hydrolases assayed during the
experiment: a cytosolic extract and bovine serum albumin (BSA) failed to aggregate with
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LAMP-2 under the conditions tested. Unlike the aggregation observed in CHG cells
(Buckmaster et a/., 1988), detergents affected aggregation of the rat liver lysosomal
enzymes, suggesting that membrane association with LAMP-2 was vital for aggregation.
Lysosomal condensation from the hybrid lysosome/late endosome organelle was shown to
be dependent on intra-organellar Ca2+ and a functional V-ATPase (Pryor et aI., 2000). If
this process involved aggregation of the lysosomal hydrolases it would be analogous to the
pH and Ca2+-dependent aggregation found in bovine adrenal granules (Colomer et aI., 1996).
Further, if this process involved LAMP-2 it may specifically aggregate the lysosomal
luminal proteins (Jadot et aI., 1997), allowing lysosome condensation without
contaminating proteins.
A pH-dependent aggregation mechanism could operate to withdraw lysosomal hydrolases
out of the late endosome, and/or it could be a feature of the lysosome itself. An advantage
of this complexation mechanism, as opposed to a purported redox-dependent storage
mechanism, is that it could encompass several different types of lysosomal hydrolases
(Jadot et a/., 1997). Further, as described by Griffiths (1996), under the electron
microscope lysosomes appear to be small, highly dense organelles, a morphology that could
be explained by aggregation of their luminal hydrolases.
The concept of lysosomal enzymes aggregating by electrostatic interactions is a fairly old
one (see for example Henning et al., 1973). However, the acceptance of this as a mechanism
for regulating and storing lysosomal hydrolases has been limited. This is partly because
erroneously low pH optima were assigned to some hydrolases (see Dehrmann et al. 1995),
which by chance coincided with the low pH of lysosomes where the bulk of substrate
hydrolysis was thought to occur. Subsequently, it has been found that most proteolysis
occurs in late endosomes which have a pH closer to the revised pH optima of lysosomal
proteases. The hypothesis that lysosomal hydrolases may be stored by low pH-induced
aggregation does not exclude the possibility that late endosomes may fluctuate between
alkaline and acidic pH values, allowing for the activation of different hydrolases with
individual pH optima (Butor et al., 1995). The lysosome with its low pH may complex the
lysosomal hydrolases, effectively storing them in a precipitated matrix.
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2.7 Conclusions
Complicating the whole field of endolysosomal proteolysis is the lack of a consistent
nomenclature, especially concerning the definition of the 'lysosome'. To many authors a
'lysosome' is any organelle containing 'lysosomal' hydrolases. However, this simple
definition may have outlived its usefulness and it may be more usefully replaced by a
functional definition, e.g. that lysosomes are organelles mainly for the storage of
'lysosomal' hydrolases in a deactivated state. To become functional, 'lysosomal'
hydrolases must be injected into a late endosome, a phagosome or an autophagosome, which
are the organelles within which hydrolysis largely occurs. This concept of a lysosome is
not too different from the original concept of a "primary lysosome" (De Duve 1983). In
fact, the only substantial difference is that it was perhaps not originally known that
"primary lysosomes" themselves are not hydrolytically active but that activity is largely
manifest in "secondary lysosomes", i.e. late endosomes, phagosomes and autophagosomes.
Another modern, functional, definition of a lysosome is that it is, "the terminal organelle in
the endolysosomal pathway and is devoid of recycling receptors" (Griffiths, 1996). In the
early definition of a "primary lysosome" this was envisioned as being a vesicle, containing
newly synthesised enzymes, which budded off the Golgi apparatus (De Duve 1983).
Griffiths (1996) has noted that lysosomes are indeed vesicle-sized, so in microscopy
studies they may easily be confused with 'lysosomal' enzyme carrier vesicles, which have a
similar cargo. However, the latter are devoid ofMPRs.
Many hydrolytic organelles (secondary lysosomes) may be assembled de novo when
required and this gives an opportunity to determine a minimal requirement for hydrolysis.
A common theme applicable to the endolysosomal system, phagosomes, and
autophagosomes is that enzymes are imported by fusion with lysosomes (where they are
stored in a largely inactive form), acidification is effected by importation of a V-ATPase,
and egress of products is effected by importation of membrane transporters. Some
pathogens exploit the endolysosomal system and escape hydrolysis by blocking the
assembly of a complete functional hydrolytic compartment.
Reactions between enzymes and their substrates, in solution, are described by the reaction,
E + S-:' ES ---7 E + P (1)
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and can be analysed by conventional kinetic methods. Such enzymes are often regulated by
soluble effector molecules, typically inhibitors in the case of non-allosteric enzymes.
Enzyme reactions in the endolysosomal system, however, can be described by the model,
given in Fig. 2.1. There are five possible points of regulation within the endolysosomal
system: i) at the point of acquisition of substrate by the endolysosomal system, ii) at the
meeting ofE and S by fusion of their respective compartments, iii) at the establishment of
conditions supporting proteolysis (or not) within the (fused) organelle, (iv) at the point of
egress of product from the system and (v) the possibility of an enzyme being retained in a
lysosome for a greater or lesser period (perhaps in an inactive form, but in any event
separate from substrate).
The model described by Fig. 2.1 can explain why there are a number of endolysosomal
compartments (to optimise luminal conditions to favour certain reactions). Steps (i) and (ii)
are regulated by signalling networks which may control the rate-limiting steps in
endolysosomal hydrolysis. They may exert their influence through molecules that interface
between the signalling and endocytic pathways. Future research efforts could be directed at
attempting to unite the signalling networks, the regulation of endolysosomal fusion
reactions, and the components that affect the luminal endolysosomal proteolytic




This chapter will describe fundamental methods that were routinely used during the course
of this research project. In addition, specialised or novel procedures that would hinder the
structure of subsequent chapters are described here.
3.1 Materials
Most of the common chemicals used during this study were from BDH, Merck or
Boehringer Mannheim and were of the highest purity available. Coomassie brilliant blue
G-250 was from Merck. Acrylamide, N,N'-methylbisacrylamide, N,N,N',N'-
tetramethylethylenediamine (TEMED), dioxane and dimethylformamide were from BDH.
Dialysis tubing, 7-amino-4-methyl coumarin, dithiothreitol (DTT), L-trans-epoxysuccinyl-
leucylamido(4-guanidino) butane (E-64), activated CH-Sepharose, 2,2' dipyridyl disulfide
and 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), pepstatin A, aminohexylagarose, N-
hydroxysuccinimide and dicyclocarbodiimide, as well as the protease substrates Cbz-R-R-
AMC and Cbz-F-R-AMC, haemoglobin, bovine serum albumin (BSA), lysozyme and
azocasein, were from Sigma (St. Louis, MO). The cation exchange chromatography gel, S-
Sepharose, was from Phannacia Biotech, Uppsala, Sweden. The Gly-Phe-GlySc ligand was
from Bachem (Switzerland). Cysteine (free base, >99% pure) was from Fluka Biochemika
(Switzerland). UltraFuge ultrafiltration centrifuge filters were from Micron Separations Inc.
(Westbro, MA). Distilled H20 (dist.H20) was produced by a Milli-RO® 15 Water
Purification System (Millipore, Marlboro, USA). Distilled, deionised water (ddH20) was
produced by a Milli-Q® Plus Ultra-Pure water system (Millipore, Marlboro, USA). The
minimum resistivity of the ddH20 was 18 MQ
3.2 Protein assays
The Bradford dye-binding assay (Bradford, 1976), as modified by Read and Northcote
(1981), was used for protein quantification.
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3.2.1 Bradford dye-binding assay
The Bradford dye-binding assay is based on the binding of the dye, Coomassie brilliant blue
G-250, to protein. The assay allows for rapid, accurate and reproducible protein
quantification. In addition, the assay requires small amounts of sample, and is resistant to
interference by chemicals commonly used during protein purification such as Tris, ethylene
diamine tetra-acetic acid (EDTA), Triton X-lOO and sodium dodecyl sulfate (SDS).
The Coomassie brilliant blue G-250 dye exists in three forms, an anionic blue form, a neutral
green form and a cationic red form. The cationic form has an absorption maximum at
470 nm. Upon binding to protein the cationic form is converted to the blue species which
has an absorption maximum at 595 nm. This shift in absorbance maximum allows for
spectrophotometric quantification of protein. The extinction coefficient at 595 nm of the
dye-protein complex is much greater than that of the unbound dye and is responsible for the
high sensitivi ty of the assay.
A large proportion of the dye binding energy is due to non-ionic interactions. This results
in variation in the binding properties of the dye with different proteins. In order to
minimise this variation, Read and Northcote (1981) modified the acid/alcohol ratios and
increased the dye concentration used in the dye reagent. The micro-assay of Read and
Northcote (1981) was used in this study for the determination of 1-5 ~g of protein.
3.2.1.1 Reagents
Dye reagent. Serva blue G dye (50 mg) was dissolved in 88% phosphoric acid (50 ml) and
99.5% ethanol (23.5 ml). This solution was made up to 500 ml with dist.H20 and stirred
for 30 min. The resulting solution was filtered through Whatman No. 1 filter paper and
stored in an amber coloured bottle. Visual checks for precipitation were made prior to use
and, if precipitation was observed, a new batch of reagent was made up.




Samples were diluted to 50 ~l with dist.H20, dye reagent (950 J.ll) was added, and the
solution was mixed and allowed to stand for 2 min for colour development. The absorbance
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was read at 595 nm against appropriate blanks. Plastic microcuvettes (l ml) were used, as
the dye reagent binds to glass (Bradford, 1976). The blue stained plastic microcuvettes
could easily be cleaned with diluted sodium hypochlorite. A standard curve, relating
absorbance at 595 nm to 0-50 J.lI (0-5 J.lg) of the standard protein was constructed by linear
regression analysis of the standard curve data.
3.3 Concentration of enzyme samples
Many of the enzyme isolation procedures used during this study required pnor
concentration of the dilute protein samples. An inexpensive and simple method of
concentrating samples was by dialysis against sucrose or polyethylene glycol (PEG).
Samples were placed in dialysis tubing with a cut-off of 12 kDa and dialysed against either
sucrose or PEG. Osmotic pressure results in the continuous effiux of water and buffer ions
from the dialysis bag, concentrating the sample. PEG (20 kDa) tends to interfere with
protein quantification and enzyme activity assays but, unlike sucrose, does not enter the
dialysis bag. When necessary, these two concentration methods were supplemented using
concentration with UltraFuge ultrafiltration centrifuge filters. The UltraFuge filters are
divided into two chambers separated by a filter with a M r cut-off of 10 000. Dilute
samples were loaded into the upper chamber and the UltraFuge filters were centrifuged
(2000 x g, 30 min, 4°C). Under the centrifugal forces, water and buffer ions pass through
the membrane, while the target proteins, which were usually between 30-50 kDa, are
retained. This method of concentration has none of the disadvantages associated with
sucrose or PEG. These filters did prove to be problematic, however, often rupturing at
very low centrifugal forces.
3.4 Electrophoretic techniques
3.4.1 Tris-tricine SDS-PAGE
The Tris-tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
system was designed to resolve smaller proteins « 100 kDa) which are sometimes poorly
resolved by conventional Laemmli SDS-PAGE. In this system, tricine rather than glycine is
used as the trailing ion in the stacking phase. Tricine, and the higher pH of the stacking
phase, causes an increase in the mobility of the protein relative to the trailing ion, al1o~ing
36
for the separation of low molecular weight protein-SDS complexes (Schagger and von
Jagow, 1987).
3.4.2 Reagents
Monomer solution [49.5% (m/v) acrylamide (T), 3% (m/v) N,N'-methylene-bisacrylamide
fQl. Acrylamide (49.5 g) and N,N'-methylene-bisacrylamide (3.0 g) were dissolved in
dist.H20 and made up to 100 m!. This solution was filtered through Whatman No. 5 paper
and stored at 4°C in the dark.
Gel buffer [3 M Tris-HCI, 0.3% (m/v) SDS, pH 8.45]. Tris (72.7 g) was dissolved in
200 ml dist.H20, and adjusted to pH 8.45 with HCI. 10% (m/v) SDS (6 ml) was added and
the solution made up to 250 m!.
10 % (m/v) SDS. SDS (10 g) was dissolved in dist.H20 and made up to 100 ml.
Anode buffer [0.2 M Tris-HCI, pH 8.9]. Tris (24.22 g) was dissolved in 950 ml of
dist.H20, adjusted to pH 8.9 with HCI and made up to 1 litre.
Cathode Buffer [0.1 M Tris-HCI, 0.1 M Tricine, 0.1% (m/v) SDS, pH 8.25]. Tris (12.1 g),
Tricine (17.9 g) and 10% (rn/v) SDS (l0 ml) were made up to 800 ml with dist.H20 and the
pH checked and adjusted if necessary. The buffer was made to a final volume of 1L.
Treatment buffer [125 mM Tris-HCI, 4% (m/v) SDS, 20% (v/v) glycerol, 10% (v/v) 2-
mercaptoethanol, 0.01% (m/v) Serva blue G, pH 6.8]. Stacking gel buffer (2.5 ml), glycerol
(2 ml), 10% (m/v) SDS (4 ml) and 2-mercaptoethanol (1 ml) were made up to 10 ml with
dist.H20. Serva blue G tracking dye [0.01% (m/v)] was added. For non-reducing SDS-
PAGE, 2-mercaptoethanol was omitted. Samples were boiled for 2 min in treatment buffer
before electrophoresis.
3.4.3 Procedure
The compositions of the resolving and stacking gels used to construct the Tris-tricine
system are described in Table 3.1. The gels were run at 80 V with unlimited mA, and
stopped when the Serva blue dye reached the bottom of the gel. The gels were stained as
described in Section 3.5.
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Table 3.1 Preparation of resolving and stacking gels for Tris-tricine SDS-PAGE.
Reagents Resolving gel Stacking gel
10% T, 3% C 4%T, 3% C
Monomer (49.5% T, 3% C) 3.6 ml 0.5 rol
Gel Buffer 6ml 1.5 ml
dist.H2O 8.4 ml 4ml
Ammonium persulfate 60 III 30 III
TEMED 6 III 12 III
3.5 Silver staining of electrophoretic gels
Protein bands were visualised using silver staining, which is at least 50-100 times more
sensitive than conventional Coomassie staining and can detect protein in the nanogram
range. The basis of silver staining is the complexation of silver ions to the ionic side-chains
of amino acids. This binding is responsible for the sensitivity of the technique. The silver-
amino acid complex is visualised by reduction with formaldehyde. Reducing reactions are
strongly favoured under alkaline conditions and these conditions were generated using
Na2C03. The colour produced upon reduction of the silver-amino acid complex depends on
the moiety that the silver ion binds to and the length of the bond and its configuration
(Nielson and Brown, 1984).
Sodium thiosulfate complexes and removes uncomplexed silver ions present in the gel that
may contribute to background staining. Treatment of gels with sodium thiosulfate decreases
the levels of background staining without impairing sensitivity (Blum et aI., 1987).
3.5.1 Reagents
Fixing solution [50% (v/v) methanol, 12% (v/v) acetic acid, 0.2% (v/v) formaldehyde].
Methanol (lOO ml), glacial acetic acid (24 ml) and 37% formaldehyde (0.1 ml) were made up
to 200 ml with dist.H20.
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Wash solution [50% (v/v) ethanol]. Absolute ethanol (100 ml) was made up to 200 ml with
dist.H20.
Pre-treatment solution [0.02% (m/v) Na2~~.5H2Ql Na2S203.5H20 (0.1 g) was made up
to 500 ml with dist.H20.
Impregnation solution [0.08 % (rn/v) AgN03, 0.03 % (m/v) formaldehyde). AgN03 (0.4 g)
and 37% fonnaldehyde (0.15 ml) were made up to 500 ml with dist.H20.
Development solution [6% (m/v) Na2C03, 0.0004% (m/v) Na2~03.5H20, 0.02% (v/v)
formaldehyde]. Na2C03, (12 g), pre-treatment solution (4 ml) and 37% fonnaldehyde
(0.1 ml) were made up to 200 ml with dist.H20.
Stop solution [50% (v/v) methanol, 12% (v/v) acetic acid]. Methanol (50 ml) and glacial
acetic acid (12 ml) were made up to 100 ml with dist.H20.
3.5.2 Procedure
All steps were carried out at room temperature In clean glass containers. All glass
containers, including volumetric flasks, were washed with dist.H20 and ddH20. After
electrophoresis, gels were soaked in fixing solution for either 1 h or overnight. Overnight
fixing significantly reduced background staining. Following fixation, the gels were treated
with wash solution (3 x 20 min). These washing steps allowed for the treatment of gels
with acid labile Na2S203.5H20, and could be increased to 30 min washes to reduce
background staining. The gels were treated with pre-treatment solution (1 min), rinsed with
ddH20 (3 x 20 s) and soaked in impregnation solution (20 min). Mter rinsing with ddH20
(3 x 20 s), the gel was immersed in development solution until bands became visible. The
gel was rinsed with ddH20, treated with stop solution, and stored in a sealed plastic bag at
4°C.
3.6 Protein fractionation using three phase partitioning (TPP)
TPP is an upstream purification method used to selectively concentrate proteins. Tertiary
butanol is completely miscible with water, but upon the addition of sufficient ammonium
suIfate the solution partitions into two phases; an upper t-butanol phase and a lower
aqueous phase. If proteins are present within the solution, they may, depending on the
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ammonium sulfate concentration, precipitate into a third phase between the upper t-butanol
and lower aqueous phases (Pike and Dennison, 1989a).
An advantage of TPP compared to most conventional ammonIUm sulfate precipitation
methods is that the precipitate is essentially free of contaminating salt, which remains in the
aqueous phase. The re-dissolved precipitate can therefore be directly applied to an ion-
exchange column without the need for desalting steps. A further advantage of TPP is that
lipids and other hydrophobic compounds are extracted into the t-butanol phase. TPP does
tend to denature some oligomeric proteins. This property was exploited in the purification
of cathepsin D from bovine spleen where haemoglobin is a major contaminant (Jacobs et aI.,
1989).
The mechanism underlying TPP has been described in detail by Dennison and Lovrien
(1997). TPP precipitation of proteins is a result of the co-operative effects of ammonium
sulfate and t-butanol. The sulfate ion effects protein precipitation by six interdependent
mechanisms: ionic strength effects, kosmotrophy, cavity surface tension enhancement,
dehydration, exclusion-crowding, and ionic interactions with cationic groups on the protein.
The latter effect is prevalent at low ammonium sulfate concentrations, when the
concentration of ammonium suifate is in the range 0.1 to 0.2 M. These ionic interactions
could explain the strong pH dependency of the method. At higher concentrations, 0.4 to
4 M suifate, ionic strength effects, kosmotrophy, cavity tension enhancement, dehydration
and exclusion-crowding come into operation. The net effect of these factors is the
conformational shrinkage and contraction of a protein, promoting protein co-crystallisation.
Further, this tightening of protein conformation stabilises protein structure, preventing
denaturati on.
The remarkable protective properties of ammonium sulfate are reinforced by t-butanol.
[-Butanol behaves as a kosmotrope and a crowding agent, promoting protein structure and
enhancing the salting out effect of ammonium suifate. t-Butanol is able to fulfil these co-
solvent functions at room temperatures, whereas Cl and C2 co-solvents (like ethanol)
require low temperatures. The flotation of a protein into the third phase (between the t-
butanol and aqueous phases) is due to an increase in the relative butanolation and
concomitant dehydration of the protein. These effects, mediated by ammonium suIfate,
increase the buoyancy of the protein, causing it to float above the salt-containing aqueous
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layer. Butanolation can however, cause denaturation of oligomeric proteins by promoting
non-native alpha helical conformations in protein structure (pike and Dennison, 1989a).
TPP has been used to purify the lysosomal proteinases cathepsins L (Pike and Dennison,
1989b), D (Jacobs et al., 1989), Sand B (Meinesz, 1996). In this study TPP was used to
purify bovine liver cathepsins Band D. A modified homogenisation step was also used
(described in greater detail in Section 4.1) in this study. In this procedure, t-butanol was
added to a final volume of 30% to the homogenisation buffer. Thus, within the initial
homogenate, protease activity was suspended (Dennison et al. 2000). TPP was effected at
a later stage during the purification, and the enzymes returned to full activity.
3.6.1 Procedure
I-Butanol was mixed into the homogenisation buffer to a final volume of 30% (v/v). The





= volume of t-butanol
= volume of buffer
t-Butanol crystallises below 25°C and was therefore warmed to 30°C prior to use. To
fractionate the t -butanol containing mixture, solid CNH4hS04 [% (rn/v) based on the total
volume of the mixture including t-butanol] was added to the mixture and dissolved by
stirring. This mixture was centrifuged (8000 x g, 10 min, 4°C) in a swing-out rotor, leaving a
firm button of precipitate between the t-butanol and aqueous phases. If necessary, after
removal of the precipitate, further CNH4)2S04 was added and the solution centrifuged as
before. This allowed a cut of the protein of interest to be made from the total protein
content of the solution. The precipitate was dissolved in an appropriate buffer, centrifuged
(15 000 x g, 10 min, 4°C), and filtered through Whatman No. 4 filter paper to remove
undissolved protein. In most cases (in this study), the precipitates were infused with t-
butanol, which had to be dialysed out.
In conventional TPP, the procedure is very similar to the modified method described above,
except that t-butanol is usually added after homogenisation.
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3.7 Sepharose-Ahx-Gly-Phe-GlySc matrix
Several affinity columns have been described for isolating cysteine proteases, including
aminophenylmercuric and Gly-Gly-(OBzl)Tyr-Arg ligand-based columns. These affinity
resins either have problems of specificity, and/or the eluted enzymes are active, and thus
unstable due to the possibility of autodigestion. An affinity column for cathepsin B
purification, Sepharose-Ahx-Gly-Phe-GlySc, was described by Rich et al. (1986).
Cathepsin B is inhibited by the Gly-Phe-GlySc peptide with a K j of 63 ~M and thus binds
strongly to the affinity matrix. However, cathepsin H does not bind to the column, and the
binding of cathepsin L to the column is essentially irreversible. Cathepsin B is eluted from
the column with 2,2' dipyridyl disulfide, which binds to the active site thiol, trapping the
enzyme in an inactive state (Rich et aI., 1986). The eluted enzyme can be rapidly activated
with reducing agent when needed. Thus, with this column, cathepsin B can be isolated with
great specificity and stability.
3.7.1 Reagents
1 mM Hydrochloric acid. 57 ~l ofHCI was made up to 500 ml with ddH20.
0.1 M Sodium carbonate buffer, pH 8.2. NaH2C03 (4.2 g) was dissolved in 400 ml of
ddH20, adjusted to pH 8.02, and made up 500 ml.
50% methanol. 50 ml of methanol was dissolved in, and made up to 50 ml with, ddH20.
6% ethanolamine. 0.6 ml ethanolamine made up to 10 ml with ddH20.
0.1 % sodium azide. NaN3 (O.lg) was dissolved in ddH20 (100 ml).
3.7.2 Procedure
Activated CH-Sepharose was swollen overnight at 4°C in 1 mM HCI. The gel was washed
three times with 0.1 M sodium carbonate (pH 8.02). The Gly-Phe-GlySc peptide (25 mg)
was mixed with 50% methanol (5 ml) and sodium carbonate buffer (3 ml). This mixture was
added to the activated CH-Sepharose 4B gel and agitated overnight at 20°C. The gel was
collected on a glass funnel and washed with 50% methanol, followed by ddH20. The gel
was collected and agitated for four hours at 20°C, washed with several changes of ddH
2
0
and stored in 0.1 % NaN3 .
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3.8 Pepstatin aminohexyl affinity resin
The fungally derived aspartic proteinase inhibitor pepstatin A (isovaleryl-Val-Val-Sta-Ala-
Sta), binds to cathepsin D with a strong, stable and reversible interaction. This interaction
was exploited to purify cathepsin D by affinity chromatography. The pepstatin
aminohexyl affinity resin used in this study was prepared according to the method of
Murakami and Inagami (1975).
3.8.1 Procedure
Pepstatin A (21.4 mg) was esterified with N-hydroxsuccinimide (3.6 mg) in the presence of
dicyc1ohexylcarbodiimide (6.45 mg). The entire activation reaction was effected in
dimethylformamide (1.25 ml) for 22 h (4°C). Aminohexyl agarose (2 g suction dry weight)
was suspended in dioxane (3.5 ml) and added to the activated pepstatin solution. The
coupling reaction was allowed to occur in a desiccator with gentle stirring (24 h, room
temperature). The gel was filtered and washed with a dimethylformamide/dioxane mixture
(1:2 v/v, 100 ml), followed by a wash with 1 M NaCI. Washed gel was poured into a glass
column (i.d. = 1.5 cm) and stored at 4°C in 1 M NaCI with sodium azide (0.01 % w/v)
preservative.
3.9 Spectroscopic assay of cysteine
Gaitonde (1967) found that ninhydrin reacted specifically with cysteine at low pH. Other
biothiols, like GSH, and other amino acids did not react with the reagent. This reaction
formed the basis for a rapid assay of cysteine. Empircally it was found that the assay was
not accurate for thiol masses> 0.5 J.lmoles.
3.9.1 Reagents
Acid ninhydrin reagent [25 mglrnl ninhydrin, 60% acetic acid, 40% HCl]. Ninhydrin
(0.25 g) was dissolved in acetic acid (6 ml) and HCI (4 ml) and was stirred at room
temperature for 20-30 min. The reagent was always made up just before use.
Thiol diluent solution [5% perchloric acid). Perchloric acid (5 ml) was dissolved in ddH20,
and made up to a final volume of 100 m!.
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95% ethanol. Absolute ethanol (95 ml) was made up to 100 ml with ddH20.
3.9.2 Procedure
Cysteine solutions containing a range of cysteine concentrations (0.1-0.5 J..lmoles in
perchloric acid to prevent oxidation; 0.5 ml) were mixed with acetic acid (0.5 ml) and acid
ninhydrin reagent (0.5 ml). The mixtures were heated (95°C, 10 min) resulting in the
formation of an intense pink color. The mixes were cooled and diluted to 10 ml with 95%
ethanol. Absorbances of the solutions were read at 560 nm and a standard curve (r
2 =
0.996) was constructed using triplicate deterrninations for each cysteine concentration.
3.10 Quantification of thiol groups on proteins
Ellman's reagent or 5,5' dithiobis(2-nitrobenzoic acid) (DTNB) provides a highly sensitive
method of quantifying thiols in solution. However, protein thiol groups often manifest
variable reactivity toward the reagent, presumably due to steric factors. Habeeb (1975)
described a method whereby the thiol groups on proteins could be quantified, by first
denaturing the protein to expose these groups.
3.10.1 Reagents
Denaturation solution [2% SDS, 0.5 mg/ml EDTA in 0.08 M Na-phosphate buffer, pH
8.0]. NaH2P04.H20 (12 g), EDTA (0.5 g) and SDS (20 g) were added to 800 ml of ddH20,
adjusted to pH 8.0 with NaOH, and made up to 1 litre.
0.1 M sodium phosphate buffer pH 8. NaH2P04.H20 (7.94 g) was dissolved in 450 ml of
ddH20, adjusted to pH 8.0 with NaOH, and made up to 500 ml.
DTNB reagent [10 mM DTNB in 0.1 M sodium phosphate, pH 8.0). DTNB (0.04 g) was
dissolved in 0.1 M sodium phosphate buffer (10 ml) and stored in an amber bottle in the
dark.
3.10.2 Procedure
It was essential that all glassware be free of thiol contamination, and glassware was
therefore washed with chromic acid and several rinses of ddH20. The test protein solution
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(0.01-0.04 j.lmoles) was diluted with denaturation solution to a final volume of 6 ml. To
3 ml of this solution DTNB (0.1 ml) was added and mixed in. The reaction was developed
in the dark for 10 min. To the remaining 3 ml, sodium phosphate buffer (0.1 ml) was added
to create a "protein-blank". A "reagent blank" was created by mixing denaturation solution
(3 ml) and DTNB (0.1 ml) and incubating the solution in the dark for 10 min. The
absorbance of the protein-DTNB mix was determined at 410 nm against the "protein-blank"
to give an apparent absorbance. The "reagent-blank" was subtracted from this value to give
a net absorbance with an £ = 13 600 M'!cm'! (Habeeb, 1975).
3.11 Fluorometric assay for cathepsin B activity
The fluorometric substrate Cbz-R-R-AMC has proved to be ideal for cathepsin B. The
AMC leaving group is non-toxic, and is sensitive enough for the detection of picomolar
amounts of enzyme. Cathepsin B favours an arginine residue at the PI position, where it
can be electrostatically anchored to a glutamic acid residue in the SI position (Musil et aI.,
1991). While cathepsin B can cleave the substrates Cbz-R-AMC and Cbz-F-R-AMC,
these also can be cleaved by cathepsins Hand L, respectively. Both cathepsin Hand
cathepsin L, and in fact most of the other mammalian cysteine proteases, cannot hydrolyse
Cbz-R-R-AMC, making it a relatively specific substrate for cathepsin B (Barrett and
Kirschke, 1981). Two assays were used in this study, a microassay for monitoring the
enzyme purification, and a macroassay for more sensitive readings.
3.11.1 Reagents
Cathepsin B assay buffer/activator [4 mM Na2EDTA 0.02% NaN3? 5 mM dithiothreitol in
0.1 M Na-phosphate buffer? pH 6.0]. NaH2P04 (6.90 g), Na2EDTA (0.93 g) and NaN3
(0.1 g) were dissolved in 450 ml dist.H20, adjusted to pH 6.0 with NaOH and made up to
500 ml. Immediately before use, dithiothreitol was added to 5 mM (i.e. 0.51 g/500 ml).
1 mM Cbz-R-R-AMC substrate stock solution. Cbz-R-R-AMC (3.1 mg) was dissolved in
dimethyl sulfoxide (DMSO) (5 ml), divided into 100 j.l1 aliquots and stored at -20°C. When
required, this stock was diluted in ddH20 to a working concentration of 40 JlM (i.e. 40 Jll
of the stock solution was made up to 1 ml with ddH20).
Assay diluent [0.1 % Brij]. Brij (0.1 g) was dissolved in ddH20 and made up to 100 ml.
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1 mM 7-amino-4-methylcoumarin standard solution. 7-amino-4-methylcoumarin (1.8 mg)
was dissolved in DMSO (l0 ml) and stored in a light-proof bottle at -20°C. Appropriate
dilutions of the stock solution were made in dist.H20.
3.11.2 Procedure
Microassay. Buffer/activator (75 ~l) was added to the enzyme sample (10 ~l) in a white
Fluronunc maxisorp microtitre plate. This mixture was incubated at 37°C for 2 min and
substrate solution (25 ~l) was added in. After 10 min at 37°C, the fluorescence of the
liberated 7-amino-4-methylcoumarin was measured in a fluorescence microplate reader
(Cambridge Technology, Model 7620) with excitation at 370 nm and emission at 460 mn.
Enzyme activity was described as arbitrary fluorescence units.
Macroassay. The enzyme sample was diluted to 125 ~l and buffer/activator (750 Ill) added
in. The mixture was incubated for 2 min at 37°C to activate the enzyme and substrate
solution (125 ~l) was added in. The fluorescence of liberated 7-amino-4-methylcoumarin
was measured continuously for 10 min in a Hitachi F-2000 spectrofluorometer with
excitation at 370 nm and emission at 460 nm. Enzyme activity was described by the SI unit
for enzyme activity, the katal.
Quantification of liberated 7-amino-4-methylcoumarin. Standard curves relating
fluorescence emitted at 460 nm to the concentration of liberated 7-amino-4-methylcoumarin
were constructed on the basis of the micro and macro assays. In each case dist.H20 was
used in place of the enzyme sample. The buffer/activator/dist.H20 mixture was pre-
incubated at 37°C for 2 min. An appropriate dilution of the standard 7-amino-4-
methylcoumarin solution was added, in place of the substrate solution, and the fluorescence
of the solution was determined after 10 min at 37°C. In each case, linear regression analysis
of the curves showed a strong correlation with r2 of 0.991 and 0.996 for the micro and
macroassay respectively. The following standard curves were determined using the results
obtained from the assays:
x = (y - 48.614)/0.181 for the microassay
x = (y - 8.609)/0.536 for the macroassay
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where x = concentration (n moles) of 7-amino-4-methylcoumarin, and y = fluorescence of
the solution. For routine enzyme assays, the enzyme activity was described as arbitrary
fluorescence units.
3.12 Assay for cathepsin D
The haemoglobin assay developed by Anson (1939) was used in this study to measure the
activity of cathepsin D. Cathepsin D hydrolysis of haemoglobin generates TCA-soluble
peptides which can be determined spectrophotometrically. Synthetic substrates have been
developed for cathepsin D. These substrates have been found to be relatively insensitive
(Pohl eta!., 1983) or, in the case of the substrate F-A-A-F(N02)-F-V-L-OM4P (Agarwal
and Rich, 1983), too expensive. During this study an attempt was made to use fluorescein-
haemoglobin as a substrate (De Lumen and Tappel, 1970). This was expected to be a trade-
off between the synthetic and the native haemoglobin assays. However, the rapid
quenching of the fluorescein fluorophore resulted in unacceptably high errors, and the assay
was not adopted.
3.12.1 Reagents
5% (m/v) Haemoglobin substrate. Bovine haemoglobin powder (0.5 g) was dissolved in
dist.H20 (10 ml) with magnetic stirring.
Assay buffer [250 mM sodium citrate, 0.02% NaN3, pH 3.2]. Citric acid (26.3 g) and NaN3
(0.1 g) were dissolved in about 450 ml of dist.H20, adjusted to pH 3.2 with NaOH and
made up to 500 ml.
5% (m/v) Trichloroacetic acid. Trichloroacetic acid (5 g) was dissolved in dist.H20 and
made up to 100 ml.
3.12.2 Procedure
Enzyme sample (26 Ill), assay buffer (506 Ill) and substrate (133 Ill) were mixed together in
a polyethylene microfuge tube and incubated at 37°C for 30 min. After 30 min, a sample
(300 Ill) was removed and added to a polyethylene microfuge tube containing TCA (240 Ill).
A reaction blank was created by replacing the enzyme sample with dist.H20 (26 Ill).
Insoluble protein was precipitated by centrifugation on a bench-top microfuge (48 x g,
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5 min, RT). The absorbance of the supematant was read against the blank supematant in a
1 ml quartz cuvette at 280 nm. One unit of enzyme activity was defined as the quantity of
enzyme producing an increase in absorbance of 1.0 in excess of the control in 60 min.
3.13 Active site titration of cathepsin B
Active site titration of cathepsin B was undertaken to determine the percentage of active
enzyme present in an isolated sample. Trans-epoxysuccinyl-Ieucylamido(4-guanidino)
butane, or E-64, is a powerful irreversible inhibitor of cysteine proteinases, originally
isolated from Aspergillusjaponicus (Hanada et aI., 1978). E-64 binds to cathepsin B in a
1: 1 molar ratio. Thus the concentration of active cathepsin B can be determined from the
minimum concentration ofE-64 required to completely extinguish enzyme activity (Barrett
and Kirschke, 1981).
E-64 binds to the S subsites of the enzyme and nucleophilic attack by the active site thiol
on the oxirane ring at the C2 position of the inhibitor results in the formation of an
irreversible thioether bond. The binding of E-64 and E-64 analogues to the active site of
cathepsin B shows a marked pH and ionic strength dependence. The binding of the
inhibitor is more effective at lower pH, possibly due to the interaction of the carboxylate
group of the inhibitor with the two protonated histidine residues (110 and 111) of the
occluding loop. High ionic strength conditions, in the region of 50-150 mM NaCI, disrupt
the electrostatic interactions of the inhibitor with the S subsites of the enzyme. The
sensitivity of the enzyme to these conditions could account for the differences in kinetic
constants obtained in different laboratories (Schaschke et aI., 1997). The pH and ionic
conditions used for active site titration were as described by Barrett and Kirschke (1981).
Active site titration was routinely used to determine the absolute concentration of
cathepsin B used in the assays described in Chapter 5, as well as to monitor changes in
enzyme activity during enzyme storage.
3.13.1 Reagents
10 mM E-64 stock solution. E-64 (1.8 mg) was dissolved in DMSO (500 Ill). Suitable
dilutions of the inhibitor were made in Ultrapure Milli-Q water. The dilutions used were




The active site titration of cathepsin B was adapted from Barrett and Kirschke (1981).
Enzyme sample (25 ~l), buffer/activator (50 ~l) (Section 3.11.1) and an appropriate dilution
of E-64 were incubated at 37°C for 30 min to allow the binding reaction to go to
completion. All reactions were carried out in triplicate. After 30 min, aliquots from each
tube was assayed (Section 3.11) and a graph of activity versus E-64 concentration
constructed. The absolute concentration of active enzyme (Eo) was determined by
extrapolating the linear portion of the graph to the E-64 concentration axis.
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CHAPTER 4
ISOLATION OF CATHEPSIN B AND CATHEPSIN D
4.1 Cathepsin B
The endolysosomal cysteine proteinase, cathepsin B [EC 3.4.22.1], is ubiquitously
distributed throughout mammalian cells and its main role appears to be in protein turnover.
Cathepsin B also plays important roles in bone resorption and antigen and hormone
processing. It has been implicated in pathological conditions like rheumatoid arthriti;s,
tumour metastasis, inflammation and, possibly, demyelination of neural tissue (reviewed in
Van et aI., 1998; Mort and Buttle, 1997; Lah and Kos, 1998).
Regulation of the cathepsin B gene is not well understood. Human cathepsin B pre-mRNA
is transcribed from a single copy gene mapping to chromosome 8p22 (Wang et aI., 1988).
The 5' flanking region of the gene has multiple transcriptional start sites, suggesting more
than one promoter (Berquin et aI., 1995). The main promoter region is localised 200 bp
upstream of exon one (Yan et aI., 1998). Whilst this region has features of a housekeeping
gene, expression of the cathepsin B mRNA is highly variable between different tissues in
the rat (San Segundo et al., 1986) and mouse (Qian et aI., 1989). This suggests that
expression of the gene may be controlled in a tissue or cell specific manner, and that
cathepsin B may participate in tissue specific functions other than intra-endolysosomal
protein degradation (San Segundo et al., 1986).
Alternate splicing of the cathepsin B pre-mRNA transcript can result in considerable
variation and heterogeneity of the transcripts produced. Most variation between the
transcripts is localised in the 5' and 3' untranslated regions. Differences in these
untranslated regions may result in different steady state mRNA levels, as well as differing
rates of translation (Berquin et aI., 1995). Thus regulation of the cathepsin B gene appears
to occur at the transcriptional and post-transcriptional level, and may result in considerable
differences in the types of transcripts and the level at which they are produced.
The cathepsin B mRNA docks onto the ribosomes of the endoplasmic reticulum (ER) and is
transcribed into a pre-propeptide. The signal sequence of the pre-propeptide is cleaved co-
translationally and the propeptide folds into its correct conformation within the ER lumen.
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Cathepsin B is roughly disk shaped with a diameter of 50 A and a thickness of 30 A. The
enzyme is bi-Iobular with a left (L) and right (R) domain separated by a water-filled
interface. The Land R domains interact by polar contacts along this interface. In addition,
polypeptide straps starting at the Nand C termini, respectively, span the interdomainal
interface holding the two lobes together (Musil et aI., 1991). Bovine cathepsin B has a
further interdomainal strap: a Cys-148-7Cys-252 disulfide bridge (amino acid numbering for
the mature enzyme) (Baudys et aI., 1990).
The interdomainal interface opens to form a V-shaped active site cleft. The active site is
buttressed by a unique structural feature, a conformationally flexible 22-residue loop,
known as the occluding loop. The propeptide chain runs along the interdomainal interface
from the enzyme's N-terminus to the active site. The propeptide is held in place by
hydrophobic and hydrophilic contacts along the interdomainal interface. The occluding
loop, which normally blocks the rear of the active site, is displaced away from the enzyme
surface by the propeptide chain (Turk et aI., 1996).
The pro-region of the enzyme prevents the improper activation of the enzyme whilst it is
travelling through the biosynthetic and sorting machinery of the cell. In addition, the pro-
region increases the stability of the enzyme at alkaline and neutral pH, preventing
denaturation (Mort and Buttle, 1997). The enzyme is transferred from the ER to the cis
face of the Golgi where it is glycosylated with an Asn-linked oligosaccharide. This
carbohydrate is phosphorylated by the transfer of a N-acetylglucosaminylphosphate group
to the C-6 hydroxyl groups of one or two mannose residues (Hasilik, 1992).
Phosphorylation of the oligosaccharide serves two purposes. Firstly, it prevents the
formation of complex oligosaccharides on the enzyme's surface. Secondly it allows the
proenzyme to bind to the mannose-6-phosphate receptors (MPRs). These receptors
deliver the pro-enzyme to the endolysosomal system, where the acidic conditions trigger
the dissociation of the enzymes from their MPRs (Hasilik, 1992). Pro-cathepsin B may
also reach the endolysosomal system by MPR-independent systems (Authier et aI., 1995;
McIntyre et al., 1993; Burge et al., 1991; Hopkins et al., 1990).
Once the enzyme reaches the endolysosomal system, it is activated either autocatalytically
or by other proteases. The propeptide region is cleaved off and degraded. Cathepsin B
undergoes a further proteolytic cleavage, removing the dipeptide Ala-48IHis-49, which
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converts the enzyme from a single polypeptide chain into a two chain form. This is the
predominant form of the enzyme within the endolysosomal system (Musil et aI., 1991).
Several isolation procedures have been described for isolating cathepsin B (Barrett and
Kirschke 1981' Willenbrock and Brocklehurst, 1985a; Rich et a!., 1986; Meinesz, 1996)., ,
Generally all these methods follow a similar strategy: homogenisation ---7 acid precipitation
---7 ammonium sulfate/acetone fractionation ---7 chromatography. The Sepharose-Gly-Phe-
GlySc affinity chromatography method described by Rich et al. (1986) was the most
effective, with reported yields greater than 100%. Further, the proportion of active enzyme
obtained using this method is between 80-100% (Rich et al., 1986). Most other
cathepsin B isolates generally contain only about 30-50% active enzyme.
The Gly-Phe-GlySc peptide has a K j of 63 ~ toward cathepsin B, but has a significantly
higher affinity for cathepsin L, and does not bind cathepsin H (Rich et aI., 1986).
Cathepsin L binding to the column is essential irreversible. The different binding affinities
of these enzymes towards the ligand allows them to be efficiently separated. Cathepsin B
can be eluted from the column using 2,2'-dipyridyl disulfide which forms a thiol-pyridyl
link with the active site cysteine of the enzyme, displacing the enzyme from the column.
An advantage of this method, compared to other cathepsin B affinity methods, such as
aminophenylmercuric chromatography, is that cathepsin B is eluted in an inactive state,
preventing autocatalysis. Subsequent treatment of the enzyme-thiol pyridyl derivative
with a reducing agent restores the enzyme to full activity.
In the published method (Rich et a!., 1986), the affinity matrix was mixed directly with the
acetone fraction from the isolation, and then poured into a column. Cathepsin B was
subsequently eluted from the column. Two potential problems could arise with this
method: firstly, some of the matrix, which is relatively expensive, could be lost when mixing
and pouring the matrix-homogenate mixture. Secondly, cathepsin L, with binds to the
matrix with great affinity (Rich et a!., 1986), is not removed prior to the affinity
chromatography step. This could eventually lead to all potential ligand sites in the column
being saturated with cathepsin L, with consequent inactivation of the column. Thus
modifications to the orginal method as detailed below (Fig. 4.1), were implemented,
essentially to remove cathepsin L before the affinity chromatography step.
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Thawing of diced,













Figure 4.1. Scheme for the isolation of cathepsin B from bovine liver.
The method was also modified 'upstream' of affinity chromatography. t-Butanol, at a
,
concentration of ca. 30%, was found to inhibit the activity of a variety of proteases, but
this activity could be recovered upon removal of the solvent (Dennison et aI., 2000). This
property allowed enzyme activity in the initial homogenate to be placed in 'suspended
animation' allowing greater yields of enzyme in subsequent purification steps (Dennison
et aI., 2000). It was also discovered (serendipitously!) that such inclusion of tertiary
butanol (t-butanol) into the homogenisation step of a cathepsin L isolation procedure,
reduced the formation of a covalent cathepsin L-stefin B complex. In previous cathepsin L
isolation procedures, two cathepsin L fractions could be isolated: a pure cathepsin L
fraction, and a covalent cathepsin L-stefin B complex fraction, that was also proteolytically
active (Pike et a!., 1992). In the original procedure, n-butanol was used to solubilise
membranes. However, by including t-butanol instead of n-butanol during homogenisation,
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cathepsin L-stefin B complex formation was inhibited (Dennison el al., 2000). This
suggested that the cathepsin L-stefin B complex was artifactually formed during the
homogenisation process; and that including I-butanol into the homogenisation step may
reduce artifact production.
A further attractive property of including I-butanol in the isolation procedure, is that it may
reduce interactions between the lysosomal membrane proteins and the lysosomal enzymes
themselves. As described in Chapter 2, lysosomal membrane proteins (LAMPs) and
hydrolases have the property of aggregating together at low pH. Most cathepsin B
isolation procedures include an acid denaturation step, in order to take advantage of the
stability of cathepsin B under acidic conditions. However, it has been observed emprically
that this step is often associated with a large loss in enzyme yield. This loss in activity
may be due to hydrolase-LAMP aggregation. By including I-butanol in the isolation
procedure, this loss was expected to be minimised. The scheme devised for cathepsin B
isolation from bovine liver is shown in Fig. 4.1.
An S-Sepharose cation exchange chromatography step was included before Sepharose-Ahx-
Gly-Phe-GlySc chromatography. This was necessary to separate cathepsin Band
cathepsin L. Both cathepsins Band L bind to the S-Sepharose matrix, but cathepsin B
elutes at a lower salt concentrations than cathepsin L. This prior removal of cathepsin L,
prevents irreversible cathepsin L binding to, and thus 'poisoning' of, the Sepharose-Ahx-
Gly-Phe-GlySc resin.
4.1.1 Reagents
Homogenisation buffer [150 mM NaCI, 1 mM Na2EDTA, 0.02% NaN3, in 50 mM Na-
acetate buffer, pH 4.5]. Glacial acetic acid (2.86 ml), NaCI (8.77 g), Na2EDTA (0.37 g) and
NaN3 (0.2 g) were dissolved in 950 ml dist.H20, adjusted to pH 4.5 with NaOH and made
up to 1 litre. Before use, I-butanol was added to the homogenisation buffer to a final
volume of30%.
Buffer A [l mM Na2EDTA, 0.02% NaN3, in 20 mM Na-acetate buffer, pH 5.0}. Glacial
acetic acid (2.29 ml), Na2EDTA (0.74 g) and NaN] (0.4 g) were dissolved in 1.9 litres of
dist.H20, adjusted to pH 5.0 with NaOH and made up to 2 litres.
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Buffer A2 [l mM Na2EDTA, 200 mM NaCl, 0.02% NaN3, in 20 mM Na-acetate buffer,
pH 5.0]. Glacial acetic acid (2.29 ml), Na2EDTA (0.74 g), NaCl (23.38 g) and NaN3 (0.4 g)
were dissolved in 1.9 litres of dist.H20, adjusted to pH 5.0 with NaOH and made up to 2
litres.
Buffer B [50 mM Na-phosphate buffer, pH 6.0, containing 0.02% NaN31 NaH2P04.H20
(7.395 g) and NaN3 (0.2 g) were dissolved in 950 ml of dist.H20, adjusted to pH 6.0 with
NaOH and made up to 1 litre.
Buffer B2 [0.5 M NaCI, 0.02% NaN3 in 50 mM Na-phosphate buffer, pH 6.0].
NaH2P04.H20 (0.793 g), NaCl (29.22 g) and NaN3 (0.1 g) were dissolved in 450 ml of
dist.H20, adjusted to pH 6.0 with NaOH and made up to 500 m!.
Buffer C [50 mM Na-formate buffer, pH 4.0 containing 0.02% NaN3l Formic acid
(2.26 ml) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H20, titrated to pH 4.0 with
NaOH and made up 1 litre.
S-Sepharose fast flow. The S-Sepharose cation-exchanger was prepared by diluting the
supplied hydrated gel 1:2 (v:v) with buffer A, and packing the resulting slurry into a glass
column under gravity. The column bed was initially regenerated with 2 M NaCI in
buffer A. The same buffer was used to regenerate the column between purification
procedures. The column was equilibrated before use by washing with 5 column volumes of
Buffer A.
Sepharose-Ahx-Gly-Phe-GlySc affinity resin. This reSIn was made up as described in
Section 3.7. The column was washed with 5 column volumes of Buffer C before use.
Bovine liver. Fresh bovine liver, obtained from the Cato Ridge abattoir, was diced into 2 x
2 cm cubes and frozen at -70°C for at least 3 days, but no longer than a month, before use.
4.1.2 Optimisation of TPP cuts for cathepsin B in bovine liver.
In previous conventional TPP isolation procedures for cathepsin B, an ammonium sulfate
cut of between 10-25% was found to give the highest yield of cathepsin B. However, by
including 30% t-butanol in the homogenisation step, the optimal ammonium suifate cut for
harvesting cathepsin B changed. Several ammonium suifate cuts were effected on the
homogenate and these were analysed for cathepsin B activity.
4.1.2.1 Procedure
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Frozen diced bovine liver was allowed to thaw overnight (12 h) at 4°C to effect release of,
lysosomal hydrolases from their endocytic compartments (the cell membranes are ruptured
by the ice crystals formed during freezing). The liver was homogenised in homogenisation
buffer (containing 30% t-butanol) at a ratio of 1:2 (liver mass to buffer) in a Waring blendor
(max. speed, 3 min/lOO g of tissue). This mixture was centrifuged (9000 x g, 20 min, 4°C)
to remove any undissolved material. The supernatant was collected and adjusted, with
magnetic stirring, to pH 4.2 using glacial acetic acid. This step is important in removing
cytosolic inhibitors of the cathepsins. The solution was centrifuged (9000 x g, 20 min, 4°C)
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to remove acid-precipitated protein, and TPP was effected on the supernatant as described
in Section 3.6. An initial ammonium sulfate cut of 10% (m/v) was used, the precipitate
collected and dissolved in buffer A (50 ml). Further cuts with 10% (m/v) increments of
ammonium sulfate were made to the solution. The precipitates at each step were also
collected and dissolved in buffer A (50 ml). The precipitates were dialysed against PEG
20000 (Section 3.3), followed by buffer A. The solutions had approximately equal
volumes after dialysis, and were assayed for protease activity (Section 3.11).
4.1.3 Isolation of bovine cathepsin B.
4.1.3.1 Procedure
Cathepsin B was isolated using a combination of the method of Rich et al. (1984), with the
modification to the homogenisation steps suggested by Dennison et al. (2000). Bovine
liver, stored at -70°C, was thawed overnight and homogenised in homogenisation buffer.
This mixture was centrifuged, adjusted to pH 4.2, and centrifuged (9000 x g, 20 min, 4°C).
Three-phase partitioning, with an ammonium suifate cut of 20-40% was effected on the,
supernatant. The precipitates from TPP were dissolved in buffer A, dialysed against PEG
20000 (Section 3.3), and further dialysed against several changes of buffer A. The resulting
dialysate was applied to an S-Sepharose cation-exchanger (2.5 cm x 20 cm). Cathepsin B
was eluted using a salt gradient (0-200 mM sodium chloride, i.e. buffer A~bufferA2), that
does not elute cathepsin L. Fractions were assayed (Section 3.11), and the cathepsin B
fraction from S-Sepharose was dialysed against several changes of Buffer B. DTT was
added to the dialysate to a final concentration of 5 mM and the mixture applied to the
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Sepharose-Ahx-Gly-Phe-GlySc column. Fluid leaving the column was collected and re-
circulated through the column to ensure maximal binding of cathepsin B. The column was
washed with two volumes of buffer B2, followed by two volumes of buffer C. Buffer C
containing 1.5 mM 2,2'dipyridyl disulfide was loaded onto the column, and left on the
column overnight to elute cathepsin B. The eluted fractions were collected, assayed,
analysed by electrophoresis, pooled and quantified using the Bradford assay.
4.1.4 Results and discussion
The method chosen to isolate cathepsin B (Fig. 4.1) was based on methods developed in
this laboratory and other published isolaton procedures. As described above, the upstream
isolation procedure used a novel technique (Dennison el aI., 2000), for homogenising bovine
liver. By including I-butanol in the homogenisation mixture, it was anticipated that artifact
formation during homogenisation would be decreased. It was found, however, that the TPP
precipitates obtained by this procedure, were infused with I-butanol that had to be dialysed
out before S-Sepharose chromatography. This meant that the procedure took longer than
conventional TPP, but this was off-set by increased yields of cathepsin B (Dennison el aI.,
2000).
As the precipitates obtained using the new homogenisation process (Dennison el aI., 2000)
were different from precipitates obtained by conventional TPP, the TPP step had to be
optimised. Two independent optimisation procedures were undertaken: both experiments
gave identical results, with cathepsin B activity appearing to be greatest in the 20-40%
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Figure 4.2. Optimal ammOl1lum sulfate cuts for harvesting cathepsinB
activity from a liver homogenate via TPP. A bovine liver was
homogenised, acid-precipitated and fractionated using 10% ammonium
sulfate cuts. TIle precipitate from each cut was dissolved in equal volumes
of buffer A (Section 4.1.1), dialysed to remove excess (-butanol, and
assayed using Cbz-R-R-AMC (Section 3.11). Each precipitate was assayed
in quintiplicate, and the data represents mean ± s.e.
The downstream chromatography procedures were also modified from the original paper by
Rich et al. (1986). In the present study, cathepsin B and cathepsin L were separated by
cation exchange chromatography. Both enzymes bind to cation exchangers with relatively
strong affinity. This binding is, in some respects, similar to our proposal that these
enzymes may bind to, and aggregate with LAMP proteins (Section 2.6.2). Cathepsin B
elutes from an S-Sepharose exchanger within the range, 0-200 mM NaCI, and cathepsin L
elutes within the range 200-600 mM NaCl. Thus no cathepsin L should be present at the
final Sepharose-Ahx-Gly-Phe-GlySc affinity chromatography step.
Several purifications of cathepsin B were undertaken, sometimes using different bovine
livers, or different liver masses. In every case, pure cathepsin B was isolated. The yields of
some of these isolations varied from 240% to 15%. These differences in yields may reflect
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differences in the starting material, as well as differences in assaying fractions from the
various steps. As described above, I-butanol decreases enzyme activity, resulting in an
apparent loss of activity. The differences in yield may reflect differences in the efficiency
of I-butanol dialysis from the homogenate and acid precipitate test fractions. Results from
one of the isolation procedures are presented in Table 4.1.
Table 4.1 The purification of cathepsin B from bovine liver





Homogenate 14000 2163 0.155 (1) (100)
Acid Ppt. 5657.60 24.22 0.004 0.003 0.011
supernatant
TPP (20-40%) 312.48 2823 9.03 58.47 130.52
S-Sepharose 57.58 3495 60.71 392.94 161.59
Sepharose-Ahx- 0.738 5208 7057 45680 240.80
Gly-Phe-GlySc
The first three steps of the isolation procedure involved crude fractionation steps before
chromatography. The purification (fold) at the TPP step is significantly higher than at the
preceding homogenisation and acid precipitation steps. Further, the yield appears to
increase to 130% (Table 4.1).
These increases do not necessarily reflect efficiency in these isolation steps, but could be
partially due to the presence of I-butanol in the initial stages of the isolation. Despite
attempts at dialysis, and dilution during the assay procedure, the activity of cathepsin B
within the homogenate and acid precipitate fractions may have been depressed. This would
result in an apparent lower total activity at the start of the purification. This appears to be
the case, as the total activity shows an apparent increase during the isolation procedure
(Table 4.1) Thus, even the overall yield of 240% may be an exaggeration. In these intial
pre-chromatography stages, it was noted that in all isolations undertaken, the total activity
of the supernatant at the acid precipitation step was always very low. The basis for this
result is not known, as the acid precipitation step, should remove cytosolic cathepsin
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inhibitors. These inhibitors should precipitate at low pH, and would therefore be discarded
in the acid precipitate. This activity is, however, recovered in latter stages.
Following TPP, the fractions were dialysed to remove excess I-butanol, and loaded onto an
S-Sepharose column. The chromatogram for this stage of the isolation is shown in Fig. 4.3.
In the figure, the 'break-through' peak is not shown as it contains no relevant information.
The start of the salt gradient from 0-200 mM NaCI is, however, indicated. Cathepsin B
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Figure 4.3. Chromatography of the pH 4.2 TPP fraction of cathepsin B
on S-Sepharose. The pH 4.2 TPP fraction (Section 4.1.3.1) was loaded
onto an S-Sepharose column (2.5 x -17.5 cm; 85.9 ml bed volume),
equilibrated in 20 mM Na-acetate, pH 5.0, containing 1 mM Na2EDTA,
0.02% NaN3 · A 0-200 mM NaCl gradient was applied at J, with a flow rate
of 10 cm h-
I
and fractions (8.3 ml)collected. These fractions were




Active fractions (fractions 20-55) were pooled and analysed for activity and protein
concentration. Compared to the TPP step, the yield remained very similar, but the
purification increased almost 7 times. This increase could be attributed to the high exchange
capacity of the S-Sepharose matrix. As the specific activity of fractions after S-Sepharose
chromatography increased significantly, the Sepharose-Ahx-Gly-Phe-GlySc affinity matrix
would be expected to bind cathepsin B more efficiently than in the procedures that did not
include this step. As described above, cathepsin L is also removed at this step.
The final stage in the isolation procedure is affinity chromatography on Sepharose-Ahx-
Gly-Phe-GlySc. The chromatogram for this step shows a single peak of activity and
protein content (data not shown). Both purification and yield increase significantly at this
step. The specific activity increases 166 fold, reflecting a large increase in purification. The
overall yield also increases almost 1.5 times. As most of the t-butanol had been dialysed
out at this stage, the increase may be attributed to displacement of cytosolic inhibitors from
the enzymes. A similar effect was described by Rich et al. (1986).
Active fractions from the Sepharose-Ahx-Gly-Phe-GlySc column, were pooled and
analysed for activity, electrophoretic purity and for percentage active enzyme. As expected
pure cathepsin B was isolated as single (approx. 29 kDa) and two-chain forms (24 and
5 kDa) when run on reducing SDS-PAGE gels (Fig. 4.4). The 5 kDa light chain does not
stain very strongly, and is easily distinguished on the gel. A similar result was obtained by
Deval et at. (1990) who also isolated cathepsin B from bovine liver. E-64 titration of the
isolated fractions showed that they were between 85-100% active, a result similar to that
achieved by Rich et al. (1986).
Using the method described here, cathepsin B could be isolated fairly rapidly, and with·
good yields. This procedure has two main advantages over the original procedure described
by Rich et al. (1986). Firstly, the affinity matrix is kept within a column, preventing
possible loss of material during the stirring in the original procedure. Secondly, cathepsin L
and cathepsin B were separated prior to the affinity step, preventing contamination, and
increasing the life of the column. The upstream isolation procedures, homogenisation, acid
precipitation and TPP, were novel and have been described in a paper by our group
(Dennison et aI., 2000). In this procedure enzyme activity within the homogenate is held in
'suspended animation', preventing artifactual reactions and this may have contributed to the










Figure 4.4. Tris-tricine SDS-PAGE of cathepsin B isolated from bovine
liver. Cathepsin B fractions from the Sepharose-Ahx-Gly-Phe-GlySc
column were boiled in reducing treatment buffer and loaded onto a 10%
tricine gel (lane 2). MW markers (phosphorylase b, 94 kDa; BSA 68 kDa;
ovalbumin, 45 kDa; carbonic anhydrase, 30 kDa; trypsin inhibitor,
20.1 kDa; lysozyme, 14.4 kDa) are indicated in lane 1.
4.2 Cathepsin D
Cathepsin D [EC 3.4.23.5] is an aspartic protease that is also ubiquitous. Like cathepsin B,
its main role within the endolysosomal system is believed to be protein turnover.
Cathepsin D is also believed to be responsible for activating the cysteine proteinases,
cathepsin B (Van der Stappen et al., 1996) and cathepsin L (Nishimura et a!., 1989;
Wiederanders and Kirschke, 1989). Cathepsin D is also involved in antigen (Rodriguez and
Diment, 1992) and hormone processing (pillai et a!., 1983), and in pathological conditions
like tumour metastasis (Capony et a!., 1989; Brouillet et al., 1990).
The human cathepsin D gene is expressed in nearly all mammalian tissues. The gene has
been localised to chromosome 11 (Hasilik et a!., 1982) and is organised into 9 exons and 8
introns (Redecker et a!., 1991). The upstream regulatory sequences of the gene lack TATA
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and CCAAT boxes, and contain a CpG island and Sp1 binding sites. These features are
consistent with those of a housekeeping gene, and are responsible for the nearly ubiquitous
expression of the gene (Redecker et aI., 1991). Transcription of the cathepsin D gene can be
induced by estrogens in MCF-7 (Cavailles et aI., 1989) and ZR-75 (Westley and May,
1987) breast cancer cells. Expression of the gene can also be induced in U-937 monocytes
by calcitriol, although it is unlikely that calcitriol directly affects the gene (Redecker et aI.,
1989). Several hormone response elements have been described for the cathepsin D gene
and these may be responsible for the regulation of gene expression (Redecker et aI., 1991).
Cathepsin D mRNA is translated into a prepropeptide. The signal sequence is cleaved co-
translationally and the enzyme folds into its proenzyme conformation within the ER lumen.
The propeptide, which prevents improper activation of cathepsin D, is necessary for the
enzyme to assume its correct conformation. Cathepsin D deletion mutants lacking the
propeptide do not assume the native conformation and are rapidly degraded in a
chloroquine-independent fashion (Conner, 1992). Cathepsin D is folded into 3 domains
typical of aspartic proteases: an N-terminal domain, a C-terminal domain and an
interdomain anti-parallel {3-pleated sheet. The interdomain region is made up of the first 7
amino acids of the N-terminal domain (residues 1-7 of the mature human enzyme), the last
16 residues of the C-terminal domain (residues 330-346) and interdomainallinking residues
(160-200). The interdomain region forms an active site cleft in which the active site
residues Asp-33 and Asp-231 are found, midway. A conformationally flexible {3-hairpin
structure known as the 'flap' region (residues 72-87), lies above the active site (Baldwin
et aI., 1993).
Cathepsin D has two N-linked glycosylation sites, one on each domain. Like other
lysosomal enzymes, these oligosaccharides are modified by the addition of phosphate
monoesters to the mannose residues on the oligosaccharide chain. This modification allows
cathepsin D to be transported to the endolysosomal system by the MPR system.
Elimination of these glycosylation sites in human fibroblasts results in cathepsin D mutants
that are stable, but are not secreted, and are poorly targeted to the lysosome (Fortenberry
et aI., 1995). In contrast to these results, MPR-independent membrane association and/or
transport of cathepsins Band D has been described in rat hepatocytes (Authier et al., 1995)
and for procathepsins D and L in macrophages (Diment et aI., 1988), Hep G2 cells
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(Rijnboutt et al., 1991a; 1991 b) and mouse fibroblasts (McIntyre and Erickson, 1991;1993).
This discrepancy suggests that MPR-independent transport systems may be cell specific.
Upon delivery to the endolysosomal system, procathepsin D is proteolytically processed
to a mature enzyme. In rat, mouse and hamster tissue the enzyme is processed to a single
chain form, whilst in human and porcine tissue cathepsin D is ultimately processed to a 2
chain form. Bovine tissue contains equivalent amounts of both forms of the enzyme
(Conner et a!., 1989). Procathepsin D is processed to a 44 kDa single chain enzyme in a
prelysosomal endocytic compartment (Rijnboutt et a!., 1992).
The 55 kDa proenzyme can undergo acid-dependent autocatalytic processing to generate
pseudocathepsin D in vitro. Low pH causes the local denaturation of the propeptide at the
active site of the proenzyme. This allows for limited processing of procathepsin D to
generate pseudocathepsin D whose size is intermediate between 55 kDa procathepsin D
and the 44 kDa single chain enzyme (Conner, 1989). The existence of pseudocathepsin D
ill vivo has been disputed by Richo and Conner (1994). They generated cathepsin D
mutants which were incapable of autocatalytic processing in vitro, but were still routed to
the lysosome and processed to mature enzyme in mouse cells. These results suggest that
pseudocathepsin D is not a normal intermediate of cathepsin D processing in )11VO. In
contrast, the gastric aspartic proteinases, pepsinogen, progastricsin and prochymosin
appear to be activated by both inter- and intra-molecular proteolytic cleavages (Richter
et al., 1998)
In some species, the 44 kDa single chain enzyme is processed into a 2-chain form. The light
(15 kDa) and heavy (30 kDa) chains of the 2-chain enzyme are non-covalently associated
(Baldwin et al., 1993). The significance of this proteolytic cleavage has not been
determined. Cathepsin D processing, from the proenzyme to mature cathepsin D, may be
carried out by cysteine proteases. Inhibition of cysteine proteases in cultured cells
prevents cathepsin D maturation (Rijnboutt et a!., 1991b). Processing of the enzyme begins
pre-lysosomally but is completed within the 'lysosome' itself (Rijnboutt et a!., 1992).
Most cathepsin D isolations centre on affinity chromatography steps that allow for the
rapid isolation of the protease, preventing autolysis and auto-inactivation. Various affinity
chromatography ligands have been used for the isolation of cathepsin D including pepstatin
(Conner, 1989; Jacobs et aI., 1989), a combination of pepstatin and concanavalin A ligands
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(Tanji et al., 1991), haemoglobin (Smith and Turk, 1974) and rabbit anti-cathepsin D IgG
(Babnik et al., 1984). The isolation used in this study was based on the method of Jacobs
et al. (1989). This method takes just 6 h and allows for the isolation of cathepsin D from
bovine spleen with a yield of ca. 8%. This method has essentially two steps: TPP and
affinity chromatography on pepstatin-Sepharose. TPP has been described in detail above
(Section 3.6). As an established method was used, conventional TPP was employed. An
important property of TPP, that is especially relevant in this isolation, is that it denatures
haemoglobin, which can be a major contaminant in cathepsin D isolations from spleen and
liver tissue (Fortgens, 1996).
The pepstatin-cathepsin D complex is stabilised by hydrogen bond interactions between
the main chain atoms of the inhibitor and the side chain and main chain atoms of the
enzyme. The central statine residue of the inhibitor is a PI-PI' dipeptide isostere of Leu-
Gly in which there is no PI' side-chain substituent. This dipeptide isostere mimics a
tetrahedral intermediate in peptide bond hydrolysis by cathepsin D, and is largely
responsible for the affinity of cathepsin D for pepstatin (Baldwin et al., 1993; Szewczuk
et al., 1992).
The binding of cathepsin D to pepstatin, which depends on hydrogen bond interactions, is
reversible and is inefficient at neutral pH values (Knight and Barrett, 1976). By raising the
pH, the pepstatin-cathepsin D interaction can be disrupted, allowing the enzyme to be
eluted off a pepstatin affinity column.
4.2.1 Reagents
Loading buffer [50 mM Na-acetate, 200 mM NaCI, 0.02% NaN3, pH 3.5]. Acetic acid
(2.86 ml), NaCI (11.69 g) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H20, titrated to
pH 3.5 with NaOH and made up to 1 litre.
Elution buffer [50 mM Tris-HCI, 200 mM NaCl, 0.02% NaN3, pH 8.5]. Tris (6.06 g),
NaCI (11.69 g) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H20, titrated to pH 8.5
with HCI and made up to 1 litre.
Bovine liver. Bovine livers were prepared as described in Section 4.1.1.
Pepstatin-diaminohexane-Sepharose. Preparation of this matrix is described in Section 3.8.
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4.2.2 Isolation of cathepsin D
Based on the results of previous cathepsin D isolations undertaken in this laboratory
(Fortgens, 1996), a TPP cut of 25-35% was used to isolate cathepsin D from bovine liver.
4.2.2.1 Procedure
Bovine liver was allowed to thaw overnight (12 h, 4°C) and homogenised in a Waring
blendor (max. speed, 3 minll 00 g of tissue) with cold dist.H20 in a ratio of 1:2 (liver mass
to volume of dist.H20). This ratio of 1:2 (liver mass to volume of dist.H20) was found to
give a better recovery of enzyme than a ratio of 1: 1 as used by Fortgens (1996). The
homogenate was centrifuged (10 000 x g, 30 min, 4°C) to remove any undissolved debris
and the supernatant decanted. The pH of the supernatant was adjusted to pH 3.2 using
HCI, with constant stirring. Acid precipitated material was removed by centrifugation
(10000 x g, 30 min, 4°C). The supernatant was subjected to TPP (Section 3.6) using an
ammonium suifate cut of 20-35%. The TPP precipitate was dissolved in loading buffer
(Section 4.2.1) at approximately one tenth of the volume of the acid precipitate volume.
This mixture was centrifuged (15 000 x g, 10 min, 4°C) and filtered through Whatman No. 4
filter paper to remove any undissolved material. The sample was loaded onto a pepstatin-
aminohexyl-Sepharose column (1.5 x 0.5 cm = 0.88 ml), that had been previously
equilibrated with loading buffer, at 5 cm h- 1. The unbound eluate was recirculated through
the column overnight to ensure complete binding of cathepsin D to any available pepstatin
sites. The column was washed with a further 2 volumes of loading buffer and cathepsin D
eluted with elution buffer. Purity of the fractions was determined by SDS-PAGE (Section
3.4) with silver staining (Section 3.5), and the fractions pooled accordingly.
4.2.3 Results and Discussion
Conventional TPP was used to isolate cathepsin D. The precipitates obtained by this
method were not infused with t-butanol, and hence extensive dialysis steps were not
necessary.
Only a single isolation of cathepsin D was undertaken in this study, as this yielded enough
cathepsin D for the studies reported in Chapter 5. Unlike the cathepsin B isolation (Table
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4.1), the isolation table for cathepsin D has a far more conventional appearance. Yield and
total activity appear to decrease, and the purification increases with each step.
















Total Specific Purification Yield
Activity Activity (fold) (%)
(units) (units/mg)
1577.4 0.636 (1) (100)
940.8 4.562 7.173 59.58
445.0 2.746 4.318 28.21
51.6 32.050 50.393 3.27
1 2
Figure 4.5. Tris-tricine SDS-PAGE of cathepsin D isolated from bovine
liver. The pepstatin-Sepharose fraction (lane 2) was boiled in reducing
treatment buffer and loaded onto a 10% tricine gel with MW markers (lane
1) (BSA 68 kDa; ovalbumin, 45 kDa; carbonic anhydrase, 30 kDa; trypsin
inhibitor, 20.1 kDa; lysozyme, 14.4 kDa).
Pepstatin affinity chromatography gives the highest increase in purificaction. The yield
recovered (Table 4.2) was less than that obtained by Jacobs et al. (1989) from spleen, but
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within a similar range. As expected, cathepsin D was isolated in the single (45 kDa) and
two-chain (30 kDa and 15 kDa) forms (Fig. 4.5).
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CHAPTERS
THE REDOX PROPERTIES OF CATHEPSIN B
5.1 Introduction
The nature of the redox environment within the endolysosomal system was reviewed in
Chapter 2, although that review was partly informed by the results reported in this chapter.
This introduction will focus more on the theory, design and rationale of the experiments
undertaken and reported in this chapter. The basic experimental design of assays used in
these experiments may be described as follows:
Enzyme + Redox Buffer + Substrate ~ Result (Activity and Stability)
The activity and stability of cathepsin B, and the activity of cathepsin D were tested using
several redox buffers. Both enzymes were isolated using affinity columns, and the enzyme
preparations were therefore close to 100% active. This is an important feature when
dealing with enzymes sensitive to redox buffers. Redox buffers, especially cysteine-cystine
buffers, have the capacity to refold redox-denatured protein (Raman et a/., 1996). As
described in Chapter 4, conventional cathepsin B isolation procedures produce an enzyme
fraction that is between 30-50% active. It has been shown empirically that by increasing
the thiol concentration in the assay buffer during E-64 titration (Section 3.1.3), the
percentage of active enzyme increases (Coetzer, 1992). In these conventional preparations,
it is therefore possible that redox buffers may refold inactive cathepsin B, leading to an
increase in the proportion of active enzyme during the assay procedures. By using an
affinity matrix, only active enzyme was isolated and used in these assays. Enzyme stocks
were periodically checked by E-64 titration to ensure that enzyme had not denatured. In
cases where the enzyme had denatured, active enzyme was re-isolated by affinity
chromatography.
Conventionally isolated cathepsin B has to be activated by a reducing agent before use, as
the enzyme is oxidised during its isolation. Following Sepharose-Ahx-Gly-Phe-GlySc
chromatography in the isolation procedure used in this study, cathepsin B is in an inactive
enzyme-thiol pyridine form. However, in vivo, cathepsin B is already in a reduced, active
state (Wilcox and Mason, 1992; Krepela et a/., 1997). Thus, cathepsin B was pre-activated
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before testing the effect of redox buffers on its actIvIty. Further, the results obtained
demonstrate the effect of the redox buffers on the enzyme itself, and not on the ability of
the buffers to activate cathepsin B. The redox properties of cathepsin B were tested in
actetate-MES-Tris (AMT) buffers. Because of the effect of pH on redox potential
(Chapter 2) cathepsin B activity and stability were determined over several pH values.
AMT buffers have the capacity to retain a constant ionic strength over a wide pH range
(Ellis and Morrison, 1982). This is an important property as it has been shown that
cathepsin B activity and stability are influenced by ionic strength (Dehrmann et al., 1996).
The principal lysosomal redox agents are cysteine and cystine (Chapter 2). There are some
technical difficulties in working with these reagents. Firstly, cysteine, unlike glutathione
(GSH), is rapidly oxidised by molecular oxygen (Mansoor et al., 1992; Newton and Fahey,
1995). This may explain why cysteine is not the principal reducing agent within the
cytosol of aerobic cells (Newton and Fahey, 1995). Thus, the buffers have to be
deoxygenated before use. Secondly, cystine is poorly soluble in aqueous solutions. This
difficulty was overcome, when making up AMT buffers containing cystine, by adding the
cystine after the addition of acetic acid to water.
The effect of redox potential, and differing concentrations and ratios of cysteine and cystine
on enzyme activity was tested. If there were changes in the activity of the enzyme, these
changes would be quantified both kinetically and thermodynamically. The kinetic changes
would have been monitored using conventional kinetic parameters: the Michaelis constant
(Km), maximum velocity (Vmax), and the turnover number (kcat)' The thermodynamic
parameters would have been described in terms of the equilibrium constant (Keq) of the
reaction:
Cathepsin B-Cystine (inactive) + 2 Cysteine H Cathepsin B (active) + Cystine
The Keq of the reaction would reflect how stable the disulfide bond between (oxidised,
inactive) cathepsin B and cystine is, compared to cysteine. If the K eq is of similar
magnitude to the in vivo ratio of cystine/cysteine, then redox regulation of the enzyme is
possible. The thiolldisulfide ratios within the endolysosomal system are not known, but an
estimate of the thiol concentration has been given by Krepela et al. (1999). If on the other
hand, there are no changes in the activity of the enzyme with redox potential, then the
enzyme may not be redox regulated.
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The enzyme's half-life (tin) gives a measure of its stability. What is actually measured, is
the time it takes for the activity of the enzyme to decrease by half. The theory of how half-
life is determined is given by Dennison et al. (1992). Basically, it is assumed that loss of
activity is a first-order process and can be monitored by measuring the loss of activity over
a period. The rate constant for this loss of activity (kobs) can be determined from activity
versus time curves, and the stability determined by the following equation (Segal, 1976):
tl/2 = 0.693/kobs (2)
For this measure to be valid, it is important that substrate is never limiting, and that there is
a measurable loss of activity over the time period employed. It was sometimes necessary
to alter the enzyme concentration to meet these conditions.
oi)
Table 5.1 Properties of whole protein substrates used in activity assays.
Name Molecular Subunits No. of No. of free Metal
weight (kDa) disulfide cysteine(s) moieties
bridges
Haemoglobin 62 4 0 2 4
BSA 69.29 1 17 1 0
RA-BSA -70 1 0 0 0
Lysozyme 16.29 1 4 1 0
Most of the assays described in this chapter were undertaken using a fluorogenic substrate.
Whole protein assays were also included in the light of several reports that have described
the effect of reducing agents on the processing and/or antigenic presentation of whole
protein substrates (Kooistra et al. 1982; Collins et al., 1991; and Merkel et aI., 1995). Four
substrates, haemoglobin, bovine serum albumin (BSA), reduced and alkylated BSA (RA-
BSA) and chicken egg lysosome, were tested. These substrates were chosen because of
their differing structural properties (Table 5.1), with the hope that the effect of redox
buffers on proteolysis could be determined.
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5.2 Reagents
Oxygen-free nitrogen. Oxygen-free nitrogen was from Afrox Ltd. (South Africa).
Acetate-MES-Tris buffers [final concentration in assay = 100 mM acetate, 100 mM MES,
200 mM Tris, 4 mM Na2EDTA). AMT buffers retain a constant ionic strength over a wide
pH range (Ellis and Morrison, 1982), and were used to construct redox buffers. All buffer
solutions were deoxygenated by boiling, cooling under a stream of oxygen-free nitrogen, and
degassed under vacuum. To these buffers was added an appropriate concentration of
reducing agent to accommodate dilution during the assays employed. For those buffers
containing cystine, the disulfide was added to the stock AMT buffers. Further steps were
done under a constant stream of oxygen-free nitrogen. Using the method of
Gaitonde (1967) (Section 3.10) it was shown that the thiol concentration within the buffers
did not change significantly over the time periods employed in these experiments.
Unfolding buffer [50 mM Tris-acetic acid, 8 M urea, 0.02% NaN3 pH 8). Tris (1.51 g),
urea (120.12 g) and NaN3 (0.05 g) were dissolved in 100 ml ofddH20, titrated to pH 8 with
acetic acid and made up to a final volume of 250 m!.
1 mM Ammonia. 68!J.l of a 25% ammonia solution was made to 1 litre with ddH20.
Storage solution. NaN3 (0.01 g) was dissolved in ddH20 (50 ml).
Sep-pak C18 thiol elution buffer [35% acetonitrile, 0.01% trifluoroacetic acidl Acetonitrile
(35 ml) and trifluoroacetic acid (10 fll) were added to ddH20 and made up to a final volume
of 100 m!.
Sep-pak C18 protein elution buffer [65% acetonitrile, 0.01% trifluoroacetic acid).
Acetonitrile (65 ml) and trifluoroacetic acid (10!J.l) were added to ddH20 and made up to a
final volume of 100 m!.
Reduced/alkylated BSA (2 mg/ml). Reduced-alkylated BSA (RA-BSA) was prepared using
the method of Mego (1984). BSA (0.04 g) was mixed with a 10-fold molar excess (with
respect to disulfide bridges) of DTT (0.0152 g) in unfolding buffer (4 h, RT). A two-fold
molar excess (with respect to DTT) of iodoacetate (0.0364 g) was added to the solution,
which was left at room temperature for 30 min. The protein solution was dialysed against
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several changes of a 1 mM ammonia solution and further dialysed against storage solution,
followed by PEG 20000, and adjusted to give a final concentration of2 mg/mI.
To determine whether the RA-BSA substrate had been completely reduced and alkylated, a
novel method based on those of Wynn and Richards (1995) and Habeeb (1975), was
developed. RA-BSA (5 ml, 2 mg/ml) was reduced with DTT (10 mM, 30 min, RT) and the
resulting mixture was acidified to pH 3 with HCI. The mixture was injected into a Sep-pak
C18 column pre-wet with Sep-pak C18 thiol elution buffer. The column was rinsed with
this buffer to elute the thiol, and fractions (1 ml) collected. These fractions were tested for
the presence of thiol using the DTNB reagent (Section 3.10). Once thiol could no longer be
detected, the column was washed with Sep-pak C18 protein elution buffer, to elute the
protein. The protein fractions were collected and quantified at 280 nm. The presence of
free thiol on the proteins was determined using the method of Habeeb (1975) (Section 3.10).
Using this method it was shown that the thiol moieties on the reduced RA-BSA, unlike
those on native BSA, had all been alkylated.
Protein substrates (2 mg/ml). The proteins, haemoglobin, BSA, and lysozyme were
separately dissolved in storage solution at 2 mg/m\.
Cathepsin B assay buffer 2 [0.1 M sodium phosphate, 4 mM EDTA, 2 mM DTT, pH 6].
NaH2P04 (6.90 g) and Na2EDTA (0.93 g) were dissolved in 450 ml dist.H20, adjusted to
pH 6.0 with NaOH and made up to 500 mI. Immediately before use, dithiothreitol was
added to 5 mM (i.e. 0.204 g/500 ml).
Cathepsin D assay buffer 2 [lOO mM sodium citrate, 0.02% NaNh pH 3.2]. Citric acid
(10.52 g) and NaN3 (0.1 g) were dissolved in about 450 ml of dist.H20, adjusted to pH 3.2
with NaOH and made up to 500 mI.
5% TCA. TCA (5 g) was dissolved in ddH20 (60 ml), and made up to a final volume of
100 mI.
Cathepsin B and cathepsin D. The isolation of these proteases is described in Chapter 4.
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5.3 Experimental Procedures
5.3.1 The effect of pH and various thiol concentrations on cathepsin B activity and
stability.
Cathepsin B was pre-activated in cathepsin B assay buffer 2 (Section 5.2) for 10 min, 25°C.
r
The enzyme (250 ng, 32 Ill) was added to pre-warmed AMT buffer (pH 5-7, 843 Ill)
containing an appropriate concentration of thiol (0-20 mM), and Cbz-R-R-AMC (125 Ill,
100 IlM). The reaction was monitored continuously at 37°C in a Hitachi F-2000
spectrofluorometer. Experiments to determine the half-life of cathepsin B under these redox
conditions were conducted as described previously (Dennison et al., 1992; Dehrmann et al.,
1995). The enzyme concentration was adjusted in these experiments to ensure that there
was a measurable loss in enzyme activity over the assay periods employed « 15 min)
(Dennison et al., 1992). Longer assay times resulted in appreciable oxidation of the redox
buffers, and were therefore not used. The data represents the mean ± standard error of at
least 3 independent determinations.
5.3.2 The effect of cystine on cathepsin B activity and stability.
Cathepsin B was pre-activated in cathepsin B assay buffer 2 (10 min, 25°C). The activated
enzyme (250 ng, 32 Ill) was added to pre-warmed AMT buffers with or without cystine
(0-0.8 mM, 843 Ill), containing an appropriate concentration of thiol (0-20 mM), and Cbz-
R-R-AMC (125 Ill, 100 IlM). These assays were undertaken in triplicate and the mean and
standard error were determined. The reactions were monitored continuously at 37°C in a
Hitachi F-2000 spectrofluorometer. In order to determine the effect of cystine on the
stability of cathepsin B, half-life assays were conducted at pH 7.0 in AMT buffers with
varying concentrations of cystine (0-0.8 mM) and cysteine (0-20 mM). At least 2
independent experiments were conducted from which the mean and standard errors were
calculated.
5.3.3 The effect of redox conditions on cathepsin hydrolysis of protein substrates.
Cathepsin B was pre-activated in cathepsin B assay buffer 2 (2 min, 37°C). The activated
enzyme (1 Ilg, 88 Ill) was added to pre-warmed AMT buffer with or without cystine (0-
0.8 mM, 787 Ill) containing an appropriate concentration of thiol (0-10 mM), and protein
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substrate (125 J.lI, 2 mg/ml). An aliquot (300 J.lI) was immediately removed and added to
5% TCA (240 J.lI) as a zero time control. After 10 min at 37°C, a further aliquot (300 J.lI)
(was removed) and added to 5% TCA (240 J.lI). The reaction mixes were centrifuged and
the absorbance quantified at 280 nm.
For the cathepsin D assays, the enzyme was pre-warmed in cathepsin D assay buffer 2
(Section 5.2) for 2 min at 37°C. Warmed enzyme (4 J.lg) was added to pre-warmed assay
buffer (750 J.lI) and protein substrate (125 J.lI, 2mg/ml). An aliquot (300 J.ll) was
immediately removed and added to 5% TCA (240 J.lI). After 10 min at 37°C, a further
aliquot (300 J.lI) was removed and added to 5% TCA (240 J.lI). The reaction mixes were
centrifuged and the absorbance quantified at 280 nm. At least 3 independent experiments
were conducted from which the mean and standard errors were calculated. Control
experiments (assays without enzyme) were also undertaken to determine whether the
susbstrates were spontaneously denaturing/hydrolysing within the redox buffers
themselves. No such effect was found.
5.3.4 Calculation of redox potential for redox buffers.
Refer to Appendix 1
5.4 Results
5.4.1 The effect of pH and thiol concentration on cathepsin B activity.
The effect of thiol concentration (provided by cysteine or glutathione) and pH on
cathepsin B activity against Cbz-R-R-AMC was explored using AMT buffers of constant
ionic strength, with varying concentrations of thiol. In contrast to other reports (see for
example Khouri et aI., 1991; Hasnain et aI., 1992; Moin et aI., 1992; Dehrmann et aI., 1996),
the activity of cathepsin B at pH 6.0 and pH 7.0, over all thiol concentrations, was similar;
and was greater than at pH 5.0 (Fig. 5.1). Despite GSH having a lower standard reduction
potential than cysteine (Segal, 1976), a GSH-containing buffer of pH 7.0, gave significantly
lower enzyme activity over the range of thiol concentrations tested, compared to cysteine-
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Figure 5.1. TIle effect of thiol concentration on cathepsin B activity. The
effect of thiol concentration on cathepsin B activity against Cbz-R-R-
AMC was monitored in AMT redox buffers containing cysteine containing
at pH 7 (-), pH6 (.), pH 5 (.A.), and in GSH-containing buffers at pH 7
(.). The reactions were monitored continuously at 37°C, and the data
represent the mean ± standard error of at least 3 independent
determinations.
The effect of cysteine on the half-life of cathepsin B at pH 6.0 and 7.0 is shown in Fig. 5.2
(the enzyme was too stable at pH 5 for a half-life to be measured). In contrast to the
activity (Fig. 5.1), the half-life was significantly greater at pH 6.0 than at pH 7.0. The
stability of cathepsin B at pH 7.0, in the absence of thiol (AMT redox buffer, pH 7.0, no
cysteine), was generally significantly lower than in the presence of thiol (AMT redox
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Figure 5.2. The effect of thiol concentration on cathepsin B stability. The
effect of thiol concentration on cathepsin B stability was monitored in
cysteine-containing AMT redox buffers at pH 7 (.) and pH 6 (e). The
reactions were monitored continuously at 37°C, and the data represent the
mean ± standard error of at least 3 independent detenninations.
It appears that cysteine alone increases the stability of cathepsin B at pH 7.0. This is
consistent with the result of Dehrmann et al. (1996). In contrast, at pH 6.0, cysteine
apparently has little effect, as the enzyme was as stable with as without cysteine (Fig.
5.3b). Krepela et al. (1999) reported that with increases in cysteine concentration,
cathepsin B showed a local minimum in activity. These authors believed that this effect
was due to cysteine thiol inhibition of the enzyme. Data from this study also shows this
effect over all pHs tested, and with GSH-containing buffers (Fig. 5.1). Further, the present
results of the effect of cysteine on cathepsin B stability (Fig. 5.2) also showed local minima
with increases in thiol concentration. These minima corresponded to the minima in the
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Figure 5.3. A comparison of the effect of cysteine on cathepsin B stability
and activity at pH 7.0 (A) and pH 6.0 (B). The data describing the effect
of cysteine on cathepsin B activity (e) and stability (D) in AMT redox
buffers was compared. The data represent the mean and standard errors of
least 3 independent determinations.
5.4,2 The effect of cystine on cathepsin B activity and stability,
Most assays of cysteine protease activity do not include cystine. However, adding cystine
to the buffers enabled calculation of reduction potentials using the N ernst equation. At
pH 6.0, starting in a buffer without cysteine, cathepsin B activity increased with decreasing
reduction potential, until approximately -80 mY, and thereafter was insensitive to changes
in reduction potential (Fig. 5.4a). This suggests that at pH 6.0, cathepsin B is capable of
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operating over a broad cysteine/cystine generated redox potential range of -80 mV to
-350 mY. Similarly, at pH 7.0, the concentration of cystine does not appear to have a



















Figure 5.4. TIle effect of redox potential and cystine concentration on
cathepsin B activity at pH 6 (A) and pH 7 (B). Cathepsin B activity
against Cbz-R-R-AMC was assessed with various concentrations of cysteine
(0-20 mM) in AMT redox buffers containing cystine at concentrations of
0.2 mM (e) or 0.8 mM (.) respectively. The redox potential of each of
the buffers was calculated using the Nemst equation. The data points at 0
mV represents an AMT redox buffer with cystine (0.2-0.8 mM), but no
cysteine. The reactions were monitored continuously at 37°C, and the data





















Figure 5.5. TIle effect of redox potential and cystine concentration on
cathepsin B stability at pH 7. Cathepsin B stability against Cbz-R-R-AMC
was assessed in AMT redox buffers containing various concentrations of
cysteine (0-20 mM), and 0.2 mM cystine (e) or 0.8 mM cystine (.). The
redox potential of each of the buffers was calculated using the Nernst
equation. The data points at 0 mV represents an AMT redox buffer with
cystine (0.2-0.8 mM), but no cysteine. The data represent the mean ±
standard error of at least 2 independent determinations.
As described, assays were of limited duration to prevent oxidation of redox buffers. The
inherent stability of cathepsin B at pH 6.0 made it difficult to assess the effect of cystine
on stability at this pH. At pH 7.0 on the other hand, cystine had a marked effect on the
stabihty of cathepsin B. Between buffers with no cysteine and those with reduction
potentials of -250 mV, a linear relationship between stability and reduction potential was
found (Fig. 5.5), with enzyme stability increasing with decreasing redox potential (i.e.
increasing concentrations of cysteine). For a given redox potential, stability was reduced in
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Figure 5.6. A comparison of the effect of cystine on cathepsin B stability
at pH 7.0. Cathepsin B stability was measures in AMT redox buffers
containing cysteine (0-20 mM) and cystine at 0 mM (e), 0.2 mM (.) and
0.8 mM (.). The data represent the mean and standard error of at least 2
independent experiments.
This effect appeared to be dose dependent with stability greater in buffers with no cystine,
followed by buffers with 0.2 mM cystine, and then buffers with 0.8 mM cystine (Fig. 5.6).
However, below -250 mY, with decreasing redox potential (i.e. increasing cysteine
concentration), the effect of cystine was ameliorated (Fig. 5.5). These results are consistent
with cathepsin B undergoing cystine-dependent oxidation, resulting in decreased stability
(Fig. 5.5), but in a manner that apparently did not affect the enzyme's activity (Fig. 5.4b).
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5.4.3 The effect of redox buffers on cathepsin B hydrolysis of whole protein
substrates
Haemoglobin, BSA, RA-BSA and lysosome were selected as substrates because of their
distinct structural features. Haemoglobin, is a tetramer with no disulfide bridges and two
free cysteines; BSA has seventeen disulfide bridges, and one free cysteine; RA-BSA has no
free thiols or disulfide bridges; and lysozyme has four disulfide bridges and a free cysteine.
The last three proteins are monomeric (Table 5.1).
With increasing concentration of cysteine, cathepsin B activity against haemoglobin showed
no consistent trend but instead a local minimum at about 0.5---71 mM, and local maxima at
0- and 5 mM cysteine, in both the presence or absence of cystine (Fig. 5.7a) were evident.
Cystine, at 0.8 mM, appeared to increase the rate compared to rates with 0 or 0.2 mM
cystine, over the entire tested range of 0---710 mM cysteine. This stimulatory effect was
not linear, however, as rates with 0 mM cystine were, at some cysteine concentrations,
greater than rates with 0.2 mM cystine and at others were less than with 0.2 mM cystine.
However, at either high or low concentrations of cysteine, cystine appeared to increase the
rates of haemoglobin hydrolysis.
Cystine exerted a similar effect on the hydrolysis ofRA-BSA by cathepsin B (Fig. 5.7b).
At lower thiol concentrations, in the presence of differing concentrations of cystine, the
rates of hydrolysis were approximately similar (Fig. 5.7b). However, at higher thiol
concentrations (> 1 mM), cystine appeares to increase the rates of cathepsin B hydrolysis
of RA-BSA. This effect was greatest with 0.8 mM cystine. Also conspicuous, was that
the activity of cathepsin B against RA-BSA, like that for haemoglobin, was relatively high
in the absence of thiol, and in the presence of 0.8 mM cystine, when compared to buffers
with no cystine or 0.2 mM cystine (Fig. 5.7a-b). The activity at 0.8 mM cystine was also
high at relatively high concentrations of cysteine.
It is likely that cystine exerts this effect on hydrolysis, only in absence of disulfide links in
the substrate. Both BSA and lysosome did not show uniform increases in the hydrolysis
rates, with increases in cystine concentration (Fig. 5.7c-d). In the case of BSA, cystine
appeared to exert no significant effect on cathepsin B activity against the substrate. At low
thiol concentrations « 1 mM), lysozyme hydrolysis by cathepsin B occurred at similar
rates in the presence of different concentrations of cystine. However, at 5 mM cysteine,
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the hydrolysis of lysozyme occurred at a greater rate in the presence of 0.2 mM cystine. In
contrast, the activity of cathepsin B at 5 mM cysteine, and in the presence of 0.8 mM
cystine, was depressed when compared to the experiments without cystine (Fig. 5.7d). In
the case of both BSA and lysozyme, the local minimum effect in activity, with increasing
cysteine concentration (Fig. 5.3) was not present. The rates of hydrolysis of all the protein
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Figure 5.7. The effect of cysteine:cystine AMT redox buffers on
cathepsin B hydrolysis of haemoglobin (A), RA-BSA (B), BSA (C) and
lysozyme (D) was assessed at pH 6.0. The redox buffers contained
cysteine (0-10 mM) and cystine at 0 mM (0), 0.2 mM (e) and 0.8 mM
(.). The data represent the mean ± standard error of 3 independent
experiments.
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The effect of cystine on cathepsin B activity against whole protein substrates is enigmatic.
The activity against substrates with no disulfide bonds appears to be stimulated by the
presence of cystine but the activity against substrates with disulfide bonds was not
stimulated. The activity of cathepsin B against the fluorometric substrates indicated that
cystine did not significantly increase activity (Fig. 5.4), and may actually contribute to
oxidative denaturation of the enzyme (Fig. 5.5). Further, control experiments demonstrated
that the redox buffers themselves were not denaturing the substrate. This suggests that the
stimulatory effect that cystine exerts on cathepsin B hydrolysis of substrates without
disulfide bridges, may be related to interaction of the enzyme with substrate. To determine
whether this effect is a general feature of lysosomal proteolysis, the action of cathepsin D
against these substrates was assessed.
5.4.4 The effect of redox buffers on cathepsin D hydrolysis of whole protein
substrates
Cathepsin D is a lysosomal aspartic protease which operates at pH values less than pH 4.0.
At this low pH thiol-disulfide exchange would be inhibited. Cathepsin D hydrolysis of
haemoglobin (Fig. 5.8a) showed that the presence of 0.8 mM cystine did not significantly
affect proteolysis at low cysteine concentrations « 1 mM). However, at thiol
concentrations greater than 1 mM the hydrolysis of haemoglobin was stimulated by the
presence of cystine. A similar pattern of hydrolysis was observed for cathepsin D
hydrolysis ofRA-BSA (Fig. 5.8b), with the highest rates of hydrolysis noted with 0.8 mM
cystine and 10 mM cysteine. In contrast, cystine did not appear to stimulate BSA
hydrolysis by cathepsin D (Fig. 5.8c). On the other hand, cystine appeared to stimulate
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Figure 5.8. The effect of cysteine:cystine AMT redox buffers on
cathepsin D hydrolysis of haemoglobin (A), RA-BSA (B), BSA (C) and
lysozyme (D) was assessed at pH 6.0. The redox buffers contained
cysteine (0-10 mM) and cystine at 0 mM (e) and 0.8 mM (.). The data
represents the mean ± standard error of 3 independent experiments.
5.5 Discussion
From previous work in this laboratory and others, the activity and stability properties of
cathepsin B appeared to be disparate. Activity appeared to have a neutral to slightly basic
pH optimum, and yet the enzyme was most stable at a more acidic pH. In the present
study, however, the activity of cathepsin B was similar at pH 6.0 and pH 7.0. This may be
due to differences in the assay and cathepsin B isolation procedures used in these
experiments. Isolated cathepsin B is usually not made up of fully active enzyme. Further
the enzyme may be oxidised, and has to be reduced to restore activity. In the present study
cathepsin B was affinity purified, and the enzyme was pre-activated before being used in
the respective (pH) test buffers. In previous experiments, less than 100% active enzyme
may have been used and/or the enzyme was activated in the test buffers themselves. In
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these cases, differences in activity at different pHs may reflect the degree of reduction at the
different pHs. Since reduction occurs more efficiently with increasing pH, the degree of
reductive activation, and hence activity, would be expected to be greater at pH 7.0 than at
pH 6.0 for a given concentration of thiol. For this reason, perhaps, cathepsin B appeared to
have a neutral pH optimum.
In contrast to the activity of the enzyme in the present study, the stability of cathepsin B
was found to be significantly greater at pH 6.0 than at pH 7.0. This suggests that the
enzyme would be capable of operating at maximal activity at pH 6.0, without the loss of
stability that occurs at higher pH. Thus, it is considered likely that in vivo, cathepsin B
generally operates at acidic, and not neutral pHs. The enzyme showed local minima in
activity in cysteine (pH 5.0-7.0) and GSH-containing buffers, as well as in stability, in
cysteine-containing buffers (pH 6.0 and 7.0). A common mechanism may be responsible
for these minima. Krepela et al. (1999) suggested that the local minimum in cathepsin B
activity with increases in cysteine concentration is due to cysteine-thiol inhibition of the
enzyme. However, the results described here suggest that this does not adequately explain
this phenomenon. A further potential flaw in the study of Krepela et al. (1999) work is
that the ratio of thiol :thiolate remains essentially the same with increases in cysteine
concentration, at a given pH. Thus, the thiolate concentration does not increase relative to
the thiol concentration, and therefore the levels of cathepsin B inhibition should have been
the same for any concentration of cysteine at a given pH. The local minimum in activity is
not present in buffers containing cystine.
GSH is the principal cytosolic reducing agent in eukaryotes, with concentrations ranging
from 0.1-10 mM (Allen, 1991; Meister, 1995). It appears that the activity of cathepsin B
is depressed in GSH-containing buffers, compared to cysteine-containing buffers at pH 7.0.
The high cytosolic GSH concentration may thus restrain cathepsin B activity in the
cytoplasm. This may provide an additional defence, should cathepsins leak from
'lysosomes' (Brunk et aI., 1995).
The effect of cysteine:cystine redox buffers on cathepsin B activity was assessed at pH 6.0
and pH 7.0. In these experiments, it was found that the enzyme activity did not change
over a broad redox potential range of -80 mV to -350 mY, i.e. from relatively oxidising
conditions to relatively highly reducing conditions. The endoplasmic reticulum, for
example, is considered to be a relatively oxidising environment, and has an estimated redox
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potential between -170 and -185 mV (Hwang et a!., 1992). In our experiments, cathepsin B
was also assayed under relatively highly reducing conditions « -250 mY), and the enzyme
activity was not affected. Thus, our data indicates that cathepsin B activity is similar in
both relatively oxidising and reducing environments. These results suggest that the activity
of cathepsin B is probably not redox regulated in vivo.
The stability of cathepsin B was also measured under varying redox conditions. At pH 6.0,
the enzyme was essentially stable to all redox conditions tested within the limits of these
assays. At pH 7.0, however, it was found that the stability was linearly related to redox
potential up until -250 mV (Fig. 5.5). The absolute concentration of cystine affected
stability, with higher concentrations of cystine depressing stability at a given redox
potential. The negative effect of cystine and oxidising redox conditions on the stability of
the enzyme at pH 7.0, could occur through two possible mechanisms. Firstly, cystine and
oxidising redox conditions may accelerate the pH-dependent denaturation of the enzyme.
Alternatively, cystine-dependent oxidative denaturation of the enzyme may occur more
efficiently at pH 7.0 than at pH 6.0, as thiol-disulfide exchange occurs more efficiently at
higher pH. These two mechanisms are not mutually exclusive. Thus, despite cathepsin B
activity showing no sensitivity to redox potential at pH 7.0, the stability of the enzyme
may be affected by redox potential and the ambient concentration of cystine.
These experiments indicate that cathepsin B activity may not be redox regulated as the
enzyme is capable of operating over a broad redox potential. As the endolysosomal redox
environment may be highly dynamic, it appears that cathepsin B may be well-suited to the
system. Could cathepsin B operate in extra-endolysosomal redox environments, and would
it be stable? The present study indicates that the activity of the enzyme does not preclude
it from operating in redox environments other than the endolysosomal system. However,
the pH, and the nature and ratios of redox agents present within these environments, may
affect the stability of the enzyme.
Most whole protein substrate hydrolysis assays have, in the past, been undertaken without
protection against oxidation. Hence, the effect of oxidised forms of reducing agents on
substrate hydrolysis has not been reported. In the present study, cathepsin B hydrolysis
was undertaken with cystine at differing levels. All assays were conducted at pH 6.0, as
the fluorometric assay data indicated that the operational pH for cathepsin B in vivo may
be acidic.
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The results indicate that the degree of hydrolysis of whole protein substrates in AMT
redox buffers depends on whether the substrate has disulfide links or not. In those
substrates without disulfide bridges (haemoglobin and RA-BSA), cystine appears to
increase the rates of hydrolysis in a dose-dependent manner. This effect is not due to
cathepsin B (Fig. 5.4), nor is it due to the effect of cystine on the substrates alone (control
experiment, Section 5.3.3). It appears therefore that cystine may exert this effect on the
protease-substrate interaction. However, in those substrates with disulfide links (BSA and
lysozyme) cystine does not appear to exert this effect on proteolysis, although, lysozyme
hydrolysis may be stimulated by 0.2 mM cystine. It should be noted that lysozyme h~s
four disulfide links compared to the seventeen disulfide links of BSA (Table 5.1). To
confirm this effect, the effect of cystine on the hydrolysis of these substrates by
cathepsin D was undertaken. Cathepsin D is an aspartic protease, and operates at
relatively acidic pHs compared to cathepsin B. However, even at these low pHs cystine
appeared to stimulate hydrolysis of substrates without disulfide bridges. Thus, this data
confirms that this effect is not due to cathepsin B alone, and may be a general feature of
proteolysis in these buffers. In the case of all substrates tested, there was no correlation
between substrate hydrolysis and redox potential.
Two questions arise: what is the mechanism behind this effect, and, is it relevant in vivo?
The mechanism by which cystine exerts its effects, may not be redox related. In those
substrates without disulfide links, or even available cysteine residues, cystine increased the
rates of proteolysis. Cystine may exert this effect by affecting the structure of the
substrates during degradation; or by influencing the enzyme-substrate interaction. It has
been shown that cystine alone is capable of refolding oxidised-denatured lysozyme (Raman
et aI., 1996). These authors also found that the cysteine:cystine redox pair was more
effective than a GSHlGSSG redox buffer system in refolding lysozyme. It may be possible
that a cysteine: cystine redox system may influence available substrate concentration,
thereby increasing the rates of proteolysis. In the cases of those substrates with disulfide
links, cystine may also exert a similar effect. However, in addition, cystine may decrease
proteolysis by hindering disulfide bond breakage. This could explain the partial increase in
proteolysis, in buffers containing cystine, of lysozyme (4 disulfide bridges), compared to
BSA (17 disulfide bridges). A feature of the effect of cystine is that it also stimulated
cathepsin D hydrolysis of substrates that had no disulfide bridges. These assays were done
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at a very acidic pH (pH 3.2), where redox reactions would be expected to occur very
inefficiently, supporting the contention that cystine's effect may not be redox related.
Is this relevant in vivo? Unfortunately, the levels and ratios of cysteine:cystine within the
endolysosomal system have not been determined. However, it is clear from the results
reported here that hydrolysis of these protein substrates does not depend on redox
potential. Collectively the data indicate that redox potential per se does not appear to have
a significant effect on proteolysis in vivo. The endolysosomal redox environmnet may,
however, exert an effect on cathepsin B stability and on protease-substrate interactions.
89
CHAPTER 6
THEORETICAL CONSIDERATIONS REGARDING POSSIBLE
THERAPY OF PATHOLOGIES BASED ON LYSOSOMAL PROTEASES
6.1 Introduction
The bulk of this thesis has been concerned with the action of proteases within the
endolysosomal system. A systemic approach was adopted in looking at protease regulation
within the endolysosomal system. In certain pathological conditions like cancer, these
proteases may be secreted and contribute to the destruction of extracellular components
(Yan et ai, 1998). Looking ahead to the possibility of controlling conditions that involve
inappropriate protease activity, some concepts on the use of protease inhibitors as
therapeutic agents were reviewed and are discussed in this chapter. As with the
endolysosomal system a system-based approach, rather than a moleculer-based approach
was adopted.
There appear to be at least two major considerations for using a protease inhibitor as a
therapeutic agent: the inhibitor should be effective, and should have good pharmokinetic
properties. In order to fulfil the latter consideration the inhibitor should have minimal
peptide character, high stability, good membrane permeability, good retention within the
body, good bioavailability and should usually be less than 1 kDa in size (Leung et al., 2000).
In order for the inhibitor to be effective in vivo it should inhibit the target protease rapidly,
and this interaction should be stable. In most cases, specific inhibitors are favoured.
However, in some cases, class specific inhibitors are favoured. The inhibitor should also be
reversible, as irreversible inhibitors tend to have highly reactive moieties that may interact
non-specifically with other electrophiles or nucleophiles found within the body (Leung
et aI., 2000). This discussion will focus on the choice of inhibitors for therapeutic
purposes.
Traditionally, natural products were screened for their inhibitory potential and empirical
methods were used to design an inhibitor with the appropriate character. However, this
screening procedure is being replaced by a new approach known as 'rational drug design'.
Using this approach, at least three strategies are used to find potential therapeutic drugs
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(Leung et aI., 2000). Firstly, the natural or perhaps the 'best' substrate of the protease is
used as a framework to design a peptide inhibitor. This inhibitor usually has a transition
state isostere to trap the enzyme catalytic mechanism in some transition state (Leung et al.,
2000). The peptidic character of the inhibitor is then reduced to ensure that the inhibitor
has good pharmokinetic properties. A second approach is to use the crystal structure of
the protease or a closely related enzyme to design an inhibitor that fits directly into the
active site of the enzyme (Leung et aI., 2000). Saquinavir, an inhibitor of the HIV-l
protease, was the first drug, designed in this way, to be approved for human use (Pakyz
and Israel, 1997; Patick and Potts, 1998). Finally, combinatorial chemistry is used to
generate a library of chemical compounds that are screened for their inhibitory nature
(Leung et al., 2000). In most cases the screening protocols used, select for competitive-
type inhibitors.
Using these approaches, there have been some successes, notably for protease inhibitors
directed at the HIV-l protease, especially when these inhibitors are used in combination
with other drugs (Leung et al., 2000). There have also been some failures, notably for
metalloprotease inhibitors in the treatment of cancers. The reasons for the failure of these
drugs could be attributed to poor clinical trial design, an incomplete understanding of the in
vivo function of these proteases, and the fact that these inhibitors are designed only to be
cytostatic (Coussens et aI., 2002).
6.2 In vitro parameters used for selecting protease inhibitors
How are good protease inhibitors selected? There are two considerations for selecting a
protease with potentially good inhibition properties in vivo. Firstly, the inhibitor's
concentration in vivo should be known. Secondly, the inhibitor should have good inhibitory
characteristics, which are usually measured in vitro. Bieth (1984, 1995) related these
ill vitro characteristics with the inhibitor's potency in vivo. The inhibitor should rapidly
inhibit the target protease, and secondly the enzyme inhibitor complex should be stable.
Assuming that the in vivo inhibitor concentration is significantly greater than the protease
concentration, and that the inhibitor behaves in an irreversible or pseudoirreversible manner,
the time that it takes a protease-inhibitor association to be >99% complete is given by the






where d(t) is the delay time of inhibition, (SaJ is substrate concentration, Km is the Michaelis
constant for that substrate, k ass is the rate constant for enzyme inhibitor reaction, and (faJ is
the inhibitor concentration (Bieth, 1984). If there are many substrates that compete with
the inhibitor for the enzyme, their affects are additive, i.e.










where k'ass is the in vivo association rate constant (Bieth, 1984). The delay time of
inhibition can then be used to determine the effectiveness of an inhibitor in vivo using an
equation that measures the degree of substrate turnover in the presence of an inhibitor:
(P~) = kear .(Eo) d(t)
(So) Km 5
(6)
where (P 00) is the product concentration at the end of the inhibition process, kea! is the
catalytic rate constant, Eo is the enzyme concentration (Bieth, 1984). Using this measure, it
can be shown that with a d(t)= 1 sec, no more than 2% of substrate will be consumed before
inhibition.
Bieth (1984) also determined that the stability of the proteinase-inhibitor complex depends
on the ratio of (faJIKj • If this ratio is greater than 1000, then a reversible inhibitor may
display pseudoirreversible inhibition, and is stable to substrate-induced dissociation of the
protease-inhibitor complex. Further, the effect of competing substrate may be minimal.
The design of proteinase inhibitors is therefore centred on minimising the delay time of
inhibition, and increasing the ratio of (faJIKj •
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In summary, to assess a protease for good in vivo inhibition properties, the following
parameters have to be checked. The Kj or apparent K j (Kjapp) of the protease-inhibitor.
reaction must be determined, and the in vivo concentration of the inhibitor should be
known. Secondly, the delay time of inhibition should be determined. If this is less than
I sec, it is reasonable to assume that the protease-inhibitor interaction occurs rapidly
enough to prevent much substrate degradation. If the (IJlK j ratio is >1000, it is likely that
the inhibitor behaves in a pseudoirreversible manner towards the protease, and the effect of
competing substrate is negligible. Finally, although not discussed above, the stability of the
protease-inhibitor interaction must be assessed. This general approach is employed in
screening for protease inhibitors as potential therapeutic agents.
6.3 Protease-inhibitors interactions: the effect of Eo
Enzyme inhibitor complex formation also shows some particular properties. It can be
shown that protease-inhibitor interactions can display either tight-binding or irreversible or
classical behaviour depending on the ratio of EjKj (Fig. 6.1) (Bieth, 1984). If the ratio of
EjK j is very high, then the inhibitor might actually titrate the protease (curve 1, Fig. 6.1)
Here, the inhibitor concentration is approximately equal to the protease concentration and
can form equimolar complexes.
If, however, the ratio of Eo/Kjis very low (for the same protease:inhibitor interaction), then
the behaviour of the protease and inhibitor is called 'classical'. Under classical conditions,
[inhibitor] » [protease], and the resulting curve has an exponential shape (curve 4, Fig.
6.1). The effect ofK j , [protease] and [inhibitor] has two important implications. Firstly, in
terms of rational drug design, inhibitors should be designed with as Iowa K j as possible to
ensure that they may operate in titration rather than classical conditions. The second
implication is that for a given inhibitor (with a fixed KD, the nature of the interaction
between the protease and inhibitor may depend on the concentration of the protease. For
example, if the enzyme concentration relative to the K j is very high (curve 1, Fig. 6.1), then
titration-type behaviour will be expected. If, however, the enzyme concentration is low
relative to the K j (curve 6, Fig. 6.1), then inhibition may be described as classical or even not
be detected.
If these properties hold in vivo, it does suggest a rather elegant mechanism in which limited
proteolysis is allowed, but large concentrations of protease are efficiently inhibited.
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Assuming that the [inhibitor] » [Eo], as the protease concentration increases, the nature of
the protease-inihibitor interaction changes from 'classical' to 'titration' (from curve 6 to
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Figure 6.1. The effect of the variable [Eo]/Ki on fractional free enzyme.
Plots were constmcted using the Morrison equation (from Bieth, 1995).
This also suggests a mechanism through which disregulated proteolysis could occur. If
relatively high concentrations of protease were secreted by tumour cells or pathogenic
organisms then titration conditions ([EoJ/K j > 100) would prevail, effectively stopping
inappropriate proteolysis. If, on the other hand, tumour cells, or other pathogenic
organisms, continually secrete small amounts of protease such that the ratio [Eo]/Kj remains
less than 10, classical conditions between the protease and inhibitor may prevail (Figure
6.1), and thus some of these proteases may escape inhibition. Whilst it may be argued that
small amounts of protease may not significantly damage host tissue, the continuous
secretion of a protease may yet result in significant damage to host tissue, whilst
circumventing host protease inhibitors. As an inhibitor may operate under classical or
titration conditions depending on the ratio of protease to inhibitor, therapeutic inhibitor
intervention In conditions where disregulated proteolysis occurs may require the
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concentration of the target protease to be known. Alternatively the maximal permissable
[protease] may need to be known.
6.4 Metabolic control analysis and inhibition in vivo
The class of protease inhibitors favoured for therapeutic applications are usually of the
competitive type. However, Cornish-Bowden (1995; 1999) has described how effective
uncompetitve inhibitors may be in vivo, especially compared to competitive-type
inhibitors. Enzyme-substrate-inhibitor interaction in vivo may be different to the situation
ill vitro (Comish-Bowden, 1995; 1999). Usually the kinetic properties of an enzyme are
studied by measuring the rate of the reaction using various substrate concentrations, i:e.
fixed substrate concentrations and variable rates. This data is then modelled on the
Michaelis-Menton equation, usually using non-linear regression analysis. The situation in
vivo may be essentially the opposite. Enzyme systems may adjust appropriate substrate
concentrations to achieve a particular rate, i.e. fixed rates and variable substrate
concentrations (Comish-Bowden, 1995; 1999). This situation might prevail in vivo for
most enzymes (Cornish-Bowden, 1995). Thus the Michaelis-Menton equation can be




Using this equation, expressIOns for uncompetitive competition and competitive
competition are given below (Comish-Bowden, 1995; 1999). For competitive inhibition,
the rate equation (Cornish-Bowden, 1995) is given by:
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Km(l+-)
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Comparing these two expressions, it can be demonstrated that there is no finite value for i
where competitive expression could yield zero substrate concentration, as both i and So
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share a linear relationship. Further, modelling of the equation by Comish-Bowden (1995;
1999) revealed that the effects of competitive inhibition may be overcome by relatively
moderate changes in the substrate concentration. On the other hand, it is clear that the
denominator of the expression for uncompetitive inhibition can be zero, suggesting that
steady-state (between the enzyme and substrate) may never be reached (Comish-Bowden,
1995). Thus, uncompetitive inhibitors are expected to be extremely potent in vivo.
The effectiveness of these inhibitors in vivo may be due to the fact that their action is
actually potentiated by substrate, making them highly efficient inhibitors. In contrast,
competitive inhibitors compete against available substrate and therefore have to be present
at significantly higher concentrations compared to uncompetitive inhibitors. This also has
implications on the cost and pharmokinetic properties of competitive versus uncompetitive
inhibitors. Uncompetitive inhibitors may be more cost-effective as they would be expected
to be effective at lower concentrations than competitive inhibitors. Further, as they may
operate at lower in vivo concentrations than competitive inhibitors, the optimisation of
their pharmokinetic profiles may be simpler.
The efficiency of uncompetitive inhibition has been demonstrated for the herbicide 'Round-
up' (glycophosphate) which inhibits 3-phosphoshikimate 3-carboxyvinyltransferase, as
well as for Li+ which inhibits myo-inositol monophosphate (used to treat manic depression)
(reviewed by Cornish-Bowden, 1999). Brefeldin A has recently been shown to be an
uncompetitive inhibitor of ADP ribosylation factor-l (or Arf-l) exchange factors which are
important for secretion by mammalian cells (reviewed in Chardin and McCormick, 1999).
It is clear that not all the enzymes inhibited uncompetitively are metabolic-type enzymes,
and thus the effectiveness of uncompetitive inhibitors is not limited to these enzymes.
Uncompetitive protease inhibitors have not been extensively reported in the literature, but
non-competitive inhibition of the trypanosomal protease oligopeptidase-Tb by suramin
was demonstrated (Morty et aI., 1998). Non-competitive inhibitors have an uncompetitive
component to them, and the effectiveness of suramin was demonstrated by its high
trypanocidal activity in vivo (Morty et aI., 1998). Uncompetitive inhibitors may be rarely
found ill vivo, in part due to their high efficiency (Comish-Bowden, 1995). However, as
long as an inhibitor has a significant uncompetitive component, it may be highly effective in
vivo (Cornish-Bowden, 1995; 1999). It may be worthwhile for inhibitor screens to be
modified to look beyond in vitro parameters such as K j , (IJlKj and the delay time of
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inhibition. The screens could also take into account the type of inhibition, or the
contribution made by uncompetitive-type inhibition. Uncompetitive protease inhibitors
may provide a new, highly efficient class of inhibitors for therapeutic intervention in
diseases involving proteases. Instead of looking at the contours of the active site,
researchers could look at the contours of the ES complex and try to rationally design
compounds which would complex this. One possibility would be to use a substrate
analogue which forms an irreversible ES complex and use this to model the contours.





In the past, proteolysis within the endolysosomal system was studied by two different
schools. The proteases within the endolysosomal system were isolated, and their kinetic
and structural properties determined in vitro. Alternatively, proteolysis within the
endolysosomal system was approached using traditional cell biology methodologies like
electron microscopy and organelle fractionation by density gradient centrifugation. Those
studies that managed to use tools from both approaches often yielded the most interesting
results (e.g. Tjelle et aI., 1996). In this thesis, an effort has been made to integrate
knowledge of the endolysosomal system (cell biology), with the properties of the enzymes
(enzyme kinetics). The approach was found to be useful, as it gave insights into how the
entire endolysosomal system may be regulated. An example of this is the proposed
mechanism for protease aggregation within lysosomes (Section 2.1). Hydrolases within
lysosomes may aggregate due to electrostatic interactions with LAMP-2 at low pH. In
trying to isolate lysosomal enzymes, their strong cationic properties are often used to
separate them by ion-exchange chromatography (Chapter 4). Thus, it was possible to
associate the proteases' electrostatic properties with regulation in vivo. Also, thi s
mechanism may explain the functional differences between late endosomes and lysosomes,
despite their similar constituents. The electrostatic properties of these proteases may also
play a role in the organelle distribution of these enzymes. As can be seen in Table 2.2, the
pI of cathepsin H > cathepsin S > cathepsin Band L. Cathepsin H may be predominately
localised to the early endosome, whilst cathepsin S is predominately located in the late
endosome. Cathepsins B and L have a late endosome-lysosome distribution. It is thus
possible that retention of a protease within a specific organelle along the endolysosomal
system is dependent on the pI of that protease.
7.2 Review of the endolysosomal system
In an effort to integrate knowledge of the endolysosomal system with our current
understanding of lysosomal proteases, it was necessary to develop a comprehensive view of
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the system, as this helped focus the research efforts, and facilitated interpretation of the
results in the context of the endolysosomal system as a whole. To this end the
endolysosomal system was reviewed, concentrating on proteolytic environments with the
system. Some important results were obtained from this review. Firstly, it became clear
that the proteases within the endolysosomal system are regulated in a manner that does not
involve inhibitors. Rather, the proteases may be subjected to 'organelle-dependent'
regulation of proteolysis, in a hierarchical system.
The principal proteolytic environments within the endolysosomal system are the late
endosome (or the hybrid organelle), the phagosome and autophagosome. Lysosomes are
believed to be storage organelles for the proteases, and the bulk of proteolysis does not
occur within these organelles. The proteolytically competent organe1les, have a common set
of molecules that appear to be necessary for proteolysis: the proteases themselves, the v-
ATPase, LAMPs and perhaps the cysteine transporter (Chapter 2). The v-ATPase and
cysteine transporter may effect changes in the luminal conditions within these organelles,
affecting both the substrates and proteases within the system. Disulfide links within the
structure of substrate may be reduced either by the cysteine itself, or the cysteine-
dependent thiol reductase GILT. Acidification may also aid proteolysis by also affecting
substrate structure. The pH and redox conditions would also affect the activity and
stability of the 'lysosomal' hydrolases within the endolysosomal system but these appear
to be well adapted to these conditions, having half-lives from days to weeks.
As demonstrated in Table 2.1 (Chapter 2), not much is known about the importance of the
lysosomal cysteine transporter in autophagy or phagocytosis. The sequence and structure
of the transporter is also not known. In fact, not much is known about the sequences of
most of the 'lysosomal' amino acid membrane transporters. To date, only a single
transporter for small and neutral amino acids has been sequenced (Sagne et aI., 2001). Using
human genome data (www.ncbi.nih.gov), and bioinformatics tools (like the Basic Local
Alignment Search Tool or BLAST), a search of the database was undertaken for the
cysteine transporter. Several search criteria were used, including known lysosomal targeting
signals like GYXX<I>, where <I> is a hydrophobic amino acid residue (Gough et aI., 1999), or
the dileucine motif (Johnson and Kornfeld, 1992). Another approach used, was to identify
cysteine transporters found in other organisms. These were then used to do BLAST
searches through the human genome database. These potential cysteine transporters were
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screened using structure prediction programmes from Swiss-Prot (www.expasy.ch) and
manually looking for lysosomal targeting signals. Potential putative cysteine transporters
were used to do BLAST searches through other databases to check whether they showed
homology to other cysteine transporters. Unfortunately the human genome database
currently has too many 'unknown' proteins for a function to be assigned, based on their
sequences. Whilst the search itself was unsuccessful, it raised some interesting points about
the cysteine transporter. Cysteine is not favoured as a reducing agent in organisms that
exist under aerobic conditions, as it is oxidised rapidly by atmospheric oxygen (Newton and
Fahey, 1995). Cysteine is, however, found as a major biothiol in organisms growing under
anaerobic conditions. For organisms growing under aerobic conditions, GSH, which oxidises
more slowly, is preferred (Newton and Fahey, 1995). As a result, cysteine transporters,
and lysosomal cysteine transporters in particular, may not be as common in nature as other
amino acid or biothiol transporters. Once the transporter has been isolated and sequenced,
the role that it has played in the evolution of endolysosomal function may be a fascinating
research topic.
The transporter is believed to support reducing conditions within the latter stages of the
endolysosomal system. The redox potential within the system, and its effect onproteases
and their substrates has not been determined. In this study an attempt was made to
determine the redox properties of a lysosomal cysteine protease, cathepsin B, and to
extrapolate these results to the possible effect of reducing conditions in vivo.
7.3 Redox properties of cathepsin B
Before the properties of cathepsin B could be characterised, an efficient isolation procedure
was needed. In the past our laboratory has utilised TPP as an upstream step in the
isolation of proteases. In this study it was discovered that, by including 30% t-butanol in
homogenisation buffers, lysosomal hydrolases were placed in 'suspended animation',
preventing artefact formation and improving yields (Dennison et al., 2000). Affinity
columns were used to ensure that the downstream purification procedures were efficient
and yielded a high proportion of active enzyme (80-100% for cathepsin B). It was
expected that the proportion of active enzyme in redox assays would be important, as redox
buffers have the capacity to refold/reactivate oxidatively denatured enzyme (Raman et al.,
1996).
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The assay procedures used in the redox experiments were also novel. Cathepsin B was
isolated in an inactive complex, but was pre-activated before use. This generally yielded
close to 100% active enzyme molecules, by E-64 titration. In cathepsin B preparations that
contain only 30-50% active enzyme, inactive molecules may be renatured by the redox
buffers. It has been shown that redox potential and pH share an inverse relationship (Segal,
1976). Thus at higher pH the greater efficiency of reduction may increase the proportion of
active enzyme molecules. This will give higher apparent activities at higher pH and an
erroneously high apparent pH optimum. This cannot happen if 100% active enzyme is
used. Further, although pre-activating cathepsin B is a standard assay procedure, most pH-
optimum studies pre-activate oxidised cathepsin B in the test pH buffer. Thus, when
determining the pH optimum of cathepsin B, the efficiency of reduction may be greater at a
higher pH than a lower pH for a given concentration of thiol. This would also tend to give
an apparently higher pH optimum for cathepsin B. In this study, cathepsin B was always
pre-activated in the same assay buffer to ensure that the enzyme used during the assay
procedures was always between 80-100% active. Finally, and in contrast to most other
cathepsin B assay procedures, care was taken to limit oxidation of the buffers by
atmospheric oxygen.
Some significant results were obtained from these experiments. In the past cathepsin B was
assigned a neutral pH optimum for activity (Khouri et al., 1991; Hasnain et a/., 1992; Moin
et a/., 1992; Dehrmann et a/., 1996). However the enzymes' stability was apparently
greater at acidic rather than neutral pH values (Dehrmann et al., 1996). The results obtained
in the present study suggested that this paradox may be an artefact created by not using
100% active enzyme. The present data indicates that both the enzymes' stability and
activity were optimum at acidic pH. Thus, the operational pH of the enzyme in vivo may
be acidic. It was also found that the enzyme showed a local minimum in activity with
increasing concentrations of cysteine. This decrease inactivity was abrogated by increasing
cysteine concentration. This effect was found over all pHs tested, and with GSH-
containing buffers. Further, the enzymes' stability showed a similar response to increasing
cysteine concentration. This data indicates that the proposed inhibition of cathepsin B
activity by the thiol form of cysteine (Krepela et a/., 1999) is unlikely. The enzyme may
become less stable, although the mechanism, and significance of this effect in vivo, is
unclear. This local minimum effect on cathepsin B activity was not present in buffers that
contained cystine.
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With buffers containing cysteine and cystine, it was possible to calculate the redox potential
and the effect of cystine on cathepsin B activity and stability was assessed. This is the
first time, to the author's knowledge, that the redox properties of any cysteine protease has
been probed. It is often assumed that cysteine proteases operate under reducing conditions,
but these conditions are usually not defined. The results obtained using a synthetic
substrate indicated that cathepsin B stability, but not activity was affected by redox
potential at pH 7.0. At pH 6.0, cathepsin B was too stable for any effect of redox potential
to be determined. However, the activity of the enzyme did not show any dependence on
redox potential over all pHs tested. Cathepsin B activity, therefore, is probably not redox
regulated in vivo. However, reducing conditions may stabilise the enzyme at higher pH as
the late endosome/lysosome pH environment may vary to support hydrcilases with basic
pH optima (Tjelle et al., 1995).
The effect of cysteine/cystine redox buffers on cathepsin B activity against whole protein
substrates was also determined. It was found that the hydrolysis of substrates without
disulfide bridges appeared to be stimulated by cystine. In contrast, for substrates with
disulfide bridges, cystine gave mixed results. Similar results were obtained with
cathepsin D, an aspartic protease that operates at very low pHs. Control experiments
indicated that the effect of cystine on cathepsin B hydrolysis of these substrates was not
due to the enzyme alone, or to degradation of the substrate by the buffer. Rather, it may
involve the interaction of enzyme and substrate. This may not necessarily be redox
dependent, as the effect of cystine was greatest on those substrates without disulfide
bridges. BSA, which has seventeen disulfide bridges showed no stimulation, whilst
lysosome, which has two disulfide bridges, showed partial stimulation of hydrolysis,
Haemoglobin and reduced-alkylated BSA, which lack free cysteine residues, showed definite
increases in hydrolysis in the presence of cystine. The stimulation of cathepsin D
hydrolysis of whole protein substrates, showed that these effects were not limited to
cysteine proteases. As redox reactions would be expected to occur inefficiently at low pH,
the results obtained using cathepsin D support the view that the effect of cystine is not
redox dependent (Chapter 5). For none of the substrates tested, under the conditions
employed in these experiments, did the rates of substrate hydrolysis show any relationship
with redox potential. Perhaps future research could be directed at exploring the effects of
cysteine:cystine redox buffers on structure and folding for proteins lacking free thiols
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groups or disulfide bridges. Once these effects are quantified, perhaps the results presented
here can be explained.
The relevance of these results in vivo is difficult to assess as components of the 'lysosomal
buffer' have not been discovered yet, nor has the intralysosomal redox potential(s) been
determined. Proteolysis within the endolysosomal system may be more complicated than
is often assumed. 'Lysosomes' have been shown to have heat-shock proteins (Cuervo and
Dice, 1998), and GILT (Arunachalam et a!., 2000). In many ways, destruction of whole
protein substrates within the endolysosomal system may be the reverse of protein folding
within the ER. The redox buffer, and proteins that affect protein structure directly may
therefore be important within the endolysosomal system. Future research efforts could be
directed at isolating the lysosomal cysteine and cystine transporters, determining the
endolysosomal redox potential(s), and the effects, if any, of these on protein hydrolysis in
vivo.
7.4 Hierarchical organisation of the endolysosomal system
There are several possible regulation points for hydrolysis within the endolysosomal
system (Figure 2.1). Of these, the signalling networks may play the largest role in
controlling the rate-limiting steps in endolysosomal hydrolysis and may exert their influence
through molecules that interface between the signalling and endocytic pathways. Some
progress has been made in uniting the signalling networks, the regulation of endolysosomal
fusion reactions, and the components that affect the luminal endolysosomal proteolytic
environment into an integrated model for proteolysis. Recently it has been shown that p38
MAP kinase may accelerate the rate of endocytosis in response to oxidative stress (Cavalli
et a!., 2001), providing a direct link between the endocytic rate and the signalling pathways.
It has also been shown that the E subunit of the V-ATPase may interact with the DH
domain ofmSos1, a guanine nucleotide exchange factor involved in Rac 1 activation (Miura
et aI., 2001). Rac 1 activation regulates various trafficking events like transferrin receptor
mediated clathrin coat vesicle formation (Lamaze et a!., 1996). Although in this case, the E
subunit affected the mSos1-Rac1-signalling pathway (Miura et a!., 2001), it does indicate
that there are domains on the V-ATPase that are capable of interacting with signalling
pathways. The activity of chloride ion channels that influence luminal pH, is regulated by
protein kinase A-dependent phosphorylation (Forgac, 1998). Thus, it is possible that
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acidification of endolysosomal organe1les may be connected to these signalling pathways.
Thus reaulation of conditions within endolysosomal organe1les, and therefore proteases,, I:>
may be integrated via signalling networks, to endocytosis and changes occurring at the
cellular level.
Endolysosomal proteolysis has previously been viewed in the following manner: substrate
is channelled into 'lysosomes', where active lysosomal hydrolases are present at high
concentrations. At these high concentrations, substrate is essentially limiting, and would be
hydrolysed very rapidly. No distinction was made between the proteolytic environments
within the endolysosomal system. In this bulk, non-specific hydrolysis model, no
consideration has been given to regulation of proteolysis, feed-back inhibition, or fluxes
through the endolysosomal system. Essentially lysosomal proteolysis has been viewed as
'garbage disposal', with no luminal regulatory steps necessary.
In the review given in Section 2.1, it was recognised that the endolysosomal system is made
up of functionally distinct, but related environments. In terms of proteolysis, the most
important of these relationships is between lysosomes and late endocytic components, i.e.
maturing phagosomes, AVds, and late endosomes. Lysosomes, despite containing the
highest concentrations of proteases within the endolysosomal system, are not the main site
of proteolysis. Proteolysis occurs primarily in pre-Iysosomal compartments, suggesting
that there may be regulation of proteolysis, i.e. the luminal conditions within the different
organe1les may support proteolysis or not.
Creation of a proteolytically competent environment within the endolysosomal system
depends of the acquisition on certain components: a v-ATPase, proteases, LAMPs, and
perhaps the cysteine transporter. These components may be acquired by fusion between
organe1les and the creation of proteolytically competent environments may thus also be
controlled by regulating the fusion between organe1les within the system. For instance,
fusion with lysosomes may be crucial to introducing the necessary proteases to create
proteolytically competent environments. Also, as substrate may be limiting within the
endolysosomal system, the channelling of substrate from the early endosome to the later
endocytic organe1les may be important. What controls the rate at which organe1les within
the endolysosomal fuse and/or reform? Is the entire endolysosomal system regulated, and if
so how? Unfortunately most studies of proteolysis within the system have been largely
descriptive in nature, detailing where proteolysis occurs but not dealing with the kinetics of
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the system. Also, most studies have not considered whether the proteases within the
system manifest systemic properties.
If we consider the endolysosomal system from proteases through to the organelles, it can be
ordered using function as an organising principle. The components that regulate
endolysosomal proteolysis may be arranged into a hierarchical model. At the base of the
hierarchy are the endolysosomal hydrolases (and substrates) themselves. The activity of
these hydrolases is regulated by the luminal conditions within the organelles. The fusion of
these organelles may be in turn regulated by Rab proteins. These proteins, and organelle
formation, may be regulated by cell signalling pathways, and these pathways may be
regulated at the cellular level. Cells are regulated at the tissue level, and so forth. It appears
that when the organisation of the endosomal system is viewed in terms of function, these
components may be arranged into a hierarchical model. This model consists of tiers, the
lowest being the endolysosomal hydrolases, which are regulated by tiers above them.
Implicit in this model is that functional control for a tier is determined by the tier above. In
essence, this model describes hierarchical function and co-ordination, with the enzymes
themselves being viewed as downstream effectors. The model applies to a cell that is part
of a tissue or 'fixed'. For non-fixed cells, like macrophages and neutrophils, the
organisational tier above the cellular level may be signals related to its function. In these
cells, co-ordinated proteolysis, as a function of overall metabolism, is not as important as
proteolysis related to their functions in pathogen clearance. In fact, most professional
phagocytes are not fixed and are thus not subject to the same hierarchies as other cells. This
model is fairly self-evident, and not a radical departure from how the endolysosomal system
has been viewed. In this model, however, the endolysosomal system is approached using
function as the basic organising principle. This, as will be described below, may have
implications for the treatment of diseases involving the endolysosomal system.
The endolysosomal system provides an entry route for mycobacterial pathogens. These
exploit phagocytosis, the very process normally used to clear pathogens from the body. As
described in Section 2.1, acidification may be essential for generating a competent
endolysosomal proteolytic environment. Not only would acidification create the
appropriate conditions for proteolysis by lysosomal proteases, but it also appears to be a
prerequisite for phagosome-late endosome fusion, and/or possibly phagosome-lysosome
fusion. Treatment of J774 macrophages with either chloroquine or bafilomycin AI, leads to
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a block in fusion between the late endosome/lysosome and latex bead-loaded phagosomes.
In contrast, cathepsin H, which is found predominantly in the early endosome, is delivered
to the phagosome at an enhanced rate. This suggests that early endosome-phagosome
fusogenicity is not inhibited, and is possibly stimulated by these drugs (Claus et al., 1998).
Thus, the progressive maturation of the phagosome is dependent on progressive
acidification.
This property of phagosomes is exploited by Mycobacterium avium which avoids
destruction and survives within the phagosomal/endolysosomal system. When compared to
Leishmania mexicana-, IgG-coated latex bead- and zymosan phagosomes, M avium
phagosomes fail to acidify. The M avium phagosomes remains at about pH 6.3-6.5, which
is very close to the pH of the early endosome. The failure of this phagosome to acidify is
due to the absence of the v-ATPase. It is not clear whether the v-ATPase is excluded, or
whether it is rapidly removed from the phagosome. Studies by Russel et a/. (1996) further
showed that M avium phagosomes, despite not maturing, are still connected to membrane
traffic and may behave as an extension of the recycling early endosome.
Another common factor in the maturation of the phagosome and the autophagic vesicle is
the apparent requirement for LAMP proteins. LAMP incorporation appears to occur
relatively early in phagosome formation, LAMP-2 being incorporated into latex bead
compartments within at least 30 min in 1774 cells (Desjardins eta!., 1994). LAMP-2
incorporation into the phagosome increases steadily until about 6-8 h, when it reaches a
plateau (Claus et aI., 1996). This time frame for incorporation into the phagosome
corresponds with the maximum incorporation of seven hydrolases into the phagosome:
cathepsin B, cathepsin L, dipeptidyl peptidase II, furin, a-galactosidase, ~-glucuronidase
and ~-hexosaminidase (Claus et aI., 1998). The M avium phagosomes show incorporation
of LAMP-1 suggesting that LAMP-1 incorporation is independent of the H+-ATPase
(Sturgill-Kozycki et aI., 1994).
When exploring how Mycobacterium bovis escapes destruction by J774 macrophages, Via et
al. (1997) showed that the M bovis-containing phagosomes fail to incorporate LAMP-2
even after an extended chase of 168 h. It may be argued that incorporation of LAMPs into
the phagosome results from the fusion of the phagosome with the late endosome/lysosome.
Indeed, the failure to incorporate LAMP-2 was correlated with the lack of incorporation of
Rab 7 into theM bovis phagosome (see Fig. 6, Via et al., 1997). Thus, rather than being a
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prerequisite for generating a proteolytic environment, the incorporation of LAMPs into the
phagosome may be coincidental. However, given their presumed role in protecting the late
endolysosomal/lysosomal membrane, LAMPs may be vital components in the phagosomal
proteolytic environment.
Acquisition of Rab proteins by the maturing phagocyte is a biochemical marker of
maturation. Rab 5 appears to be recruited to the phagosomal membrane at the earliest
stages tested (± 30 min, see Fig. 6, Via et aI., 1997; Fig. 5, Jahraus et aI., 1998) and it is
possible that it may have been recruited at an even earlier stage. Rab 5 regulates one of the
fastest endocytic transport routes, from the plasma membrane to the early endosome
(Rybin et aI., 1996). Apart from facilitating content mixing with the early endocytic
apparatus (Mayorga et al., 1991; Piu et aI., 1992; Jahraus et aI., 1998), Rab 5 may also
ensure the rapid delivery of phagocytosed material to the endocytic hydrolases. Rab 5
appears to be retained on the phagosome for up to 168 h (Via et aI., 1997). Given the
highly dynamic nature of this cell line's endocytic system (see above), the retention of
Rab 5 on the phagosomal membrane may still allow for fusion reactions with the late
endocytic structures although early endosome fusion reactions may be favoured.
In latex bead phagosomes, Rab 7 also appears to be recruited to the phagosomal membrane
at the earliest time point tested (1 h) (Via et aI., 1997). Thus, both Rab 5 and 7 are present
on the phagosome. Although Rab 5 is present on all organelles of the endolysosomal
system, it is found at highest concentrations on the early endosome, and lowest
concentrations on the lysosome (Jahraus et al., 1998). Further, Rab 5 appears to stimulate
fusion between the phagosome and endocytic structures until about 4 h (Jahraus et aI.,
1998). Thus, although Rab 5 does appear to be a lifetime resident of the phagosome, it
probably functions in stimulating (more) early endocytic fusion events. Rab 7 may be
responsible for stimulating later endocytic fusion events. The temporal control of fusion
events by these Rabs is probably not distinct, and may be a fail-safe mechanism against
bacterial strategies to escape destruction by the endolysosomal system.
The above model for the function of Rab 5 and Rab 7 work is based on the strategy of
M bovis in escaping destruction once phagocytosed. M bovis phagosomes, compared to
latex bead phagosomes, fail to recruit Rab 7 even after extended periods. In fact, they
appear to accumulate Rab 5 (Via et aI., 1997). Given the distribution of Rab 5 on the
endocytic organelles (see above) it is probable that fusion reactions with the early
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endosomes may occur more frequently than with the later endocytic structures. With age,
the phagosome becomes progressively less fusogenic (Jahraus et aI., 1998), and thus, M
bovis may completely escape destruction. In terms of the hierarchical model proposed
these mycobacteria affect the formation of proteolytically competent organelles (second
organisational tier).
In the process of trypanosome invasion of mammalian cells, lysosomes are exocytosed to
the plasma membrane surface in a manner dependent on an elevated intracellular calcium
concentration (Rodriguez et aI., 1997). This process, mediated by cAMP (Rodriguez et ai.,
1999), has been detected in a variety of cell types and is microtubule independent
(Rodriguez et a!., 1997). In all cases, only about 10-20% of the lysosome population was
recruited to the plasma membrane surface (Rodriguez et a!., 1997). The ability of the
trypanosome to cause lysosomal exocytosis is an example of a disruption at a tier above the
organelle level.
The above discussions on pathogen invasion of host cells was not meant to be an exhaustive
review of these subjects. What is clear from these discussions is that these bacterial
pathogens do not try to directly inhibit the proteases, or any other anti-microbial agents
that a cell may possess. Rather, pathogens, like Mycobacterium tuberculosis or
T,ypanasoma cruzi, probably interfere with the functioning of the endolysosomal system
at the organelle and overall cell tiers. In terms of the hierarchical model, this would be at
functional tiers above the enzyme level. This strategy may be more effective than dealing
with the individual host proteases.
In tumorigenic cells, the organisation of the hierarchy of a 'fixed' or tissue-type cell may be
distorted to resemble that of a non-fixed cell. This may be the mechanism that these cells
use to acquire signals for protease secretion. Proteolysis is no longer controlled at a tissue
level. Further, the unique metabolic nature (like aerobic glycolysis) and microenvironments
around tumour cells may result in relationships within a tier being distorted. Thus, for
example, the hypoxic, glucose deficient microenvironment around certain tumours may
result in cathepsin Band L secretion (Cuvier et a!., 1997).
In terms of the theoretical model proposed, it may be easier to block proteolysis by
disrupting an organisational tier above the proteases. For example, cathepsin proteases
secreted by tumorgenic cells are believed to play an important role in metastasis (Yan et a!.,
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1998). Instead of inhibiting the proteases, it may be more effective to block secretion of the
enzymes in the first place. It is possible that even the molecules used by bacterial cells may
be used to block secretion of hydrolases by tumor cells. It is also clear that it may be
possible to determine hierarchical organisation levels of bacteria or other pathogens, and to
target these. The organisational levels mayor may not involve organelles, but perhaps
molecules that regulate the effector molecules of the pathogenic response may be attacked.
This theoretical model is not wholly unprecedented and has echoes of a field of study in
physics called complex emergent systems. Complex systems deals with the organisation of
matter in disequilibrium states. Chaos theory became a prominent research field in physics
during the 1980s (Bak, 1997). Using simple, though non-linear equations, it was shown
that within a number of degrees of freedom, systems begin to show extremely aperiodic
behaviour (Sardar and Abrams, 1999). In fact, the behaviour of the system could not be
predicted after a certain number of degrees of freedom. An example of this is the equations
used to described the gravitational force between two objects in space. If a third object is
added to the system, calculation of the forces between these objects becomes impossible
(Sadar and Abrams, 1999). This is largely due to the fact that these expressions for
gravitational force are non-linear. Chaotic systems are highly complex, i.e. they show
variability at all scales. In contrast, stable systems are in dynamic equilibrium (Sardar and
Abrams, 1999).
The transition between an equilibrium, or stable state, and a chaotic, disequilibrium state, is
where systems develop self-organising criticality (SaC) (Bak, 1997). Here, at thi s
transition point, systems begin to show complex, emergent behaviour. Whilst these
systems exhibit variability at both large and small scales, they also have curious properties,
not found in chaotic systems: they have the capacity to adapt, and have emergent
properties with dynamics that sometimes work at scales very different from the rules that
form them (Holland, 1995). This is a highly significant property of these systems and may
be the physical basis for the hierarchical system proposed for the endolysosomal system.
This effect of rules can be described with the following example: quarks combine to yield
nucleons which in turn combine to form atoms. This process can be carried from here,
atoms ---t molecules ---t proteins ---t systems. This 'inter-locking' organisation of matter is
the physical basis for the organisation of matter (Holland, 1995). The rules governing the
behaviour of enzyme systems are thus based on the rules governing the formation of
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nucleons, and so forth. However, the rules defining an enzyme system are, in a real sense,
independent of the rules governing nucleon formation (Holland, 1995). Similarly, although
protein structure depends on amino acid interaction(s), the folding of proteins may depend
on free energy requirements for the whole molecule and not on component amino acid
residues. These rules are termed emergent behaviour.
While it may be debatable as to whether the endolysosomal system shows some of the
adaptive properties associated with sac (Bak, 1997) or complex adaptive systems
(Holland, 1995), it can be speculated that the physical organisation of the system, and
perhaps other enzyme systems, display emergent behaviour. The rules governing the
behaviour of the endolysosomal system as a whole, may be different, but not in oppositiort,
to the rules governing the kinetics of the individual lysosomal hydrolases. Hence, the
organisation of the endolysosomal system may appear to be hierarchical. This is significant
as the endolysosomal system may then be subject to systemic regulation.
7.5 Protease inhibitors as therapeutic agents
In Chapter 6 the rationale and parameters used In selecting protease inhibitors for
therapeutic purposes was discussed. The in vitro parameters used for determining whether
an inhibitor may show promise in vivo are the delay time, and the ratio of inhibitor
concentration to the K j . However, it is also clear that the protease concentration may
influence the type of interaction between the inhibitor and protease. Future research could
be directed at determining whether this effect is relevant in vivo.
Lessons from metabolic control analysis suggest that uncompetitive inhibition may be more
efficient than competitive inhibition in vivo. This efficiency stems largely from the fact that
the effect of uncompetitive inhibitors are actually potentiated by substrate. Competitive
inhibitors on the other hand, compete against substrate and have to be present at
significantly higher concentrations than the substrate, and/or need to have a greater affinity
for the enzyme than the substrate does. However, the effectiveness of competitive
inhibitors may be overcome by relatively small changes in substrate concentration (Cornish-
Bowden, 1995). This has many implications for the use of competitive inhibitors as
therapeutic agents in terms of their cost and pharmokinetic properties. To date, no
uncompetitive protease inhibitors have been found. As described by Cornish-Bowden
(1995), the efficiency of these inhibitors may be the reason that they have not been selected
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for in nature. High throughput inhibitor screens for potential protease inhibitors may be
modified to detect for uncompetitive inhibition, or at least to search for inhibitors with a
significant uncompetitive component to them.
New approaches to drug design are also being explored. Recently, Eisenthal and Cornish-
Bowden (1998) modelled the glycolytic pathway in Trypanosoma brucei. Their model
revealed that by inhibiting pyruvate transport, metabolites may build-up within T. brucei,
severely affecting the viability of the organism. This approach is a significant step forward
in drug design as a systemic attack on the organism may be more effective than inhibiting a
single agent. Zhang and Rathod (2002) have studied the effect of the antifolate drug
WR92210 on host and malarial parasite dihydrofolate reductase enzymes. It was found
that the host cells are able to overcome inhibition by this drug by virtue of their ability to
increase production of dihydrofolate reductase. The malarial parasite, with its simpler
organisation, lacks the ability to respond to such changes, and is therefore susceptible to
WR92210. In this case, the relative sophistication of the mammalian versus parasite
organisation is being exploited. These two are important paradigm shifts in the field of drug
design, as they show the operation of therapies at systemic levels. Goldberg (2002) has
suggested important lead compounds may be missed using screens that simply do head-to-
head comparisons. Rather the effects of potential drug candidates may need to be assessed
on proteosome, cellular, or even whole organism levels (Goldberg, 2002).
7.6 Future perspectives
Much of the discussion in this final chapter has focused on the need for integrating
knowledge from enzymology and cell biology into a systemic approach. Certainly, much
knowledge has been gained on the molecules and some of mechanisms that are part of
regulatory and effector anns of the endolysosomal system and other systems. This
molecular knowledge is vital, but only an introductory step. Integrating this knowledge into
systemic models may require a multi-disciplinary approach with contributions from
physics, mathematics, enzymology and cell biology. A more complete understanding of the
system would certainly yield deeper insights into the evolution of such systems, and
perhaps suggest therapeutic strategies for diseases that are associated with them.
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APPENDIX 1
The programme for calculating the redox potential of cysteine:cystine redox buffers was
written in BASIC for Mactintosh. The programme used to calculate the redox potentials
for a series of cysteine (0.1-0.5 mM):cystine (0.8 mM) buffers is given below. Other redox
potentials were similiarly calculated.
REM Nemst Equation 3a (with given cystine and cysteine cones)
REM R = gas constant
REM T = temp degrees centigrade
REM TA = absolute temp
REMpH=pH
REM F = Faraday constant
REM Eo = standard reduction potential of cysteine
REM Cys = concentration of cystine
REM C = half concentration of cysteine
REM N = maxima potential concentration of cystine
R = 8.31: T = 37: NI = 2: pH = 7: F = 96406!: Eo = -0.22: Cys = 0.8
LPRINT "pH =", pH
LPRINT "Cystine =" Cys
LPRINT "Eo", "[Cysteine]", "Cysteine/cystine"
FOR C = 0.1 TO 0.5 STEP 0.1
TA = T + 273
D = Cys/(C*C)
E = LOG (D)
A = (2.303*R*TA)
B = NI *F
M = (2*C)/Cys
H = (A/B)*E
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Homogenization in 30% t-butanol Is amethod with potential for wide appli-cation In the Isolation of proteins
from animal, plant or microbial sources.
Unusually, for an organic solvent, t-butanol
stabilizes protein structure. It also inhibits
enzyme activities and protein/protein
interactions. By inhibiting proteolysis and
obviating unwanted protein/protein inter-
actions, the presence of approximately 30%
t-butanol in a homogenization buffer gener-
ally minimizes the formation of artifacts
and gives a higher yield. The presence of
t-butanol in the homogenate leads naturally
on to concentration and fractionation of
proteins by three-phase partitioning,.
simply by the addition of Increments of
ammonium sulfate. In turn, fractions from
three-phase partitioning have a low salt
content and are thus poised for Ion-
exchange chromatography.
Because proteins must be in solution to be
separated and purified, protein isolation
usually starts , .... ith homogenization of the
tissue from which the protein is to be
isolated.] However, the breakdown of
cellular compartmentation, concomitant
with homogenization, can lead to un-
wanted protein/protein interactions and
the consequent formation of homogeni-
zation artifacts. A major problem is prote-
olysis, caused by the release of proteases
·School of Molecular and Cellular Biosciences, University
01 Natal, Private Bag X01, Scottsville, Pietermaritzburg,
3209 South Africa.
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In this method, t-butanol is added to
about 20-30% (volume ratio) to a protein
. solution. Subsequent addition of suffi-
cient ammonium sulfate causes the solu-
tion to divide into three phases, an upper
t-butanol phase (which contains any
non-polar solutes); a lower aqueous
phase (containing the ammonium sul-
fate) and a third, intermediate, phase of
precipitated (and concentrated) protein.
The extent to which protein precipitates
from the compartments where they are into the third phase is a function of the
usually sequestered,'and for this reason ammonium sulfate concentration and
protease inhibitors are often added to a TPP can thus also be used for the fraction-
homogenization buffer. This is less appro- ation of proteins.
priate, however, when cellular proteases TPP has some advantages over com'en-
themselves are the subject of interest. In tional salting out. First, with conventional
the intact cell, proteases and their endog- I salting out, the solution becomes 'i1i\creas-
enous inhibitors often occur in different .! inglydense with increasing ammonium
compartments. For example, the 'Iyso- sulfate concentration, until the' stage is
somaI' cysteine proteinases, cathepsins B, reached where it becomes difficult to
L, H, S, etc., occur in the endosomal sys- sediment the precipitated protein. InTPp,
tem whereas stefin B, their endogenous however, the precipitated protein floats
inhibitor, occurs in the cytoplasm. on the aqueous layer and 50, as this
Normally, the cysteine cathepsin/stefin B becomes ever denser with increasing
interaction is a tight, but non-covalent, ammonium sulfate concentration, the
interaction. However, we have found precipitated protein floats more and more
that formation of an artifactual, covalent, easily. Secondly, the precipitated protein
complex of cathepsin Land stefin B is from conventional salting out generally
apparently catalysed by a factor concur- has a high salt concentration, so salting
rently present in liver homogenates.2.3 lout must be followed by adesalting
The possibility exists that many other sim- step, or by hydrophobic interaction chro-
ilar, artifactual protein/protein interac- I matography, which can tolerate high salt
tions may occur in a homogenate and any I concentration. By contrast, the precipitate
method that can inhibit both proteolysis I from TPP has a low salt concentration
and other protein/protein interactions in I and so TPP can be followed immediately
a homogenate is therefore to be wel- " by ion-exchange chromatography, for
comed, example,
t-Butanol (1) is a reagent used in the I' Uniquely among common organic 501-
established method for protein fraction- vents, t-butanol stabilizes proteins rather
ation known as three-phase partitioning I' than denaturing them.4A common prop-
(TPP),4 erty of all agents that stabilize protein
structure is that they are excluded from
the protein interior.sFor example, the sul-
fate ion, the principal agent in salting out
of prot~ins from water or wate,r/t-butanol
co-so.lvent~,s.t~bilizes protein structure
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because the sulfate ion accretes to itself
more than 14 water molecules and so the
hydrated ion is very large and is unable to
access the protein interior.4 The fact that
t-butanol stabilizes rather than-denatures
proteins may be due to the fact that it too
may be too large to gain access to the pro-
tein interior. However, most proteins
have surface hydrophobic patches, con·
stituting up to 50% of the surface area/
and t-butanol appears to bind to these
patches, which accounts for the fact that
proteins float in TPP.
All enzymes that have been tested are
inhibited by t-butanot with approxi-
mately 30% t-butanol being required to
completely extinguish activity? In most
cases, for instance in all of the many pro-
teins that have been isolated by TPp'l
this loss of activity may be reversed by re-
moving the t-butanol, for example by
dialysis or by phase separation inTPP. The
only exception found thus far is haemo-
globin, which is denatured by t-butanol,
probably by irreversible changes to the
inter-subunit interactions. This is not dis-
advantageous, however, because in many
cases haemoglobin is a problematic con-
taminant in the isolation of proteins from
animal tissue.The basis for the inhibiting
action of t-butanol is not yet clear, but it
has been noted that in the presence of
In Briet...
Conser,'atioll ill crisis?
Papers presented at the most recent sympo-
sium of the Wildlife Management Association
of Southern Africa, held at George, expressed
concern about threats to South Africa's
biodiversity. It was reported that 'the indige-
nous freshwater fishes of the Western and East-
ern Cape are rapidly approaching Widespread
and final extinctions'. Dean Impson of Cape
Nature Conservation showed that of the 19
indigenous freshwater fishes of the Western
Cape rivers (of which 16 are found only there).
11 species are now critically rare or endangered
in terms of Red Data Book criteria. Of these
fish, only one species was endangered in 1977,
three in 1987, nine in ,1996 and 11 species in
1999.
Moreover, the provincial conservation agen-
cies have been losing large numbers of staff as
long-serving personnel have been given sever-
ance packages and then not replaced. In the
Western Cape, there were eight staff members
involved in freshwater conservation in the pro-
vincial conservation authority in 1993. By last
year this number had decreased to two. Kas
Hamman, the director of Cape Nature Conser-
vation, reported that there had been a 30% loss
of conservation staff from the agency in the last
three years. At the same time, funding for na-
hue conservation management and research
had been reduced throughout the country, it
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t-butanol some proteins undergo con-
formational changes, favouring an
increased proportion of a-helices.e Not
only are enzyme activities extinguished
by t-butanol, but it appears that pro-
tein/protein interactions are also inhib-
ited.7
The fact that t-butanol can inhibit prote-
olysis or enzyme/inhibitor interactions
suggests that there may be merit in using
t-butanol right at the outset of a protein
isolation, that is, the tissue beinghomoge-
nized in the presence of 30% t-butanol.
This concept was tried in the isolation of
the lysosomal cysteine proteinase,
cathepsin B, from liver tissue, with a re-
sulting 6-fold increase in final yield. A
problem attending the isolation from !i\'er
of the rela ted lysosomal cysteine pro-
teinase, cathepsin L, is the formation in
the homogenate of a proteolytically ac-
tive, covalent, complex of cathepsin L
with the cytoplasmic inhibitor, stefin B,
\vhich compromises the yield of the free
enzyme.2.3 Homogenization in 30%
t-butanol obviated formation of the com-
plex, resulting in a 40% increase in yield of
the free enzyme.' With homogenization
in 30% t-butanot the homogenate is
poi.sed for fractiona tion by TPB simply by
adding increments of ammonium sulfate.
Since the sulfate ion is more effective at
was said. A common sentiment at the sympo-
sium was that if current trends in staffing and
funding cuts continued, the likelihood .of
South Africa maintaining its natural resource
base was 'minimal'.
Bleeli Collection honoured b~:
UNESCO
The remarkable archive of documents re-
cording the language and folklore of a group of
San (Bushman) people, held jointly by the Uni-
versity of Cape Town and the National Library,
has been formally listed in UNESCO's Mem-
ory of the \Vorld Register. The papers, com-
piled over many years by Dr Wilhelm Bleek, his
daughter Dorothea and sister-in-law Lucy
L1oyd, starting in Cape Town in the 18705, in-
clude nearly 12 000 pages of verbatim accounts
of Bushman life, ritual and myth. Bleek was a
German linguist who worked originally with
IXam convicts who had been sent to work on a
breakwater in Table Bay. The lXam language is
now extinct. These records played an impor-
tant part in revealing the meaning of San rock
art as pioneered by David Lewis·Williams at
the University of the Witwatersrand.
The Memory of the World programme, of
which the register is an integral part, is to
'guard against collective amnesia', and aims to
preserve valuable archives throughout the
world. .
lIealth;y funding for sports
science
Discovery Health will donate millions of
rands for sports science research at the Univer-
News & VieI,',
low pH,4 homogenizat~on in a low p
buffer should be the first choice. In tur;
the low-salt active fraction from TPP
poised for fractiof\ation by ion-exchan~
or affinity chromatography. For the latte
removal of residual t-butanol, for exan
pIe by dialysis, may be advantageous.
It would appear that in the propertie
of t-butanol, nature has provided prc
teinologists with the gift of a uniquel
llseful tool. We believe that t-butanol wi
have Widespread application in the isola
tion of proteins from animal, plant .an<
microbial sources, when its fundamenta
difference from other organic solvent5
such as ethanol and acetone, is full)
appreciated.
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sHy of Cape Town over the next 10 years. The
healthcare company's generosity \.,.ilI be used
variously on behalf of the Bioenergetics of
Exercise Research Unit, to fund the chair of
acclaimed sports scientist Tim Noakes, and the
High Performance Centre at the Sports Science
Institute. The investment should evenhlally be
worth well over R20 million.
Professor Noakes was recently honoured as
one of the 22 founding members of the Interna-
tional Olympic Committee's new Olympic
Academy of Science. Although the role of the
academy is still undecided, Noakes considers
that it should coordinate research to under-




The University of Pretoria has established
the African Water Issues Research Unit in
the Department of Political Sciences, with
Anthony Turton, a political scientist who has
specialized in the politics of water in southern
Africa, as its head. The unit plans to develop a
scientific understanding of the role of water in
terms of social and econoniic stability, and to
forge strong interna tionallinks. More informa-
tion about A'rVIRA plans is available on the
university's website (http://www.up.ac.z.y
academicllibartslpolscVawira) or via e-ma!l
(awira@'postino.up.ac.za). ' '
The university has also formed a 'strategic
alliance' with the CSIR in water research, one "
of a number of such initiativesbetween'the t\'lO;
institutions, to promote research and traini~g.:.t~
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A typical protein isolation from tissue consists of u
stream methods of homogenization/extraction and co
centration and crude fractionation, where 'yield is tl
most important criterion, and more discriminating dowj
stream stages such as chromatography, where purific:
tion is the more important criterion. Three-phase pari
tioning (TPp2) (using t-butanol and ammonium sulfat<
is an upstream procedure used for concentration an
crude fractionation early in a protein isolation procedur
It has been applied to the isolation of a number of diffe
ent proteins, including cathepsins (1, 2), and the princ
pIes of the method have been explored (3, 4).
A common property of all agents that stabilize pn
tein structure is that they are excluded from the pn
tein domain (5). t-Butanol is unique among commo
water-soluble organic solvents in that it tends to ne
denature proteins, suggesting that it too may be tc
large to gain access to the protein interio~ (4). Ho"
ever, at a concentration of ca. 30%, t-butanol appear
to generally inhibit the activity of enzymes (Fig. 1 an
Ref. 6). In the case of cathepsins Band L, and presuiT
ably all proteins which have been isolated byTPP (se
Table 1, Ref. 4), these changes are reversible and ae
tivity is restored upon removal of the t-butanol.
Homogenization is often the first step in a protei]
isolation and many unwanted molecular interaction
may occur in a homogenate, e.g., proteolysis (e.g., Ref. 7
or proteinase/inhibitor interactions (e.g., Ref. 8), leadinl
to the generation of artifacts and perhaps comprorIDsinj
yield. In previous cathepsin isolations, we have used l
sequence of homogenization ~ pH 4.2 precipitation -
TPP. Because t-butanol reversibly inactivates many en
zymes, including proteases (Fig. 1), it was consideree
that these three steps may be profitably combined, b)
incorporating 30% t-butanol directly in a low-pH homog
1 To whom correspondence should be addressed. Fax: 0027-33-260·
5462. E-mail: dennison@Unpsun1.cc.unp.ac.za.
2 Abbreviations used: t-butanol, 2-methylpropan-2-ol; TPP, three·
phase partitioning; Cbz, carbobenzoxy; AMC, 7-amido-4-methyl·
coumarin.
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FIG. 1. Effect of t-butanol concentration on the activity of some
enzymes: (A.) cathepsin B; (0) cathepsin L; (0) cathepsin D; (-)
a-glucosidase; (6) fruit bromelain; (e) trypsin; (+) chymotrypsin.
enization buffer. Here we report on the application ofthis
approach to the isolation of cathepsins Band L from
rabbit liver and sheep liver, respectively.
Cathepsins Band L were extracted from liver tissue
by established methods (8), which served as controls,
and by a method incorporating t-butanol in the homog-
enization buffer. Fresh livers from each species were
separately diced and separated into two portions, con-
taining equal amounts from each liver, which were
separately frozen at -70°C and stored for at least 48 h
but not more than 2 weeks.
In the control method for cathepsin B, thawed rabbit
liver (originally 300 g, i.e., before being frozen) was
homogenized for 3 min in two parts of homogenization
buffer (150 mM Na acetate, 1 mM EDTA, pH 4.0) in a
Waring Blendor and centrifuged (9000g, 20 min, 4°C).
The supernatant was adjusted to pH 4.2 with dilute
acetic acid and centrifuged (l5,100g, 20 min, 4°C).
t-Butanol was added to constitute 30% of the total
combined volume of t-butanol plus supernatant and a
















centrifuging (l5,100g, 10 min, 4°C), after each precip-
itation. The 20% precipitate was discarded and the
20-40% precipitate was redissolved, in one-tenth of
the volume of the acid supernatant, in Buffer A (20 mM
Na acetate, 1 mM NazEDTA, 0.02% NaN3 , pH 5.0). The
redissolved solution was centrifuged (15,100g, 10 min,
4°C) to remove any insoluble material. The clarified
solution was applied to a column of S-Sepharose (2.5 X
18.3 cm) and unbound material was eluted with Buffer
A. Bound material was eluted with a gradient of 0-300
mM NaCl in Buffer A in ca. six column volumes. Frac-
tions active against Cbz-Arg-Arg-AMC were pooled.
In the novel method using t-butanol in the homoge-
nate, rabbit liver was homogenized as before, but in a
mixture of two parts of homogenization buffer and
sufficient t-butanol to give 30% (v/v) t-butanol in the
homogenate. The homogenate was centrifuged (9000g,
20 min, 4°C), the supernatant adjusted to pH·4.2 with
dilute acetic acid, and the mixture again centrifuged
(15,100g, 20 min, 4°C). A 20-40% ammonium sulfate
TPP cut was taken, as before, and chromatography was
as described above.
A similar approach was used with cathepsin L, ex-
cept that the homogenization "buffer" in the control
consisted of 2% n-butanol-1% NaCl-0.1% EDTA and a
20-45% TPP cut was taken (8). In the novel method,
liver was homogenized in a mixture of two parts of
homogenization buffer (150 mM Na acetate, 1 mM
EDTA, pH 4,0) and sufficient t-butanol to give 30%
(v/v) t-butanol in the homogenate. .
The results for cathepsin B (Table 1), which were
essentially reproducible in repeat isolations: reveal
very much less activity in the homogenate obtained in
the presence of t-butanol, despite the fact that the
assays were done after removal of the t-butanol. How-
ever, there is a relatively large increase in activity
after the TPP step (2,8-fold) in the case of the homog-
TABLE 1
Extraction and Upstream Fractionation of Cathepsin B from 300 g of Rabbit Liver
Total protein Total activity Specific activity Purification
Volume (m}) (mg) (D) (D/mg) (fold) Yield (%)
Control
Homogenate (supernatant) 642 20,897 1,362,183 65 (1) (100)
TPP cut (20-40%) 98 4,763 228,194 479 7.4 16,8
S-Sepharose 21 63 55,020 874 13.4 4.0
Homogenization in 30% t-butanol
Homogenate (supernatant) 842 6,155 813,322 132 (l) (100)
TPP cut (20-40%) 78.5 507 639,585 1261 9,6 78.6 (47)"
S-Sepharose 14.6 93 198,557 2142 16.2 24.4 (15)
Improvement 3,6-fold 2,5-fold
a Figures shown in italics represent yield based on the control homogenate without t-butanol.
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TABLE 2
Extraction and Upstream Fractionation of Cathepsin L from 180 g of Sheep Liver
159
Total protein Total activity Specific activity Purification
Volume (ml) (mg) (U) (U/mg) (fold) Yield (%)
Control
Homogenate (supernatant) 345 4630 12,537 2.7 (1) (100)
TPP cut (20-45%) 42 181 3,270 18.1 6.7 26.1
S-Sepharose 33 0.8 2,133 2585.5 954.0 17.0
Homogenization in 30% i-butanol
Homogenate (supernatant) 520 6682 27,981 4.2 (1) (100)
TPP cut (20-45%) 44 707 3,339 4.7 1.1 6.0 (13.3)"
S-Sepharose 35 0.9 2,983 3278.0 782.3 10.7 (23.8)
Improvement lA-fold 1.3-fold
o Figures shown in italics represent yield based on homogenate without i-butanol.
enate containing t-butanol. The TPP step removes
most of the t-butanol, as this is salted out to form a
separate phase, while selectively fractionating the pro-
teins. It appears that, in the presence of t-butanol,
cathepsin B is more effectively extracted but that most
of its activity is latent until made patent by the TPP
step; by contrast, in the control isolation, there is a
relatively large loss of activity during TPP. Here we
have reported only on a novel approach to the extrac-
tion of cathepsin B from liver: for final isolation of the
enzyme, a choice of downstream methods is available,
including affinity chromatography on Sepharose-Ahx-
Gly-Phe-Gly-Sc (9).
In the case of cathepsin L, higher apparent yields
were obtained at all steps in the extraction using 30%
t-butanol, with an increase in yield of about lA-fold
being finally obtained after S-Sepharose chromatogra-
phy (Table 2). In previous isolations of cathepsin L
from sheep (8), human, and baboon liver (10), we have
consistently obtained the enzyme in two forms: as the
ca. 24-kDa free enzyme and as a ca. 35-kDa, proteo-
lytically active, covalent complex of cathepsin L with
stefin B. In the present study, after homogenization in
30% t-butanol, no evidence of this complex was found,
supporting the contention that it may be an isolation
artifact. Presumably, its formation in the homogenate
is inhibited by 30% t-butanol.
Although t-butanol is not generally denaturing, it does
. irreversibly denature hemoglobin. This has been used to
advantage (e.g., see Refs. 1, 11) but the denaturing effect
on hemoglobin does not apply to all proteins with a qua-
; ternary structure (11). In general, it appears that homog-
enization in 30% t-butanol gives a "cleaner" extract which
is easier to handle in centrifugation steps. This may re-
flect the fact that t-butanol denatures hemoglobin and
solubilizes hydrophobic compounds.
We attribute the improved yields ofcathepsins Band
L partly to the ability of t-butanol to inhibit enzyme
activity (including proteolysis) and prevent unwanted
protein-protein interactions. Homogenization in 30%
t-butanol is probably not limited in its usefulness only
to the isolation of cathepsins as described here and we
believe that it may be a generally useful upstream
method in the extraction of proteins from animal,
plant, and microbial tissues.
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Endolysosomal proteolysis and its regulation
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The endolysosomal system comprises a unique environment for
proteolysis, which is regulated in a manner that apparently does
not involve protease inhibitors. The system comprises a series of
membrane-bound intracellular compartments, within which en-
docytosed material and redundant cellular components are
hydrolysed. Endocytosed material tends to flow vectorially
through the system, proceeding through the early endosome, the
endosome carrier vesicle, the late endosome and the lysosome.
Phagocytosis and autophagy provide alternative entry points
into the system. Late endosomes, lysosome/late endosome hybrid
organelles, phagosomes and autophagosomes are the principal
sites for proteolysis. In each case, hydrolytic competence is due
to components of the endolysosomal system, i.e. proteases,
lysosome-associated membrane proteins, H+-ATPases and poss-
ibly cysteine transporters. The view is emerging that Iysosomes
are organelles for the storage of hydrolases, perhaps in an
inactivated form. Once a substrate has entered a proteolytically
competent environment, the rate-limiting proteolytic steps are
probably effected by cysteine endoproteinases. As these are
affected by pH and possibly redox potential, they may be
regulated by the organelle luminal environment. Regulation is
probably also affected, among other factors, by organelle fusion
reactions, whereby the meeting of enzyme and substrate may be
controlled. Such systems would permit simultaneous regulation
of a number of unrelated hydrolases.
Key words: autophagy, endosome, lysosome, proteolysis.
Scheme 1 Points at which the endolysosomal system may be regUlated
Regulation may occur at: (i) the point of acquisition of substrate (5) by the endolysosomal
s,Y,stem, (ii) the meeting of enzyme (E) and substrate by fusion of their respective compartments,
(Ill) the establishment of conditions supporting proteolysis (or not) and, (iv) the point of egress
of product from the system. Enzyme may be retained in a lysosome for a greater or lesser
period, possibly in an inactive state (v). The colours turquoise, yellow and orange, in that order,
represent declining pH.
described by the reactions shown in Scheme I. As shown, there
exists the possibility of regulation at five points: (i) at the point
of acquisition of substrate by the endolysosomal system, (ii) at
the meeting ofE and S by fusion of their respective compartments,
(iii) at the establishment of conditions supporting proteolysis (or
not) within the (fused) organelle and, possibly (iv) at the point of
egress of product from the system. Point (v) represents the
possibility of an enzyme being retained in a lysosome for a
greater or lesser period (perhaps in an inactive form, but in any
event separate from substrate). In terms of flux through the
INTRODUCTION
Protein degradation within the cell is principally effected by the
endolysosomal, proteosome-ubiquitin and calpain systems. In
contrast with the proteosome~ubiquitin and calpain systems, the
endolysosomal system largely carries out non-specific bulk pro-
teolysis. The endolysosomal membrane creates a sealed limited
environment that allows for optimum functioning of its hydro-
lases, and yet prevents inappropriate autodegradation. The
membrane also houses transporters that remove amino acids,
'generated by proteolysis, to the cytoplasm.
Apart from degradation, the endolysosomal system is also
involved in related functions, such as regulation of signal
transduction, antigen presentation and storage. These functions
are divided among the various organelles making up the system,
which may be thought ofas distinct, but connected environments.
At the most basic level, the operation of the endolysosomal
system of all cells types consists of enzymes that are responsible
for degrading substrate that enters the endolysosomal system.
The substrate, in turn, must be channelled to the enzymes. Both
the enzyme and substrate are maintained in (separate) sealed
compartments prior to proteolysis. These sealed environments
must be capable of meeting, with the creation of an environment
that allows for optimal degradation of the substrate.
Reactions between enzymes (E) and their substrates (S) in
solution are described by the reaction (where P is the product)
E+S ...... ES -> E+P
and can be analysed by conventional kinetic methods.
Such enzymes are often regulated by soluble effector molecules.
Enzyme reactions in the endolysosomal system, however, can be
(i)
S-" p
Abbreviations used: AVd, autophagic vacuole;, AVi, nascent autophagic vesicle; CHO, Chinese-hamster ovary; ECV, endosome carrier vesicle' ER
endoplasmiC reticulum , GILT, Y-Interferon-Induclble lysosomal thiol reductase; ([125I]tyn-SS_POL, [125lJiodotyramine linked to poly(o-I sine) b 'a 3~
(proplonyldlthlo)-proplonlc aCid spacer; LAMP, lysosome-associated membrane protein; MPR, mannose-6-phosphate receptors YPOI Py t .
disulphide Isomerase; V-ATPase, vacuolar ATPase, ' ,ro eln
1 To whom correspondence should be addressed (e-mail dennisonC@nu.ac.za).
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system, regulation at (i) and (ii) could be called 'upstream
regulation', whereas regulation at (iii), (iv) and (v) could be
termed 'downstream regulation'.
Regulation of substrate acquisition into the endolysosomal
system and of organelle fusion/budding events [Scheme 1, steps
(i) and (ii)] is effected by several signalling networks (reviewed in
[1-9]). The signalling networks may include small G-proteins and
their signalling cascades, the actin network, and/or phospha-
tidylinositol 3-phosphate and associated kinases [1-9]. These
signalling networks interact with the endolysosomal system
through interface molecules that are part of both the endocytosis
and the signalling networks [3,7,8]. In the present review,
attention will be focused largely on possible regulatory mecha-
nisms operating at points (iii) and (v), i.e. on factors that may
affect the activity of the enzymes.
ORGANIZATION OF THE ENDOLYSOSOMAL PATHWAY
The basic organization of the endolysosomal pathway in a
mammalian epithelial cell is depicted in Figure 1, although
details may vary with cell type. Currently, there are two models
to explain how the organelles within the endolysosomal pathway
are related to each other [10,11]. Although the two theories differ
on the temporal organization of the pathway, the spatial and
functional aspects are very similar.
The' maturation model' suggests that each organelle along the
endocytic pathway is a transient, but distinct, compartment that
matures into the next organelle along the pathway. In this model,
the early endosome is envisioned as being formed de novo by the
fusion of uncoated primary endosomes derived from the plasma
membrane. This transient compartment then matures into a
transient late endosome, which in turn matures into a lysosome,
the terminal organelle [10]. Each maturation stage has its own
unique set of biochemical markers associated with it. These
markers and membrane components are recycled by carrier
vesicles during maturation [10]. In a related model, proposed by
Thilo et al. [12], maturation occurs from the primary endosome
until a pre-lysosomal compartment is formed. This compartment
then communicates with the lysosome through vesicular traffic.
In the 'pre-existing compartment model', the early and late
endosomes are considered to be stable specialized compartments
linked by vesicular traffic [11]. The early and late endosomes are
regarded as' compartments', which are stable and do not undergo
maturation, but are capable of homotypic fusion. 'Vesicles',
unlike compartments, are considered incapable of homotypic
fusion. Compartments are considered to be more structurally
complex and to have more specialized functions compared with
vesicles [11].
The first organelle along the endolysosomal pathway, the early
endosome (Figure I), is a major sorting station. Based on the
recycling behaviour of ligand-receptor complexes, the early
endosome population may be subdivided into at least two
subpopulations, the sorting and recyclirig endosomes [13]. The
luminal pH within the sorting endosome is between pH 6.3-6.5,
and is generated by an H+-ATPase and regulated electrogenically
by an Na+,K+-ATPase [14,15]. At this slightly acidic pH, ligands,
such as low-density lipoprotein and a 2-macroglobulin, dissociate















Figure 1 Representation of the endolysosomal system
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plasma membrane, whereas their ligands, low-density lipoprotein
and cx2-macroglobulin, are trafficked to the late endosome
(reviewed in Mellman [16]). Some receptors, such as the trans-
ferrin receptor, can be recycled to the plasma membrane directly
from the sorting endosome (fast cycle), or directed to the recycling
endosome and then to the plasma membrane (slow cycle) [17].
The recycling endosome may also play a role in directing receptors
to the leading edge of migrating cells [17].
The next stage on the endolysosomal pathway is the endosome
carrier vesicle (ECV) or multivesicular body. ECVs appear to
be large (0.4-0.7 p,m in diameter), usually spherical vesicles,
often with a membrane-enriched luminal content (reviewed in
[11,18,19]), and are responsible for transferring material from
early to late endosomes [11].
Formation of ECVs is dependent on the acidification of their
luminal interior and can be blocked by the vacuolar ATPase (V-
ATPase) inhibitor, bafilomycin A1 [20]. Indeed, the luminal pH
of the ECV drops from that of the early endosome to pH 5.0-5.5
[21]. Endocytosed material may not always be transferred to late
endosomes via the ECV. In the mouse macrophage cell line 1774,
early and late endosomes are capable of fusing directly with each
other [22]. This suggests that certain cell types may have
specialized endocytic fusion machinery depending on their func-
tion.
Distal to the endosome carrier vesicle is the late endosome
(sometimes called the pre-Iysosomal compartment), followed by
the lysosome (Figure 1). A modern definition of a lysosome is
that it is 'the terminal organelle on the endocytic pathway and
is devoid of recycling receptors' [11]. Complicating the field of
endolysosomal proteolysis is the fact that not all authors make a
distinction between the late endosome and the lysosome. In the
studies of de Duve [23] 'Iysosomes' were defined on the basis of
two criteria: the existence of a limiting membrane and the
presence within the organelle of acid hydrolases. Thus to many
authors, Iysosomes are any organelles containing acid hydrolases,
i.e. 'lysosomal' enzymes (in referring to 'lysosomal' hydrolases
here, we put the term' lysosomal' in quotation marks because
some of these enzymes are, in fact, not limited to Iysosomes, but
are found throughout the endolysosomal system). However,
from a modern perspective, this definition encompasses early and
late endosomes, Iysosomes, phagosomes and autophagosomes. It
has also been found that not all 'lysosomal' enzymes have an
acidic pH optimum [24,25], and that not all late endosomesj
lysosomes are acidic [24].
Both late endosomes and Iysosomes contain 'lysosomal'
hydrolases and lysosome-associated membrane proteins
(LAMPs) [11], and both are enriched in lysobisphosphatidic acid
[26]. Lysobisphosphatidic acid is a phospholipid found at high
concentrations on the internal membranes of late endosomes
where it may play an important role in the degradation of
glycolipids and the transport of membrane proteins and Iipids
[27]. Under certain conditions, the two organelles may also have
similar distributions in density gradients. However, there are
differences, for example, mannose-6-phosphate receptors
(MPRs) and the regulatory (RII) domain of the cAMP-dependent
protein kinase are found on late endosomes, but not lysosomes
[11]. Their ultrastructural morphologies are also different. Late
endo~omes have a complex morphology [11], which is organized
by mIcrotubules [28]. In sections, they often have a multivesicular
appearance, with intra-luminal membrane whorls (see, for ex-
ample, [29,30]). In contrast, Iysosomes appear as rougWy spheri-
cal, electron-dense organelles with a simpler organization [11,30].
Based on their relatively simple ultrastructure and their markers
lysosomes may be closer to 'vesicles' than to 'compartments:
[11]. A significant difference between lysosomes and other
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'vesicles', however, is their capacity to undergo homotypic
fusion [31]. To date, no specific marker has been described for
lysosomes.
Late endosomes and lysosomes are apparently in dynamic
equilibrium. Fluid-phase markers, like BSA-gold, are distributed
between the late endosome and lysosome after extended chase
periods [It]. Their concentrations of LAMPs are approximately
equal, suggesting that their membranes are also in equilibrium.
The mechanisms involved in establishing equilibrium may include
vesicular transport [32], 'kiss and run' events [33] or direct fusion
(reviewed in Luzio et al. [34]) and may vary with cell type.
Despite their close association, late endosomes and Iysosomes
have distinct functional differences. Although containing only
20 % of the total hydrolase pool, late endosomes are the main
site for proteolysis [29,30]. By contrast, Iysosomes contain the
bulk of the' lysosomal' hydrolase pool but only about 20 % of
total proteolysis takes place in Iysosomes. It has consequently
been suggested that lysosomes may act as storage organelles for
these hydrolases [11,29].
Fusion of late endosomes and lysosomes produces a hybrid
organelle with properties of both [34]. Bafilomycin A
1
did not
decrease late endosome-lysosome fusion, suggesting that acidifi-
cation was not a requirement for hybrid formation [35]. However,
lysosome recondensation from the hybrid organelle was de-
pendent on a functional V-ATPase [36]. A further requirement
for hybrid organelle formation was the presence of intra-
organellar Ca2+ and calmodulin. Intra-organellar Ca2+ is also
required for fusion and recondensation oflysosomes to and from
the hybrid organelle [36].
Although the lysosome is the terminal organelle of the endo-
lysosomal system, lysosomes should not be viewed as dead-end
organelles, as 'secretory Iysosomes' may be a feature of many
normal cells [37]. An increase in intracellular Ca2+ levels typically
results in secretion of about 5-15 % (rising to 60 % in haemato-
poietic cells) of the total content of lysosomes. A rise in Ca2+
levels causes lysosomal membranes to fuse with the cell membrane,
resulting in exocytosis of the lysosomal contents [37]. The process
is thought to be regulated by synaptotagrnin VII [38], and may
constitute a mechanism for the repair of damaged plasma
membrane [39]. Mechanisms for the secretion of 'lysosomal'
proteases are clearly of interest in the context of cancer, where
these enzymes have been purported to play an extracellular role.
Many cells of haematopoietic origin are capable of exocytosing
multivesicular bodies that contain internal vesicles called exo-
somes. These exosomes may be involved in multiple functions,
including T-Iymphocyte stimulation (reviewed in Denzer et al.
[40]).
DELIVERY OF SUBSTRATES
Substrates destined for degradation can enter the endolysosomal
lumen by three broad mechanisms: endocytosis, autophagy and
phagocytosis. These mechanisms all result in environments that
support proteolysis, using a common set oflysosomal hydrolases.
!his present review of these processes, although not exhaustive,
IS ~uned at finding common luminal features that may provide
mSlgh.ts into the minimal requirements for endolysosomal pro-
teolYSIS and may also suggest possible modes of regulation of
proteolysis.
Endocytosis
Endocytosis can be divided into three distinct mechanisms:
receptor-mediated endocytosis, constitutive endocytosis and ca-
veoh formatIOn. Ligand-receptor complexes that enter the endo-
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Table 1 Common luminal features of proteolytic organelles of the endolysosomal system
Organelle Hydrolases LAMPs MPR V-ATPase Lumenal Ca1+ Cysteine transporter References
Early endosome + (cathepsin H) + + + [11,71,72]
Late endosome + + + + + [11,71,72,75]
Lysosome + + + + + [11,36,71,75,126,127]
Hybrid organelle + + + ? + ? [30,34,36]
AVd + + + + ? [52,60-63J
Phagosome + + + ? ? [11,13,71,72]
lysosomal system can be sorted into one of three pathways: (i)
the entire ligand-receptor complex may be recycled back to the
plasma membrane; (ii) the ligand-receptor complex may dis-
sociate, with the receptor being recycled and the ligand directed
further along the pathway; or (iii) the entire ligand-receptor
complex may be targeted to the later stages of the pathway (see
Warnock [41] and references therein). This sorting process thus
occurs within the early or late endosomes.
In contrast with receptor-mediated' endocytosis, substrates
entering the pathway by fluid-phase endocytosis are constitutively
directed to further stages along the endolysosomal pathway.
Pulse-chasing fluid-phase markers, such as horseradish per-
oxidase and BSA labelled with gold, into a cell first labels early
endosomes (5 min), and with longer chase times (< 30 min) the
later endosome populations become labelled (see, for example,
Aniento et al. [19] and Rabinowitz et al. [42]).
Autophagy
Autophagy is responsible for the destruction of most endogenous
proteins, the removal of obsolete and/or damaged organelles,
cellular re-modelling during differentiation, metamorphosis and
ageing [43,44]. It may be activated when amino acids are limiting
in vitro [45] and in vivo [46]. There are four distinct autophagic
mechanisms: macro-autophagy, micw-autophagy, crinophagy
and chaperone-mediated autophagy. Micro-autophagy happens
when parts of the cytoplasm are taken up directly by lysosomes,
occurring when lysosomes invaginate their membranes. Crino-
phagy is a process whereby secretory granules fuse directly with
lysosomes. Chaperone-mediated autophagy effects direct import
of cytosolic polypeptides into the endolysosomal system. Micro-
autophagy, crinophagy, and chaperone-mediated autophagy
have been reviewed previously [44,47,48]. The regulation of
autophagy has been reviewed previously [44,49].
Macro-autophagy occurs when entire regions of the cytoplasm
are sequestered by a membrane and degraded. This process
occurs in at least three distinct stages that are characterized by
morphological and biochemical changes to the sequestered
cytosol. These stages from sequestration to degradation occur
rapidly, with a half-life of approx. 9 min. [50]. The first stage is
referred to as sequestration, and is characterized by the formation
de novo of an organelle referred to as a nascent autophagic vesicle
(AVi) or the phagophore. A consistent terminology to describe
the various stages of autophagy has not yet emerged, and the
terminology of Dunn [51,52] will be used here. The signals
responsible for the sequestration step are being resolved and may
involve G-proteins [49,39-55], a novel protein-conjugation sys-
tem (see Mizushima et al. [56] and Kirisako et aL [57]), protein
and lipid kinases, Ca2+ and adenosine nucletotides, and the
cytoskeleton (reviewed in Kim and Klionsky [49]).
The source of the sequestering membrane is a matter of
dispute, but it may originate from the rough endoplasmic
reticulum (ER) [51] or the post-Golgi region [58,59]. AVis have
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a distinctive structure, with membrane structures and entire
organelles engulfed by the forming AVi (see, for example Figure
I in [60]). The AVi does not have lysosomal hydrolases or
LAMPs associated with it [52,62,63]. It is therefore presumed
that the AVi is not involved in proteolytic degradation of the
engulfed cytoplasm.
The AVi apparently undergoes biochemical and morphological
changes (maturation), acquiring lysosomal membrane proteins
(such as LAMPs) and hydrolases that subsequently allow it to
degrade the sequestered substrate [52,62,63]. The AVi also
develops an acidic luminal interior [52,64] and becomes capable
of proteolysis. The fully matured vesicle is called an autophagic
vacuole (AVd) [51,52]. In contrast with the AVi, the AVd usually
has a single membrane, the other membrane structures pre-
sumably having been degraded or recycled.
The mechanism of AVd formation from the AVi has not been
resolved. The AVi may fuse directly with lysosomes, which
rapidly converts it into an AVd [60]. Alternatively, it has been
demonstrated that the endocytic and autophagic pathways
converge after the AVi and early endosome stages respectively,
resulting in formation of amphisomes [61,62]. In either case, the
AVd acquires its lysosomal hydrolases from the endolysosomal
system.
Phagocytosis
Although a number of cell types are capable of phagocytosis, the
most important professional phagocytes are neutrophils and
mononuclear phagocytes [65]. The discussion in this review will
be'limited to macrophages. Macrophages have a complement of
cysteine endoproteases similar to that of most epithelial cells.
Presumably, the components necessary for a fully functional
proteolytic system are the same, or very similar, in both cell
types. A notable exception is that macrophages contain the
powerful cysteine endoprotease, cathepsin S [66].
Phagocytosed particles are usually in the size range 0.3-
0.5 ,urn in diameter or larger. Their adhesion to the macrophage
surface may depend on a number of forces: van der Waal's-,
hydrophobic-, electrostatic- or receptor-mediated interactions
[65]. The adhesion of a particle to the membrane surface triggers
a cascade of signalling events (reviewed in May and Machesky
[9], and Kwiatkowska and Sobota [67]) that lead to the formation
of a phagosome. Initially, the phagosome lumen resembles the
extracellular environment, but the phagosome soon undergoes
a series of biochemical changes (maturation), accompanied
by changes to the lumen environment. This process is Rab-
dependent and involves fusion of the developing phagosome with
endocytic organelles [22,68-70]. The changes to the phagosome
include: V-ATPase-dependent acidification, and acquisition of
Rabs, LAMPs and lysosomal hydrolases [71,72]. Some phago-
cytosed pathogens escape destruction by disturbing the matu-
ration process. For example, phagosomes that ingest Mycobac-
terium avium cells fail to acidify [73], and those ingesting M. bovis
cells fail to incorporate Rab7 [74] and consequently do not
participate in late endocytic fusion events [22,74]. Thus the
pathogen escapes destruction by the hydrolases that are found in
late endosomes/lysosomes.
Based on their importance for endocytosis, autophagy and
phagocytosis, the apparent minimal requirements for generating
functional proteolytic environments within the endolysosomal
system are summarized in Table 1, and are discussed in greater
detail below.
COMMON FEATURES OF LUMEN PROTEOLYTIC ENVIRONMENTS
Hydrolases
Most of the soluble endolysosomal hydrolases are synthesized as
pre-proellzymes [75]. The signal peptide is cleaved co-transla-
tionally and the hydrolases fold into their precursor form within
the ER lumen. These precursors undergo asparagine-linked
glycosylation and carbohydrate processing, which continues in
the Golgi. Within the Golgi, two enzymes, N-acetylglucosaminyl-
phosphotransferase and a-N-acetylglucosaminidase, add a man-
nose-6-phosphate label [75,76]. Thus the labelled precursors
become ligands for the membrane bound MPRs, which direct
them to the endolysosomal system (reviewed in Hasilik [75] and
Kornfeld [76]). Glycosylation may also serve to protect the
hydrolases from destruction within the endolysosomal system
[77].
There are over 50 'lysosomal' hydrolases, and some of these
enzymes show no sequence homology with each other. Their
recognition by the phosphotransferase therefore involves com-
mon tertiary structural features [78-80]. There are two MPRs;
the 275-kDa cation-independent MPR and the 46-kDa cation-
dependent MPR [76]. These receptors have different affinities for
the soluble precursors, depending on their carbohydrate structure
[81]. Together, these two receptors are able to sort efficiently the
diverse array of soluble precursors for targeting to the endolyso-
somal system. Evidence also exists for MPR-independent target-
ing mechanisms [75]. Within the endolysosomal system, pro-
teolytic removal of a pro-piece serves to generate the mature
active enzyme.
The endolysosomal protease pool may be divided into the
endo- and exo-peptidase pools. The endoprotease pool (Table 2)
is mainly made up of cysteine and aspartic proteases, and the
exopeptidase pool of cysteine and serine proteases. Serine pro-
teases, which are the most numerous and diverse hydrolase class
in nature, are notably absent from the endoproteolytic pool. The
Table 2 Endoproteases found within the endolysosomal system
Catalytic Operating
Name group M, pH' pi Distribution References
Cathepsin B Cys 27 5-6.5 5.4 Ubiquitous [66,77,139]
Cathepsin D Asp 42 2.8-5.0 5.5-6.5 Ubiquitous [77,144]
Cathepsin E Asp 100 3-3.5 4.1-4.4 Restricted [77,145]
Cathepsin G Ser 30 7.5 10 Neutrophils [77,138]
Cathepsin H Cys 28 5.0---{).5 7.1 Ubiquitous [66,77,143]
Cathepsin L Cys 29 4.5-60 5.8---{).1 Ubiquitous [66,77,140]
Cathepsin N Cys 34 3.5 62 Ubiquitous [66,79]
Cathepsin S Cys 24 5.D-7.5 6.3---{).9 Restricted [66,79,141 J
Cathepsin T Cys 34 69 ? Restricted [66,77,146J
Cathepsin K Cys 27-29 6.0-6.5 ? Osteoclasts [142]
Legumain Cys 31 4-6 ? Ubiquitous [66J
* 'Operating pH' is the pH at which the enzyme is stable, which may be different from the
pH optimum.
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serine protease cathepsin G is found exclusively in haematopoietic
cells and is not a true endolysosomal enzyme (Table 2).
Once a substrate is delivered into a proteolytically competent
compartment, it is presumed that the rate-limiting steps in
substrate hydrolysis are affected by endoproteases. Their action
would generate peptide fragments that would serve as substrates
for the lysosomal exopeptidase pool. Thus the present discussion
will focus on the endopeptidases, most of which belong to the Cl
family of cysteine proteases (Table 2). The Cl family all show a
common fold with the archetypal protease of this family, papain.
These enzymes are bi-Iobular with left and right domains. These
domains are highly conserved and all members show common
secondary structure elements in their respective domains. Differ-
ences between these proteases are usually due to deletions or
insertions in the loop regions between the conserved structural
elements that comprise the papain fold [66].
The active site is in a deep cleft between the left and right
domains. The active site cysteine residue, Cys25 (papain number-
ing), and histidine residue, His159 (papain numbering), form a
thiolate-imidazolium ion-pair that is responsible for catalysis.
Other highly conserved residues are Asn175 , which is believed to
orientate the imidazolium ring, and Gln19 , which is part of the
oxyanion hole. Substrates bind into the active site in an extended
conformation, and the carbonyl carbon of the scissile bond
undergoes nucleophilic attack from the active-site thiol. This
results in the release of amine product. The resultant acyl-
enzyme reacts with water to release the carboxyl product
(deacylation), resulting in the regeneration of the free enzyme. A
detailed description of the catalytic mechanism is provided by
Storer and Menard [82].
Why has this family of proteases been selected in preference to
other types of proteases? Perhaps uniquely, these enzymes have
the following features that make them well suited to the endo-
lysosomal system.
• The nascent enzymes must be capable of being recognized by
the phosphotransferase system within the ER. This recognizes
structural features, and not a linear sequence [78-80]. This
may thus place limits on the hydrolases that could be
accommodated within the system. Gene duplication may have
created variants of these unique enzymes within the endo-
lysosomal system.
• The lysosomal cysteine proteases are required to cleave a wide
variety of substrates and thus their active sites cannot be
optimized for a specific substrate. However, the catalytic
mechanism of this class of cysteine peptidases is very efficient
wh~n compared with the catalytic mechanism employed by
serme proteases (see, for example, [83]). This may off-set any
loss of effiCiency due to a relatively non-specific active site.
• The luminal conditions of pH and redox potential within the
late endolysosomal system are designed to denature substrates
allowing for increased hydrolytic efficiency. These condition~
may be in a constant state of flux, allowing many different
hydrolase classes to operate within the system. The cysteine
?roteas~s must be stable to these denaturing conditions and,
m additIOn, must be capable of operating over a broad pH
range. The enzymes themselves also have to be fairly resistant
to proteolySIS. The catalytic ion-pair of the papain superfamily
appears to be active over a wide pH range [82], a requirement
that cannot be met by any of the other proteolytic classes. This
would allow these enzymes to operate in the dynamic endo-
lysosomal proteolytic environment [24]. However, in contrast
to other members of the papain superfamily, the endolyso-
somal enzymes tend to be unstable at neutral to alkaline pH
values [66]. ThiS may protect the cell against these enzymes.
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The enzymes themselves appear to be stable to the de-
naturing conditions within the endolysosomal system and
have half-lives that run from days to weeks [77].
• Some of the cysteine proteases are restricted to specific
organelles. For example, cathepsin H appears to be restricted
to the early endosome in J774 macrophages [72]. This suggests
that this enzyme must have features that restrict it to this
specific organelle, at least in this cell type.
• Finally, endolysosomal proteinases may be capable of regu-
lation without the need for inhibitors. There is no evidence of
intra-endolysosomal inhibitors, and yet proteolysis may be
shut-down in (storage) Iysosomes. This suggests that these
enzymes have properties that allow them to be regulated
within the endolysosomal system.
Thus quite apart from being efficient hydrolases, these enzymes
appear to fulfil a number of requirements that allow them to
operate within the endolysosomal environment. Of these ad-
ditional requirements, the ability to be regulated, without the
need for intra-endolysosomal inhibitors, may be amongst the
most significant.
Cathepsin D is an aspartic endoprotease found within the
endolysosomal system. Unlike its cysteine protease counter-
parts, this enzyme is capable of operating at very acidic pHs.
Thus cathepsin D could effect proteolysis at pH values where
the cysteine proteases may be inactivated by protonation of the
active-site thio1.
LAMPs
LAMPs are the major protein constituents oflate endolysosomal
membranes, which is consistent with a putative role in protecting
these membranes from hydrolysis and thus preventing leakage of
the hydrolases into the cytoplasm. The phagosome, AVd, late
endosome and lysosome are all enriched in LAMP proteins.
LAMPs are ubiquitously distributed throughout mammalian
cells, and make up as much as 50 % of the total protein found on
'lysosomal' membranes. LAMP-l and LAMP-2 are evolu-
tionarily related: both are type-I membrane proteins, with a
short cytoplasmic tail, a transmembrane region and a large
luminal domain. The short (1Q-II residues) cytoplasmic tail
contains targeting information directing the LAMPs to the late
endosome/lysosome (reviewed in Peters and von Figura [84]).
Proteolytic processing of this tail probably ensures that the
protein is retained by these organelles [85]. Although LAMPs
and MPRs are directed to the same organelles, they use different
targeting machinery [86].
The large luminal domain of the LAMPs has a high carbo-
hydrate content with 16-20 N-Iinked glycosylation sites, as well
as a-linked glycosylation sites. The luminal domain of these
proteins also has a proline-rich hinge region and four contiguous
diSUlphide bridges [84]. The high sialic acid content of their car-
bohydrate moieties contributes to their low pI, which may be of
functional significance. LAMPs may participate in aggregation
of the soluble lysosomal contents [87]. This could be due to the
low pI of the LAMPs, allowing these proteins to behave as cation
exchangers. This putative regulatory mechanism will be discussed
in greater detail below. When expressed on the cell surface,
LAMPs may also play a role in cell adhesion processes [88].
LAMP-I- [89] and LAMP-2-deficient [90] mice have been
generated recently. The LAMP-I-deficient mice were viable and
fertile, and had lysosomes with properties similar to control
Iysosomes. The loss of LAMP-l appeared to be compensated for
by increased expression of LAMP-2 [89]. LAMP-2 mutants, on
the other hand, showed increased mortality compared with con-
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trol mice and showed extensive accumulation of AVis. These
results su'ggest that LAMP-2 is necessary for maturation of the
AVi to the AVd [90]. The LAMP-l and LAMP-2 double mutation
is lethal [89].
Cysteine transporter
The primary function of endolysosomal proteolysis is to degrade
macromolecules for recycling into anabolic reactions. Egress of
the products of proteolysis from this sealed environment is
largely undertaken by transporters, which have been described
for carbohydrate monomers, nucleosides, amino acids and ions
(reviewed in Pisoni and Thoene [91]). Two of the transporters
that could be involved in regulating the redox potential of the
endolysosomal environment are the cystine- and cysteine-specific
transporters, and the possible role of these in supporting lysoso-
mal proteolysis will be the focus here.
Disulphide bridges are important in the structural stability of
proteins, and reduction of these in the endolysosomal environ-
ment may increase the rate of proteolysis. Cysteine is believed to
be the physiological reducing agent involved [91]. However,
reduction of disulphide bridges by cysteine results in the gener-
ation ofcystine [92], which is poorly soluble and crystallizes unless
it is removed from the' lysosome'. This occurs in the disease,
cystinosis, due to a defect in the cystine transporter [91]. The
properties of the cystine transporter have been evaluated in vitro
using counter-transport and trans-stimulation studies, although
such studies are complicated by the heterogeneity of' lysosomal'
preparations.
In contrast with other' lysosomal' transporters, the cysteine-
transporter produces a net influx of cysteine into 'Iysosomes'.
When human fibroblasts were incubated with [35S]cystine, at
least 50--60 % of the total radioactivity taken up by the cells was
found to be associated with' Iysosomes' in the form of cysteine
[93]. This uptake occurred rapidly (2-5 min) and the transporter
was found to be highly specific. Transport into the' lysosome' was
stimulated when the pH outside was greater than the luminal
pH [94]. Cysteine-transport activity has also been described in
lysosomal fractions from macrophage and B-celllymphoma cell
lines [95]. In the B-cell lymphoma cell line, cysteine transport
activity was also detected in antigen processing compartments
[95], suggesting that reduction may be a feature of antigen
processing.
The' lysosomal' cysteine transporter, similar to most endolyso-
somal transporters, has not been isolated and therefore its
intracellular location has not been directly established. However,
there is evidence that disulphide reduction occurs in the late
endosome compartments, rather than in early endosomes [96,97J,
suggesting that the cysteine transporter may not be present in
early endosomes.
The presence of the cysteine transporter can be interpreted as
evidence of reducing conditions within the endolysosomal en-
vironment. Indeed, the proteolytic environment may be reducing,
but the situation is not as simple as often presented. That
reduction does occur is evident from studies on toxins, such as
diphtheria toxin, which requires reducing conditions to be active
[98,99J. Reduction also appears to be an essential component of
antigen processing (see, for example, Collins et a1. [97J and
Merkel et a1. [100]). Presentation of the insulin A chain requires
that the cysteine residues are in the thiolate form [lOIJ. Fur-
thermore, Gainey et a1. [95J demonstrated that presentation of
antigens with disulphide bonds requires compartments capable
of cysteine transport. The effect may also be a general one, i.e.
that reducing conditions enhance substrate proteolysis, which is
not limited to antigen processing.
Reducing conditions may affect both proteases and their
substrates. It is often assumed that a reducing environment IS
necessary for the activity of the lysosomal cysteine proteases.
However, although isolated cysteine proteases do reqUIre re-
ducing agents in order to be active, there is no evidence that these
enzymes are oxidized in vivo [102-104]. Oxidation may, therefore,
be an isolation artefact. In the reduced activated form, the
isolated enzymes are more stable to neutral pH conditions [25].
As will be described below, the late endolysosomal environment
may not always be acidic and may cycle in neutral or even
alkaline conditions. A reducing environment may serve to
stabilize these proteases during the purported pH changes.
Reducing conditions would also affect the substrate proteins.
It was found that substrates with disulphide links are cleaved
with greater efficiency by lysosomal proteases in the presence of
a reducing agent [105,106]. Reducing agents are believed to work
synergistically with the proteases by reducing the disulphide
links, relaxing the substrate structure and exposing more sites for
proteolysis. Thus a reducing endolysosomal environment does
seem to confer several advantages for proteolysis. However,
Lloyd [92] has pointed out that the stoichiometry of the reduction
reaction does not necessitate the continuous influx of cysteine
and has suggested that the cysteine transporter may simply serve
an anaplerotic function, replenishing cysteine lost to auto-
oxidation. It must also be questioned how endolysosomal pro-
teins containing essential disulphide bridges (e.g. cathepsins and
LAMPs) are protected against reduction.
A further question is the effect of (low) pH on the reduction
potential within the endolysosomal system. Feener et al. [96]
constructed a probe comprising [125I]iodotyramine linked to
poly(D-lysine) by a 3-(propionyldithio)-propionic acid spacer
([125I]tyn-SS-PDL), which was acid stable and resistant to pro-
teolysis, but sensitive to reduction. This probe was found to be
inefficiently reduced within the endolysosomal system, which
suggested that the Golgi/trans-Golgi may be the main site of
reduction [96]. In experiments in vitro, the probe was inef-
ficiently reduced by cysteine (5 mM) at low pH [96]. A basis for
this result may be found by considering the effect ofpH on reduc-
tion potential. At fixed cysteine/cystine concentrations, redox
potential is inversely proportional to pH, so the reduction poten-
tial will be more oxidizing at lower pH. Low pH conditions
within the endolysosomal system may thus generate a relatively
oxidizing environment.
How may this evidence for and against a reducing endolysoso-
mal proteolytic environment be reconciled? The extremely rapid
sequestration of cysteine by 'Iysosomes' [93], we believe, is
inconsistent with a purely anaplerotic function for the cysteine
transporter, as suggested by Lloyd [92]. Moreover, the experi-
ments describing the synergistic effects of cysteine on proteolysis
were all undertaken at acidic pH [105,106], suggesting that
reduction is not precluded by low pH. To keep the reduction
potential more or less constant, however, at low pH, a higher con-
centration of cysteine and/or a lower concentration of cystine is
required. Perhaps the function of the cysteine and cystine trans-
porters is thus to maintain the redox potential within limits by
ensuring an influx of the thiol and efflux of the disulphide.
The cytosolic redox buffer is glutathione and cytosolic GSH/
GSSG ratios range from 30: I to 100: I, which corresponds to a
redox potential of about -221 mV to -236 mV [107]. Protein
disulphide bridges are largely formed in the ER secretory pathway
by the enzymes Erolp (in yeast) and enzymes of the protein
disulphide isomerase (PDI) family [108]. The redox buffer in the
ER/Golgi secretory pathway may also be glutathione, but here
it is more oxidizing than the cytosol, with a GSH/GSSG ratio of
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Scheme 2 Reduction of substrate proteins in the endolysosomal system
It is hypothesized that greater specificity and elficiency of reduction of substrate proteins may
be effected by the interposition of GILT-type enzymes between cysteine and the substrate
protein. Ox., oxidized; Red., reduced.
[107]. This is in agreement with the optimum GSH/GSSG ratio
for the activity of PDI in vitro. However, Pdilp (the yeast
analogue of PDI) occurs largely in the disulphide form in vivo,
and Frand et al. [108] have argued that this balance point is due
to efficient oxidation by Ero1p and relatively inefficient reduction
by GSH. In the disulphide form, PDI-type enzymes can act as
oxidases, transferring disulphides directly to oxidizable proteins.
An essentially opposite situation may occur in the endolyso-
somal system where efficient hydrolysis requires the reduction of
protein disulphide bridges. Here the reducing agent is thought to
be cysteine, but the cysteine/cystine concentration and ratio is
unknown. Nevertheless, modelling of the Nernst equation reveals
that to achieve a redox potential of -160 mV to -170 mV (i.e.
the same as in the ER) at pH 5.0 with a cysteine/cystine redox
buffer (at I mM total half-cystine), a cysteine/cystine ratio of
about 180: 1 to 200: 1 is required, and to achieve - 221 mV to
- 236 mV (i.e. the same as in the cytosol) requires ratios of 500:
I to 600: I. This could provide a reason for the existence of the
cysteine transporter.
A lysosomal reductase, y-interferon-inducible lysosomal thiol
reductase (GILT), has been described [109], which is optimally
active at acidic pH, is activated by cysteine (and not by
glutathione) and is capable of reducing protein disulphides.
Although details are unknown, it is possible that reduction of
protein disulphides may occur in a manner such as shown in
Scheme 2. The proposed interposition of GILT between cysteine
and oxidized proteins (Scheme 2) is analogous to the interposition
of PDI between oxidants and protein substrates in the ER,
and could play a similar role in introducing greater efficiency and
specificity into the reduction reactions. For example, the fact that
the [125I]tyn-SS-PDL probe of Feener et al. [96] was not reduced
may be because GILT could not recognize this substrate.
Similarly, lysosomal proteases with disulphide links may have
structural features that exclude them as substrates for GILT.
Acidification
An acidic luminal environment is important for the following
functions.
• Receptor-mediated endocytosis and recycling. Receptors, such
as the MPR, require acidic conditions in order to discharge
their ligands and recycle.
• Movement/maturation of organelles. ECV formation requires
a functional V-ATPase [29], which suggests a link between the
movement of substrate along the endolysosomal pathway and
acidification.
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• Activity of membrane transporters. 'Lysosomal' membrane
transporters, such as the cystine transporter [110], have acidic
pH optima that effectively ensures that amino acid transport
is from the lysosome to the cytoplasm [91] .
• Activation of lysosomal hydrolases and proteolysis. Many of
the lysosomal hydrolases are proteolytically processed to their
mature forms under acidic conditions [75], some by auto-
processing. Furthermore, many of these hydrolases have acidic
pH optima and are therefore maximally active under acidic
conditions. An acidic environment may also contribute to
denaturation of substrate proteins, which increases the rates
of proteolysis.
An acidic luminal environment is established by the V-ATPase
and a redox chain [Ill], both of which pump protons into the
lumen. The lysosomal redox chain uses cytoplasmic NADH as
an electron donor in a chain that has oxygen as the final electron
acceptor [111]. The V-ATPase is made up of two multi-subunit
sectors: Vo' an integral membrane sector, and V!, which is
essentially a cytoplasmic sector. The V0 sector is made up of at
leastnine subunits (100, 38,19 and 17 x 6 kDa), and is responsible
for proton translocation. The Vi sector is also made up of at least
nine subunits (73 kDa x 3, 58 kDa x 3, 40, 34 and 33 kDa) and is
responsible for the ATPase activity. The ATP-binding regions
are found on the 73-kDa A-subunits, which show a high degree
of co-operativity in ATP catalysis (reviewed in Futai et al. [112]).
Also found within the A subunit is a conserved region known as
the P-loop. The P-Ioop has a cysteine residue (Cys254), which is
capable of undergoing thiol/disulphide exchange with Cys532,
allowing for redox regulation of the V-ATPase [113]. Disulphide-
bond formation is believed to induce a conformational change,
depressing ATPase activity and inhibiting proton translocation
[113]. This mechanism provides a further link, though of a
different type, between redox potential and pH.
Although the V-ATPase is responsible for translocating pro-
tons into the endolysosomal lumen environment, regulation of
the pH of this environment also depends on other factors.
Continuous influx of protons into an organelle would result in
the generation of a net positive membrane potential that would
inhibit further proton translocation. It is believed that inwardly-
directed CI- ion channels, and perhaps cation channels also, may
help regulate the pH of an organelle (reviewed in Futai et al.
[112]). The CI- channels, in turn, may be regulated by protein
kinase A-dependent phosphorylation [114]. As described above,
the early endosome pH is regulated by an Na+/H+-exchanger that
helps to create an internal positive membrane potential, inhibiting
further proton uptake [14,15]. The 'lysosomal' pH may be
maintained by a Donnan-type equilibrium [116,117]. The number
ofV-ATPase molecules found on an organelle may also influence
the pH of that organelle [115]. Other regulatory features include
reversible dissociation-reassembly of the V-ATPase complex,
changes in the coupling efficiency between ATP hydrolysis and
proton transport and low-molecular-mass activator and inhibitor
proteins (reviewed in [115]).
Given the importance of an acidic environment to the proper
functioning of the endolysosomal system, are all Iysosomes
acidic? Some of the cysteine endoproteases found within the
endolysosomal system are capable of working over a broad pH
range. In fact, cathepsin B has a neutral pH optimum against
synthetic substrates in vitro [25,118-121]. Cathepsin S is also
capable ofoperating at neutral pH [66]. Butor et al. [24] confirmed
the late endolysosomal location of two enzymes, sialic acid-
specific 9-0-acetyl-esterase and glycosyl-N-asparaginase, both of
which have neutral to alkaline pH optima, and demonstrated
further that not all 'Iysosomes' were acidic. They [24] suggested
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that the' lysosomal' pH may cycle between acidic and neutral
pHs, allowing for the optimal activity of the different hydrolases
found within the system. A similar pH cycle may also exist as a
consequence of a late endosome/lysosome traffic cycle.
Luminal Ca2+
The role of cytoplasmic Ca2+ in lysosomal homotypic fusion
[122], lysosome-plasma membrane fusion [37] and phagosome-
lysosome fusion [123,124] has been well documented. However,
the role of luminal Ca2+ in regulating proteolysis within these
organelles has not been as extensively studied. To the best of our
knowledge, the role of intra-organellar Ca2+ in regulating phago-
some function is unknown. Autophagy, however, appears to
depend on intracellularly sequestered Ca2+ [125], although the
identity of the organelle(s) involved is not known. Lysosomes
have been shown to be an intracellular pool for Ca2+ [126], and
the existence of a lysosomal Ca2+ transporter has been demon-
strated [127]. The Km for this lysosomal Ca2+ transporter is
approx. 5 mM [127], which is significantly higher than the luminal
Ca2+ concentration [128]. This lysosomal Ca2+ transporter may
therefore play a role in Ca2+efflux from Iysosomes, rather than
influx. Calcium sequestration by Iysosomes may be via endo-
cytosis, as the extracellular Ca2+ concentration can be in the
micromolar range [128]. As discussed above, hybrid organelle
formation is dependent on Ca2+ release from the lumen of late
endosomes and Iysosomes to facilitate membrane fusion [36].
Luminal Ca2+may also play a role in lysosome reformation from
the hybrid organelle [36]. The effect of Ca2+ on lysosomal
proteases has not, to the best of our knowledge, been reported.
REGULATION OF ENDOLYSOSOMAL PROTEOLYSIS
Regulation by intra-luminal redox conditions?
A conceivable control mechanism for endolysosomal cysteine
proteinases is via regulation of the redox conditions in the intra-
luminal environment, as discussed above. Both cathepsin Band
cathepsin L are stable in the range pH 4.5--6.5 and require a
reducing environment for activity in vitro [66], which is thought
to be required to maintain the active-site cysteine residue in a
thiol form. However, there is no evidence that these enzymes are
oxidized in vivo. Labelling with the inhibitor benzyloxycarbonyl-
[1251]iodo_Tyr-Ala-diazomethane (Z_[1251]_Tyr-Ala-CHN2) of
cathepsin B in isolated mouse liver Iysosomes did not increase
with the addition of dithiothreitol or cysteine [102]. These two
reducing agents also did not enhance the activity of cathepsin B
in extracts from lung carcinomas and lungs [103,104]. This
suggests that redox regulation of the active-site thiol may not
occur in the endolysosoma1 proteolytic environment. Further-
more, it also suggests that these enzymes may not necessarily
become oxidized upon their secretion into the extracellular
environment.
Although the active site thiols of these enzymes may not be
oxidized, it is possible that their ionization state may be altered.
At very low pH, the activity of the cathepsins is depressed. This
may be related to a pH-dependent change in the ionization state
from a thiolate (RS-) to a thiol (RSH) form. However, at low pH
cathepsin D would be active (Table 2).
A study by Krepela et al. [104] suggested that cathepsin B may
be inhibited by low concentrations of the thiol (RSH) form of
cysteine, which acts as a competitive inhibitor. The inhibitory
effect of the thiol form of cysteine could be reversed by increasing
concentrations of the thio1ate (RS-) form, and was less prevalent
at higher pH. These authors [104] suggested that cysteine may
bind into the SI' subsite of the enzyme, inhibiting its function.
This subsite varies between the different cathepsins [66] and may
not be a general regulatory mechanism for all the enzymes.
However, since cathepsin B is the most prevalent endoprotease,
regulating its function may significantly affect proteolysis within
the endolysosomal system.
A study of the effects of changes in redox potential on the
activity of (lOO % active) cathepsin B, showed that the redox
potential itself had very little effect on the activity (c. S. Pillay
and C. Dennison, unpublished work). It is concluded that,
although the endolysosomallumen may be reducing, changes in
cysteine/cystine-induced redox potentials are probably not in-
volved in regulating endolysosomal proteases. Moreover, an
expectation of any regulatory mechanism is that it should include
all hydrolases within the system, and other endolysosomal
hydrolases, e.g. a-glucosidase, have no cysteine residues that
could be affected by redox changes.
Unfortunately, the cysteine transporter has not been isolated
and its intracellular location, e.g. lysosomes versus late endo-
somes, and whether it is present in autophagic vacuoles, have not
been determined. Thus, at this stage, it is not possible to unequi-
vocally state that reducing conditions are, or are not, a necessary
attribute of a proteolytic compartment.
Regulation by pH
Regulation by pH changes, in contrast with redox changes, could
simultaneously influence many enzyme classes. Factors that
could regulate the luminal pH include: the redox state of the
cysteine on the P-loop of the V-ATPase, the presence of active
Cl- transporters on the organelle, a Donnan-type equilibrium,
the number of V-ATPases found on that organelle, factors that
influence the reversible dissociation/reassembly of the V-ATPase
complex, changes in the coupling efficiency between ATP-
hydrolysis proton transport and low-molecular-mass activator
and inhibitor proteins [112,115], and possibly also a membrane
redox chain [111]. What is not clear is how these factors work
together to establish the lumen pH. As described above the
lumen pH may be dynamic. Within the early endosome, pH
appears to regulated by G-proteins (reviewed in Warnock [41]),
which respond to transporter entry into the early endosome.
Also, Na+/K+ exchangers help modulate this environment. The
(relatively high) pH within this environment allows cathepsin H
to function optimally.
Acidification could also contribute to the storage of endolyso-
somal enzymes by complexation. Kostoulas et al. [129] found
that elastase and other enzymes within theazurophil granules of
human neutrophils bound to sulphonated glycosaminoglycans
by electrostatic interactions at low pH. It was proposed that this
may be a storage mechanism for these enzymes. Pryor et al. [36]
suggested that lysosome condensation may be similar to secretory
granule formation. A feature of secretory granules is that they
contain condensed cores of aggregated proteins, a morphology
similar to that of lysosomes [11]. Using bovine pituitary gland
cells, it was demonstrated that the granule content proteins and
the luminal domains of granule membrane proteins could ag-
gregate at low pH (pH < 5.5) [130]. A similar result [130] was
obtained for bovine adrenal glands, although aggregation
depended on the presence of Ca2+. Proteins destined for consti-
tutive secretion did not aggregate with the granule content and
luminal membrane proteins, and this property may serve as a
segregation mechanism for those proteins to be stored and those
that are constitutively secreted [130].
The aggregation of lysosomal enzymes at pH 4.8 in Chinese-
hamster ovary (CH0) cells has been described [131]. This
aggregation was disrupted by NaCl, suggesting an electrostatic
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mechanism. Horseradish peroxidase that had been chased into
the CHO cells failed to aggregate with the lysosomal enzymes,
suggesting that aggregation was specific. Jadot et al. [87] showed
that rat liver lysosomal enzymes aggregated at low pH. This
aggregation occurred between pH 4.5 and 5.0, and was mediated
by the integral membrane protein LAMP-2. Under these low pH
conditions, lysosomal enzymes bind by electrostatic interactions
to the LAMP-2 proteins, immobilizing them in a matrix. This
process was specific for the 11 lysosomal hydrolases assayed
during the experiment; a cytosolic extract and BSA failed to
aggregate with LAMP-2 under the conditions tested. Unlike
the aggregation observed in CHO cells [131], detergents affected
aggregation of the rat liver lysosomal enzymes, suggesting that
membrane association with LAMP-2 was vital for aggregation.
Lysosomal condensation from the hybrid lysosome-late endo-
some organelle was shown to be dependent on intra-organellar
Ca2+ and a functional V-ATPase [36]. If this process involved
aggregation of the lysosomal hydrolases, it would be analogous
to the pH- and Ca2+-dependent aggregation found in bovine
adrenal granules [130]. Furthermore, if this process involved
LAMP-2 it may specifically aggregate the lysosomal luminal
proteins [87], allowing lysosome condensation without con-
taminating proteins.
A pH-dependent aggregation mechanism could operate to
withdraw lysosomal hydrolases out of the late endosome, and/or
it could be a feature of the lysosome itself. An advantage of this
complexation mechanism, as opposed to a purported redox-
dependent storage mechanism, is that it could encompass several
different types of lysosomal hydrolases [87]. Furthermore, as
described by Griffiths [11], lysosomes viewed by electron mi-
croscopy appear to be small highly dense organelles, a mor-
phology that could be explained by aggregation of their luminal
hydrolases.
The concept of lysosomal enzymes aggregating by electrostatic
interactions is a fairly old one (see, for example, Henning et al.
[132]). However, the acceptance of this as a mechanism for
regulating and storing lysosomal hydrolases has been limited.
This may be because erroneously low pH optima were assigned
to some hydrolases (see Dehrmann et al. [133]), which by chance
co-incided with the low pH of lysosomes where the bulk of
substrate hydrolysis was thought to occur. Subsequently, it has
been found that most proteolysis occurs in late endosomes,
which have a pH closer to the revised pH optima of lysosomal
proteases. The hypothesis that lysosomal hydrolases may be
stored by low pH-induced aggregation does not exclude the
possibility that late endosomes may fluctuate between alkaline
and acidic pH values, allowing for the activation of different
hydrolases with individual pH optima [24]. The lysosome with its
lower pH may complex the lysosomal hydrolases, effectively
storing them in a precipitated matrix.
This proposed regulatory mechanism could itself be regulated
by the factors discussed above that influence V-ATPase activity,
i.e. the activity of the lysosomal proteases may be influenced by
factors that influence the V-ATPase activity.
CONCLUSIONS AND FUTURE PERSPECTIVES
Complicating the whole field of endolysosomal proteolysis is
the lack of a consistent nomenclature, especially concerning the
definition of the 'lysosome'. To many authors a 'lysosome' is
any organelle containing 'lysosomal' hydrolases. However, we
believe that this simple definition has outlived its usefulness and
that it may be more usefully replaced by a functional definition,
e.g. that lysosomes are organelles mainly for the storage of
'lysosomal' hydrolases (probably in an inactivated state, due to
© 2002 Biochemical Society
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acid-induced complexation or simply lack of substrate). To
become functional, 'lysosomal' hydrolases must be injected into
an endosome, phagosome or autophagosome, which are the
organelles within which hydrolysis largely occurs. This concept
of a lysosome is not too different from the original concept of a
'primary lysosome' [23].
Another modern functional definition of a lysosome is that it
is 'the terminal organelle in the endolysosomal pathway and is
devoid of recycling receptors' [11]. In the early definition of a
'primary lysosome', this was envisioned as being a vesicle
containing newly synthesised enzymes, which budded off the
Golgi apparatus [23]. Griffiths [11] has noted that lysosomes are
indeed vesicle-sized, so in microscopy studies they may easily be
confused with' lysosomal'-enzyme-carrier vesicles, which have a
similar cargo. Unlike carrier vesicles, however, lysosomes are
MPR negative.
Many hydrolytic organelles (secondary lysosomes) may be
assembled de novo when required and this gives an opportunity
to determine a minimal requirement for hydrolysis. A common
theme applicable to the endolysosomal system, phagosomes and
autophagosomes is that enzymes are imported by fusion with
lysosomes, acidification is effected by importation ofa V-ATPase
and egress of products is effected by importation of membrane
transporters. Some pathogens exploit the endolysosomal system
and escape hydrolysis by blocking the assembly of a complete
functional hydrolytic compartment. Of the proposed common
factors required to generate a proteolytic luminal environment
(Table 1), the least is known about the lysosomal cysteine
transporter. Future studies could be directed at determining the
location of this transporter within the endolysosomal system,
and the role(s) it plays in proteolysis, especially in processes such
as phagocytosis and autophagy.
Is endolysosomal proteolysis subject to flux control? With
feedback regulation, the downstream rate of proteolysis [Scheme
1, steps (iii) and (iv)] would affect upstream rates of substrate
acquisition. Observations by Kominami et al. [134] of the large
accumulation of hepatic autophagic vacuoles containing undi-
gested material, after treatment of rats with leupeptin in vivo,
suggests that there may be no feedback regulation. A second
possibility is that proteolysis within the endolysosomal system is
sufficiently efficient, and that regardless of the amount of
substrate channelled to the proteases, the system could cope.
Retention of reserves of temporarily unneeded hydrolases, by
storage in Iysosomes, would give the system greater elasticity and
the ability to respond quickly to changes in demand. In this case,
regulation of flux would best be effected in the initial stages of the
process, such as substrate acquisition [Scheme I, steps (i) and
(ii)].
It has become apparent that regulation of endocytosis, as an
example, is effected by complex signalling networks [1-9]. These
signalling networks exert their influence through molecules that
interface between the signalling and endocytic pathways. Future
research efforts could be directed at attempting to unite the
signalling networks, the regulation of endolysosomal fusion
reactions and the components that affect the endolysosomal
luminal proteolytic environment into an integrated model for
proteolysis. Some progress has been made in this regard. Re-
cently, it has been shown that p38 mitogen-activated protein
kinase may accelerate the rate of endocytosis in response to
oxidative stress [135], providing a direct link between the
endocytic rate and the signalling pathways. It has also been
shown that the E subunit of the V-ATPase may interact with the
Dbl-homology domain of murine Sosl, a guanine nucleotide
exchange factor involved in Racl activation [136]. Rac I ac-
tivatIOn regulates various trafficking events, such as transferrin
© 2002 Biochemical Society
receptor-mediated clathrin-coated-vesicle formation [137]. Al-
though in this case, the E subunit affected the mSosl-Racl
signalling pathway [136], it does indicate that there are domains
on the V-ATPase capable of interacting with signalling pathways.
The activity of CI- channels that influence luminal pH, is
regulated by protein kinase A-dependent phosphorylation [114].
Thus, it is possible that acidification of endolysosomal organelles
may be connected to these signalling pathways. Regulation of
conditions within endolysosomal organelles, and in turn the
activity of the proteases, may therefore be integrated via sig-
nalling networks to endocytosis and changes occurring at the
cellular level. In turn, the cell is regulated by the tissue and,
ultimately, by the whole-body system. Endolysosomal hydrolases
are thus envisioned to be the downstream effectors ofa hydrolytic
system, which is ultimately regulated at the whole-body level.
We thank Or Gareth Griffiths (EMBL, Heidelberg, Germany) for a critical reading of
the draft manuscript and for many helpful suggestions.
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In order to test the hypothesis that the lysosomal cys-
teine protease cathepsin B may be redox regulated
in vivo, cathepsin B activity and stability were meas-
ured in cysteine- and/or cystine-containing buffers.
Cathepsin B activity in cysteine-containing buffers
was similar at pH 6.0 and pH 7.0, over all thiol con-
centrations tested. In contrast, the stability of the en-
zyme was greater at pH 6.0 than at pH 7.0. This sug-
gests that the enzyme's operational pH in vivo may be
< pH 7.0. The activity of the enzyme was depressed in
glutathione-containing buffers. When assessed in
cysteine:cystine redox buffers (pH 6.0 - 7.0) cathep-
sin B was active over a broad redox potential range,
suggesting that cathepsin B activity may not be redox
regulated. However, at pH 7.0, the stability of cathep-
sin B decreased with increasing reduction potential
and ambient cystine concentration. This suggests
that the stability of the enzyme at neutral pH is de-
pendent on redox potential, and on the presence of
oxidising agents.
Key words: Cathepsin / Endosomes / Lysosomes /
Proteolysis / Redox potential.
Introduction
The late endolysosomal system is a dynamic environ-
ment for proteolysis. The pH within late endocytic or-
ganelles may fluctuate between neutral and acidic pHs
(Butor et al., 1995). Since redox is affected by pH (Segal,
1976), the redox environment may be expected to be
similarly dynamic. The redox conditions within the en-
dolysosomal system have, however, not been defined
though the luminal environment is believed to be reduc-
ing. Reducing conditions would facilitate breakage of
disulfide links in substrate proteins, loosening their struc-
ture, and increasing rates of proteolysis (Kooistra et al.,
1982). It was also speculated that reducing conditions
might activate cysteine proteases like cathepsin B. How-
ever, it is now known that lysosomal cysteine proteases
are active in vivo and do not require reduction in order to
be active (Wilcox and Mason, 1992; Krepela et al., 1997).
Nevertheless, reducing conditions may stabilise these
enzymes at neutral pH (Dehrmann et al., 1996).
Reducing redox conditions within the late endolysoso-
mal system are generated by an inwardly directed cys-
teine transporter (Pisoni et al., 1990). Within the lumen of
these organelles cysteine would act on the disulfide links
of the substrate, liberating cystine. Cystine, which may
also be generated by auto-oxidation, is exported via a
cystine-specific transporter. A defect in this transporter
leads to the disease cystinosis (Jonas et al., 1982; Pisoni
and Thoene, 1991).
A report by Krepela et al. (1999) suggested that
cathepsin B activity may be regulated by the cysteine thi-
01. Thus, the activity and stability of cathepsin B may be
affected by redox conditions, making these conditions
potential regulators of the enzyme within the endolysoso-
mal system. Cathepsin B has also been implicated in a
number of diseases (Van et al., 1998), and in apoptosis
(Guicciardi et al., 2000; Foghsgaard et aI., 2001), where
the enzyme is operating in redox environments outside
of, and thus different from, the endolysosomal system. In
this study, the effect of redox conditions on the activity
and stability of cathepsin B were explored, with a view to
determine whether the enzyme may be redox regUlated in
vivo.
Results
The Effect of pH and Thiol Concentrations on
Cathepsin B Activity
The effect of thiol concentration (provided by cysteine or
glutathione) and pH on cathepsin B activity against Cbz-
R-R-AMC was explored using Acetate-MES-Tris (AMT)
buffers of constant ionic strength (Ellis and Morrison,
1982), with varying concentrations of thiol. In contrast to
other reports (see for example Khouri et al., 1991; Has-
nain et al., 1992; Moin et al., 1992; Dehrmann et al.,
1996), the activity of cathepsin B at pH 6.0 and pH 7.0,
over all thiol concentrations, was similar and was greater
than at pH 5.0 (Figure 1). Despite glutathione (GSH) hav-
ing a lower standard reduction potential than cysteine
(Segal, 1976), a GSH-containing buffer of pH 7.0 gave
significantly lower enzyme activity over the range of thiol
concentrations tested, compared to cysteine-containing
AMT buffers at pH 7.0 (Figure 1).
The effect of cysteine on the half-life of cathepsin B at
pH 6.0 and 7.0 is shown in Figure 2 (the enzyme was too
stable at pH 5 for a half-life to be measured). In contrast
to the activity (Figure 1), the half-life was significantly
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longer at pH 6.0 than at pH 7.0. The stability of cathep-
sin B at pH 7.0 in the absence of thiol (AMT redox buffer,
pH 7.0, no cysteine) was significantly lower than in the
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Most assays of cysteine protease activity do not include
cystine. However, adding cystine to the buffers enabled
calculation of reduction potentials using the Nernst equa-
tion.
At pH 6.0, starting in a buffer without cysteine, cathep-
sin B activity increased with decreasing reduction poten-
tial, until approximately -80 mV, and thereafter was in-
sensitive to changes in reduction potential (Figure 3A).
The Effect of Cystine on Cathepsin B Activity and
Stability
Redox Potential (V)
cysteine) (data not shown). It appears that cysteine alone
increases the stability of cathepsin B at pH 7.0. In con-
trast, at pH 6.0 cysteine apparently has little effect, as the
enzyme was as stable with or without cysteine (Figure 2).
Krepela et al. (1999) reported that with increases in
cysteine concentration, cathepsin B showed a local min-
imum in activity. These authors believed that this effect
was due to cysteine thiol inhibition of the enzyme. Our
data also shows this effect over all pHs tested, and with
GSH-containing buffers (Figure 1) as well. Furthermore,
our results describing the effect of cysteine on cathep-
sin B stability (Figure 2) also showed local minima with in-
creases in thiol concentration. These minima corre-
sponded to the minima in the activity data (Figure 1), sug-
gesting a common mechanism that affects both stability
and activity.
Fig. 3 The Effect of Redox Potential and Cystine Concentra-
tion on Cathepsin B Activity at pH 6 (A) and pH 7 (8).
Cathepsin B activity against Cbz-R-R-AMC was assessed with
various concentrations of cysteine (0-20 mM) in AMT redox
buffers containing cystine at concentrations of 0.2 mM (e) or 0.8
mM (.), respectively. The redox potential of each of the buffers
was calculated using the Nernstequation. The data points at
omV represent an AMT redox buffer with cystine (0.2-0.8 mM),
but no cysteine. The reactions were monitored continuously at





























Fig. 1 The Effect of Thiol Concentration on Cathepsin B Activ-
ity.
The effect of thiol concentration on cathepsin B activity against
Cbz-R-R-AMC was monitored in AMT redox buffers containing
cysteine at pH 7 (.), pH 6 (e), pH 5 (A), and in GSH-containing
buffers at pH 7 (+). The reactions were monitored continuously
at 3JOC, and the data represent mean values ± standard devia-













Fig. 2 The Effect of Thiol Concentration on Cathepsin B Stabil-
ity.
The effect of thiol concentration on cathepsin B stability was
monitored in cysteine-containing AMT redox buffers at pH 7 (.)
and pH 6 (e). The reactions were monitored continuously at
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Reduction Potential (V)
Fig. 4 The Effect of Redox Potential and Cystine Concentra-
tion on Cathepsin B Stability at pH 7.
Cathepsin B stability against Cbz-R-R-AMC was assessed in
AMT redox buffers containing various concentrations of cys-
teine (0-20 mM), and 0.2 mM cystine (e) or 0.8 mM cystine (.).
The redox potential of each of the buffers was calculated using
the Nernst equation. The data points at 0 mV represent an AMT
redox buffer with cystine (0.2 - 0.8 mM), but no cysteine. The
data are given as mean ± SO of at least 2 independent determi-
nations.
This suggests that at pH 6.0, cathepsin B is capable of
operating over a broad cysteine/cystine generated redox
potential range of -80 mV to -350 mV. Similarly, at
pH 7.0, the concentration of cystine does not appear to
have a significant effect on the activity of cathepsin B
(Figure 3B).
As described in the Materials and Methods section,
assays were of limited duration to prevent oxidation of re-
dox buffers. The inherent stability of cathepsin B at pH
6.0 made it difficult to assess the effect of cystine on sta-
bility at this pH. At pH 7.0, on the other hand, cystine had
a marked effect on the stability of cathepsin B. Between
buffers with no cysteine and those with reduction poten-
tials of - 250 mV, a linear relationship between stability
and reduction potential was found (Figure 4), with en-
zyme stability increasing with decreasing redox potential
(i.e. increasing concentrations of cysteine). For a given
redox potential, stability was reduced in buffers contain-
ing 0.8 mM cystine compared to buffers with 0.2 mM cys-
tine. This effect appeared to be dose-dependent with
higher stability in buffers with no cystine, followed by
buffers with 0.2 mM cystine, and then buffers with 0.8 mM
cystine (not shown). However, below - 250 mV, with de-
creasing redox potential (i.e. increasing cysteine concen-
tration), the effect of cystine was ameliorated (Figure 4).
These results are consistent with cathepsin B undergoing
cystine-dependenf oxidation, resulting in decreased sta-
bility (Figure 4), but in a manner that apparently did not af-
fect the enzyme's activity (Figure 3B).
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Discussion
Based on previous work in our laboratory and others, the
activity and stability properties of cathepsin B appeared
to be disparate. Activity appeared to have a neutral to
slightly basic pH optimum, and yet the enzyme was most
stable at a more acidic pH. In our assays, however, the
activity of cathepsin B was similar at pH 6.0 and pH 7.0.
This may be due to differences in the assay and cathep-
sin B isolation procedures used in these experiments.
Isolated cathepsin B is usually not made up of fully active
enzyme. Furthermore, the enzyme may be oxidised, and
has to be reduced to restore activity. In our assays
cathepsin B was affinity purified, and the enzyme was
pre-activated before being used in the respective (pH)
test buffer. In previous experiments, less than 100% ac-
tive enzyme may have been used and/or the enzyme was
activated in the test buffers themselves. In these cases,
differences in activity at different pHs may reflect the de-
gree of reduction at the different pHs. Since reduction
occurs more efficiently with increasing pH, the degree of
reductive activation, and hence activity, would be ex-
pected to be greater at pH 7.0 than at pH 6.0 for a given
concentration of thio!. For this reason, perhaps, cathep-
sin B appeared to have a neutral pH optimum.
In contrast to the activity of the enzyme, the stability of
cathepsin B was significantly greater at pH 6.0 than at pH
7.0. This suggests that the enzyme would be capable of
operating at maximal activity at pH 6.0, without the loss
of stability that occurs at higher pH. Thus, in vivo, we be-
lieve that it is likely that cathepsin B generally operates at
acidic, and not neutral, pHs. The enzyme showed local
minima in activity in cysteine (pH 5.0 - 7.0) and GSH-con-
taining buffers, as well as for stability in cysteine-contain-
ing buffers (pH 6.0 and 7.0). We believe that a common
mechanism is responsible for these minima, and that
cysteine-thiol inhibition of the enzyme (Krepela et al.,
1999) does not adequately explain this phenomenon.
GSH is the principal cytosolic reducing agent, with
concentrations ranging from 0.1 -10 mM (Alien, 1991;
Meister, 1995). It appears that the activity of cathepsin B
is depressed in GSH-containing buffers, compared to
cysteine-containing buffers at pH 7.0. The high cytosolic
GSH concentration may thus restrain cathepsin B activi-
ty in the cytoplasm. This may provide an additional de-
fence, should cathepsins leak from 'Iysosomes' (Brunk
et al., 1995).
The effect of cysteine:cystine redox buffers on cathep-
sin B activity was assessed at pH 6.0 and pH 7.0. In these
experiments, it was found that the enzyme activity did not
change over a broad redox potential range of - 80 mV to
-350 mV, i.e. from relatively oxidising conditions to rela-
tively highly reducing conditions. The endoplasmic retic-
ulum, for example, is considered to be a relatively oxidis-
ing environment, and has an estimated redox potential
between -170 and -185 mV (Hwang et al., 1992). In our
experiments, cathepsin B was also assayed under rela-
tively highly-reducing conditions « - 250 mV), and the
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enzyme activity was not affected. Thus, our data indi-
cates that cathepsin B activity is similar in both relatively
oxidising and reducing environments. These results sug-
gest that the activity of cathepsin B is probably not redox
regulated in vivo.
The stability of cathepsin B was also measured under
varying redox conditions. At pH 6.0, the enzyme was es-
sentially stable to all redox conditions tested within the
limits of these assays. At pH 7.0, however, it was found
that the stability was linearly related to redox potential up
to - 250 mV (Figure 4). The absolute concentration of cys-
tine affected stability, with higher concentrations of cys-
tine depressing stability at a given redox potential. The
negative effect of cystine and oxidising redox conditions
on the stability of the enzyme at pH 7.0 could occur
through two possible mechanisms. First, cystine and ox-
idising redox conditions may accelerate the pH-depend-
ent denaturation of the enzyme. Alternatively, cystine-de-
pendent oxidative denaturation of the enzyme may occur
more efficiently at pH 7.0 than at pH 6.0, as thiol-disulfide
exchange occurs more efficiently at higher pH. These two
mechanisms are not mutually exclusive. Thus, despite
cathepsin B activity showing no sensitivity to redox po-
tential at pH 7.0, the stability of the enzyme may be af-
fected by redox potential and the ambient concentration
of cystine.
In conclusion, our experiments indicate that cathep-
sin B activity may not be redox regulated. In fact, and in
contrast to our initial hypothesis, the enzyme is capable
of operating over a broad redox potential. As the en-
dolysosomal redox environment may be highly dynamic,
it appears that cathepsin B may be well-suited to the sys-
tem. Could cathepsin B operate in extra-endosomal re-
dox environments, and would it be stable? We believe
that the activity of the enzyme does not preclude it from
operating in redox environments other than the en-
dolysosomal system. However, the pH, and the nature
and ratios of redox agents present within these environ-
ments, may affect the stability of the enzyme.
Materials and Methods
Materials
A Sepharose-Gly-Phe-GlySc affinity matrix for the isolation of
cathepsin B was prepared according to the procedure of Rich
et al. (1986). The Gly-Phe-GlySc ligand was from Bachem
(Bubendorf, Switzerland). The S-Sepharose matrix, L-trans-
epoxy-leucylamido(4-guanidino) butane (E-64), Cbz-R-R-AMC,
cystine, dithiothreitol (DTT), GSH and other common reagents
were from Sigma-Aldrich (Johannesburg, South Africa). Cys-
teine (free base) was from Fluka (Sigma-Aldrich, Johannesburg,
South Africa). Oxygen-free nitrogen was from Afrox Pty Ltd. (Jo-
hannesburg, South Africa). Fresh bovine livers were from Ab-
bakor (Cato Ridge, South Africa).
Isolation of Cathepsin B
Cathepsin B was isolated from bovine liver using the method of
Rich et al. (1986), with the modification to the homogenisation
steps suggested by Dennison et al. (2000). Bovine liver was ho-
mogenised according to Dennison et al. (2000). Three-phase
partitioning (Dennison and Lovrien, 1997) was effected on the
acid supernatant and the resulting precipitate was dissolved in
buffer A (20 mM sodium acetate, 1 mM EDTA, 0.02% NaN3 ,
pH 5.0) and applied to an S-Sepharose cation-exchanger
(2.5 cm x 20 cm). Cathepsin B was eluted using a salt gradient
(0 - 200 mM sodium chloride in buffer A), and dialysed against
buffer B (50 mM sodium phosphate, 1 mM EDTA, pH 6.0) The
dialysate was applied to a Sepharose-Gly-Phe-GlySc affinity
column (1.25 cm x 7 cm) and eluted as described by Rich et al.
(1986). The eluted fractions were electrophoretically pure (silver
stain) and were quantified using the Bradford assay with the
modifications suggested by Read and Northcote (1981). En-
zyme stocks were periodically tested by E-64 titration (Barrett
and Kirschke, 1981) and were typically between 80-100% ac-
tive. In those fractions where a loss of activity was noticed, the
fractions were re-purified by affinity chromatography. It is impor-
tant that the isolated enzyme is maximally active, as judged by
E-64 titration. When cathepsin B is isolated without an active-
site-directed affinity chromatography step, only a fraction (usu-
ally <40%) ofthe isolated enzyme is active, with the balance per-
haps being partially oxidised to a greater or lesser extent. If less
than 100% active enzyme is used, inactivated enzyme mole-
cules may be reactivated by the redox buffers, effectively chang-
ing the concentration of active enzyme. For example, Coetzer
(1992) found that the proportion of active cathepsin L, measured
in an E-64 assay, increased with an increase in Dn concentra-
tion in the assay buffer.
Redox Buffers!Activators
In order to study the responses of cathepsin B to changes in re-
dox potential, buffers need to be completely deoxygenated be-
fore use, as cysteine is sensitive to oxygenation (Mansoor et al.,
1992; Newton and Fahey, 1995) and the redox buffer composi-
tion may change without proper protection against oxygen. As-
says for activity and stability also have to be of limited duration
for the same reason. In our hands, the stability of cathepsin B
decreased significantly when the redox buffers were not deoxy-
genated. Redox potentials were calculated using the Nernst
equation (see for example Hwang et al., 1992).
The Effect of pH and Thiol Concentrations on
Cathepsin B Activity and Stability
Dehrmann et al. (1995, 1996) demonstrated that the activities of
cathepsins Band L are sensitive to the ionic strength of buffers
used to assay the enzyme. Hence, in this study, AMT buffers,
which retain a constant ionic strength over a wide pH range,
were employed (Ellis and Morrison, 1982). AMT buffers were
used at a final concentration in the assay of 100 mM acetate,
100 mM MES, 200 mM Tris, 4 mM N~EDTA. For those buffers
containing cystine, the disulfide was added to the stock AMT
buffers: cystine, which is poorly soluble in aqueous solutions,
was added after the acetate, and before the other reagents. All
buffer solutions were deoxygenated by being boiled, cooled un-
der a stream of oxygen-free nitrogen, and degassed under vac-
uum. An appropriate concentration of reducing agent was
added to accommodate dilution during the assays employed.
Further steps were done under a constant stream of oxygen-free
nitrogen. Using the method of Gaitonde (1967) it was shown that
the thiol concentration within the buffers did not change signifi-
cantly over the time periods employed in these experiments.
Cathepsin B was pre-activated in assay buffer (0.1 Msodium
phosphate, 4 mM EDTA, 2 mM Dn, pH 6) for 10 min, 25°C. The
active enzyme (250 ng, 32 ~I) was added to pre-warmed AMT
buffer (pH 5 - 7, 843 ~I) containing an appropriate concentration
ofthiol (0-20 mm), and Cbz-R-R-AMC (125 ~I, 100 ~M). The re-
action was monitored continuously at 37 QC in a Hitachi F-2000
spectrofluorometer (Advanced Lab Systems, Johannesburg,
South Africa). Experiments to determine the half-life of cathepsin
B under these redox conditions were conducted as described
previously (Dennison et al., 1992; Dehrmann et al., 1995). The
enzyme concentration was adjusted in these experiments to en-
sure that there was a measurable loss in enzyme activity over the
assay periods employed «15 min) (Dennison et al., 1992).
Longer assay times were not used as they resulted in apprecia-
ble oxidation of the redox buffers. The data represents the mean
± standard error of at least 3 independent determinations.
The Effect of Cystine on Cathepsin B Activity and Stability
Cathepsin B was pre-activated in assay buffer as before. The ac-
tivated enzyme (250 ng, 32 ~I) was added to pre-warmed AMT
buffers with or without cystine (0 - 0.8 mM, 843 ~I), containing an
appropriate concentration of thiol (0-20 mM), and Cbz-R-R-
AMC (1 00 ~M, 125 ~I). The reaction was monitored continuously
at 3rC in a Hitachi F-2000 spectrofluorometer. The data repre-
sent the mean ± standard error of at least 3 independent deter-
minations. In order to determine the effect that cystine has on
the stability of cathepsin B, half-life assays were conducted at
pH 7 in AMT buffers with varying concentrations of cystine
(0-0.8 mM) and cysteine (0-20 mM). In these experiments at
least two independent experiments were conducted, from which
the mean and standard errors were calculated.
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